entity,paper_id,relation
joseph ward,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
oluwapelumi adeyemi,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
niall mclean,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
stonehouse a#,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
chris neil,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
tobias tuthill,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
lidia lasecka-dykes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
david kealy,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
morgan herod,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
emma ,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
warner ,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
 gold,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
caroline wright,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
sarah ,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
nicola ,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
david rowlands,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
donald king,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
virus,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
disease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
pseudoknots,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
production,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
rna,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
replication,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
loop,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
importance,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
genome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
function,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
translation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
frame,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
presence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
text,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
authorfunder,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
nucleotide,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
pseudoknots,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
disease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
kb,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
foot,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
ires,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
rna,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
shape,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
deletion,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
abstract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
cis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
replicons,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
pk,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
poly,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
series,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
reading,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
utr,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
signals,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
genomes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
stem,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
entry,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
site,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
contribution,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
hydroxyl,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
mutation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
initiation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
picornaviruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
replication,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
c,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
tandemly,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
acetylation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
permission,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
experiments,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
virus,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
report,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
fmdv,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
extension,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
cre,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
reuse,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
pks,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
domains,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
advantage,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
packaging,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
ribosome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
authorfunder,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pk4,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
primers,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
decrease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
neb,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
fastqc,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ligation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
basic,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
blast,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
error,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
experiments,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
elements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
hindrance,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
vp2,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
features,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
construct,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
truncation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
repeats,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
effects,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pairing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
loops,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
nmia,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
sem,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
construction,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pk1,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
hybridisation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
insertion,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
reporter,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
report,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
kpni,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
reverse,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
reactivity,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
hindiii,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
a5,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
library,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
linearised,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
localisation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
plasmids,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
interaction,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
aatii,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
deletion,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
proteinsb,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
introduction,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
figurea,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
treatment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
copies,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
mutagenesis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
kit,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
fmdv-,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
idba,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
potential,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
s,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
sickle,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
genes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
importance,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
vp4,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
replication,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
containment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
picornaviruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
c,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
stems,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
prep,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
from-4,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
yeast,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
numbers,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
novo,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
absence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
culture,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
levels,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
trna,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
aflii,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
assays,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pks,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
evidence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
spei,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
preprint,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
passaging,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
stem,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
picornavirus,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
genomes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
dnase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
lifecycle,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
t7,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
requirements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
holder,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
passage,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
differences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
series,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
role,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
g,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
addition,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
p2,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
amplification,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
c0,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
httpsdoiorg10110120200110901801,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
recombination,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
competition,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
transcription,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
reactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
shape,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
presence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
lasergene,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
co-467,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
polymerase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
poly,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ud,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
formation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
utr,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
signals,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
hiscribe,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
package,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
requirement,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
rna,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
assembly,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
lines,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
files,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
structure,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pk,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
seqman,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
packaging,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
reads,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
downstream,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
local,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
host,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
copyright,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
disadvantage,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
figureb,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
observation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
kpni-131,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
mengo,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
p3,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
biorxiv,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
synthesis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pcr,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
date,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
bars,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
replicons,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
sub,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
algorithm,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
star,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
removal,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
fmdv-1311,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
vectors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
screen,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
n,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
sequence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
loop,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
vector,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
impact,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
mutations,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
strain,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
search,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
dna,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
data,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
fmdv,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
digestion,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
heterogeneity,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
vp0,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
reduction,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ptgfp,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
software,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
forward,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
upstream,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
cells,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
fastq,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
findings,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
tool,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
protein,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
doi,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
transfection,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
alighnment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
significance,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
tandem,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
wt,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
contigs,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
mapping,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
orientation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
purification,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
vpgc,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
duplication,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
peer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
tissue,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
plasmid,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
advantage,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
aii,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pbluescript,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
similarity,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
fragment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
site,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
reuse,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
function,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
events,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
p,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
controld,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
quality,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
virus,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pro,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
figurec,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
amounts,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
c11,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
hf,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
purelink,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
variation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
gnn,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
isolates,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
plaques,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
permission,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
nhei,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
replicon,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
cycle,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
residues,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
aspects,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
consensus,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
decline,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
authorfunder,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ud,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
polymerase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
miseq,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
poly,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
wt,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
assembler,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
idba,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
rna,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
peer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
mice,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
virusd,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
metagenomic,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
error,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
trans,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pk,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
replication,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
picornaviruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
c,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
novo,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
tracts,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
copyright,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
mouth,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
reuse,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
preparation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
genome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
sequencing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pks,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
assays,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
bars,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
cis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
replicons,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
virus,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
figure,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
preprint,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
c11,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
disease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
sem,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
gnn,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
c0,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
activities,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
population,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
protocol,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
viral,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
gfp,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pathways,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
n,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
holder,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
precursor,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
permission,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
b,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
data,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
alignment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
polyc,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
library,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
depth,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
economy,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
mutational,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
cleavage,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
replicon,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
bhk-21,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
bhk,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
foot,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
consensus,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
cells,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
and-613,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
illumina,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
carla mavian,00340eea543336d54adda18236424de6a5e91c9d,has_author
costanza manes,00340eea543336d54adda18236424de6a5e91c9d,has_author
ilaria capua,00340eea543336d54adda18236424de6a5e91c9d,has_author
marco salemi,00340eea543336d54adda18236424de6a5e91c9d,has_author
mattia prosperi,00340eea543336d54adda18236424de6a5e91c9d,has_author
simone marini,00340eea543336d54adda18236424de6a5e91c9d,has_author
tracing,00340eea543336d54adda18236424de6a5e91c9d,has_title
sars,00340eea543336d54adda18236424de6a5e91c9d,has_title
perspective,00340eea543336d54adda18236424de6a5e91c9d,has_title
implications,00340eea543336d54adda18236424de6a5e91c9d,has_title
cov-2,00340eea543336d54adda18236424de6a5e91c9d,has_title
title,00340eea543336d54adda18236424de6a5e91c9d,has_title
analysis,00340eea543336d54adda18236424de6a5e91c9d,has_title
peer,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
heterogeneity,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
analysis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
months,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
holder,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
international,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
nd0,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
tracing,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
sequences,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
authorfunder,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
countries,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
sars,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
perpetuity,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
preprint,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
dissemination,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
cc,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
quality,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
economies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
cov-2,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
copyright,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
channels,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
finding,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
analyses,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
limitations,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
data,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
coronavirus,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
epidemic,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
information,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
stigmatization,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
phylogenetic,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
nc,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
studies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
plethora,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
efforts,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
distress,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
presence,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
license,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
societies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
genome,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
journals,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
calibrations,00340eea543336d54adda18236424de6a5e91c9d,has_body
s2,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408480betacovyunnanivdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
date,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406031betacovtaiwan22020,00340eea543336d54adda18236424de6a5e91c9d,has_body
absence,00340eea543336d54adda18236424de6a5e91c9d,has_body
bic,00340eea543336d54adda18236424de6a5e91c9d,has_body
singapore,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407893betacovaustraliansw012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
research,00340eea543336d54adda18236424de6a5e91c9d,has_body
structure,00340eea543336d54adda18236424de6a5e91c9d,has_body
cases,00340eea543336d54adda18236424de6a5e91c9d,has_body
topology,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407084betacovjapanaii-0042020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl409067betacovusama12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
infections,00340eea543336d54adda18236424de6a5e91c9d,has_body
figures,00340eea543336d54adda18236424de6a5e91c9d,has_body
corners,00340eea543336d54adda18236424de6a5e91c9d,has_body
cluster,00340eea543336d54adda18236424de6a5e91c9d,has_body
iq,00340eea543336d54adda18236424de6a5e91c9d,has_body
scattering,00340eea543336d54adda18236424de6a5e91c9d,has_body
simulation,00340eea543336d54adda18236424de6a5e91c9d,has_body
tempest,00340eea543336d54adda18236424de6a5e91c9d,has_body
cq-0012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411955betacovusaca82020,00340eea543336d54adda18236424de6a5e91c9d,has_body
resolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
s1,00340eea543336d54adda18236424de6a5e91c9d,has_body
model,00340eea543336d54adda18236424de6a5e91c9d,has_body
samples,00340eea543336d54adda18236424de6a5e91c9d,has_body
rate,00340eea543336d54adda18236424de6a5e91c9d,has_body
sz-0052020,00340eea543336d54adda18236424de6a5e91c9d,has_body
criterion,00340eea543336d54adda18236424de6a5e91c9d,has_body
exploration,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406862betacovgermanybavpat12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
routes,00340eea543336d54adda18236424de6a5e91c9d,has_body
conclusion,00340eea543336d54adda18236424de6a5e91c9d,has_body
university,00340eea543336d54adda18236424de6a5e91c9d,has_body
coronavirus,00340eea543336d54adda18236424de6a5e91c9d,has_body
policy,00340eea543336d54adda18236424de6a5e91c9d,has_body
hb-022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406534betacovfoshan20sf2072020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406036betacovusaca22020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408976betacovsydney22020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408666betacovjapanty,00340eea543336d54adda18236424de6a5e91c9d,has_body
hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412029betacovhongkongvm200019882020,00340eea543336d54adda18236424de6a5e91c9d,has_body
quality,00340eea543336d54adda18236424de6a5e91c9d,has_body
position,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411926betacovtaiwan32020,00340eea543336d54adda18236424de6a5e91c9d,has_body
genome,00340eea543336d54adda18236424de6a5e91c9d,has_body
approximation,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407071betacovengland012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
datasets,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl404228betacovzhejiangwz-022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
assessment,00340eea543336d54adda18236424de6a5e91c9d,has_body
portugal,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407896betacovaustraliaqld022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410531betacovjapanna-20,00340eea543336d54adda18236424de6a5e91c9d,has_body
netherland,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407987betacovsingapore22020,00340eea543336d54adda18236424de6a5e91c9d,has_body
countries,00340eea543336d54adda18236424de6a5e91c9d,has_body
httpswwwgisaidorg,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl403933betacovguangdong20sf0132020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl403963betacovnonthaburi742020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406862,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl413014betacovcanadaon,00340eea543336d54adda18236424de6a5e91c9d,has_body
copyright,00340eea543336d54adda18236424de6a5e91c9d,has_body
phylogeny,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410720betacovfranceidf0372-isl2020,00340eea543336d54adda18236424de6a5e91c9d,has_body
wuhan,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408977betacovsydney32020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412969betacovjapanhudpkng19,00340eea543336d54adda18236424de6a5e91c9d,has_body
distribution,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408486betacovjiangxiivdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
authorfunder,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411952betacovjiangsujs022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
terms,00340eea543336d54adda18236424de6a5e91c9d,has_body
data,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407079betacovfinland12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
australia,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406716betacovchinawhu012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
figure,00340eea543336d54adda18236424de6a5e91c9d,has_body
johns,00340eea543336d54adda18236424de6a5e91c9d,has_body
direction,00340eea543336d54adda18236424de6a5e91c9d,has_body
updates,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406535betacovfoshan20sf2102020,00340eea543336d54adda18236424de6a5e91c9d,has_body
v-0292020,00340eea543336d54adda18236424de6a5e91c9d,has_body
virus,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406538betacovguangdong20sf2012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
mexico,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412971betacovfinlandfin-252020,00340eea543336d54adda18236424de6a5e91c9d,has_body
hb-072020,00340eea543336d54adda18236424de6a5e91c9d,has_body
finland,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412983betacovtianmenhbcdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
lineage,00340eea543336d54adda18236424de6a5e91c9d,has_body
usa,00340eea543336d54adda18236424de6a5e91c9d,has_body
link,00340eea543336d54adda18236424de6a5e91c9d,has_body
phylogenies,00340eea543336d54adda18236424de6a5e91c9d,has_body
hb-062020,00340eea543336d54adda18236424de6a5e91c9d,has_body
alignment,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl402120betacovwuhanivdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
envf13,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406034betacovusaca12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411902betacovcambodia00122020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408430betacovfranceidf05152020,00340eea543336d54adda18236424de6a5e91c9d,has_body
mitigation,00340eea543336d54adda18236424de6a5e91c9d,has_body
inference,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412898betacovwuhanhbcdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
wh-042019,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408481betacovchongqingivdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412899betacovwuhanhbcdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
-root,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410546betacovitalyinmi1-cs2020,00340eea543336d54adda18236424de6a5e91c9d,has_body
oxford,00340eea543336d54adda18236424de6a5e91c9d,has_body
epidemiology,00340eea543336d54adda18236424de6a5e91c9d,has_body
hasegawa,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410537betacovsingapore62020,00340eea543336d54adda18236424de6a5e91c9d,has_body
transversions,00340eea543336d54adda18236424de6a5e91c9d,has_body
germany,00340eea543336d54adda18236424de6a5e91c9d,has_body
option,00340eea543336d54adda18236424de6a5e91c9d,has_body
shimodaira,00340eea543336d54adda18236424de6a5e91c9d,has_body
figurec,00340eea543336d54adda18236424de6a5e91c9d,has_body
groups,00340eea543336d54adda18236424de6a5e91c9d,has_body
performed000,00340eea543336d54adda18236424de6a5e91c9d,has_body
transitiontransversions,00340eea543336d54adda18236424de6a5e91c9d,has_body
china,00340eea543336d54adda18236424de6a5e91c9d,has_body
implications,00340eea543336d54adda18236424de6a5e91c9d,has_body
rell,00340eea543336d54adda18236424de6a5e91c9d,has_body
correlation,00340eea543336d54adda18236424de6a5e91c9d,has_body
transitionstransversions,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl403928betacovwuhanipbcams,00340eea543336d54adda18236424de6a5e91c9d,has_body
quartets,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406844betacovaustraliavic012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410044betacovusaca62020,00340eea543336d54adda18236424de6a5e91c9d,has_body
bootstrap,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407988betacovsingapore32020,00340eea543336d54adda18236424de6a5e91c9d,has_body
contagion,00340eea543336d54adda18236424de6a5e91c9d,has_body
editorial,00340eea543336d54adda18236424de6a5e91c9d,has_body
hu-12019,00340eea543336d54adda18236424de6a5e91c9d,has_body
caution,00340eea543336d54adda18236424de6a5e91c9d,has_body
ml,00340eea543336d54adda18236424de6a5e91c9d,has_body
signal,00340eea543336d54adda18236424de6a5e91c9d,has_body
rd,00340eea543336d54adda18236424de6a5e91c9d,has_body
cgu-012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410984betacovfranceidf0515-isl2020,00340eea543336d54adda18236424de6a5e91c9d,has_body
distress,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406531betacovguangdong20sf1742020,00340eea543336d54adda18236424de6a5e91c9d,has_body
information,00340eea543336d54adda18236424de6a5e91c9d,has_body
sc-0012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412026betacovhefei22020,00340eea543336d54adda18236424de6a5e91c9d,has_body
discrimination,00340eea543336d54adda18236424de6a5e91c9d,has_body
sz-0022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412862betacovusaca92020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412459betacovjingzhouhbcdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl403935betacovguangdong20sf0252020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412974betacovitalyspl12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412028betacovhongkongvm200010612020,00340eea543336d54adda18236424de6a5e91c9d,has_body
observation,00340eea543336d54adda18236424de6a5e91c9d,has_body
points,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412968betacovjapanhudpkng19,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl413020betacovswitzerland10004773772020,00340eea543336d54adda18236424de6a5e91c9d,has_body
testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408515betacovwuhanivdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
measures,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412979betacovwuhanhbcdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
cc,00340eea543336d54adda18236424de6a5e91c9d,has_body
holder,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl403936betacovguangdong20sf0282020,00340eea543336d54adda18236424de6a5e91c9d,has_body
substitution,00340eea543336d54adda18236424de6a5e91c9d,has_body
cladograms,00340eea543336d54adda18236424de6a5e91c9d,has_body
sidecenter,00340eea543336d54adda18236424de6a5e91c9d,has_body
models,00340eea543336d54adda18236424de6a5e91c9d,has_body
assumptions,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl404253betacovusail12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl402127betacovwuhanwiv022019,00340eea543336d54adda18236424de6a5e91c9d,has_body
nextstrain,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406970betacovhangzhouhz-12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406973betacovsingapore12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
answers,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl413018betacovsouthkoreakumc022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411957betacovchinawh-092020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl402119betacovwuhanivdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
urgency,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408667betacovjapanty,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408009betacovusaca42020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407215betacovusawa1-f62020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl402123betacovwuhanipbcams,00340eea543336d54adda18236424de6a5e91c9d,has_body
hb-012019,00340eea543336d54adda18236424de6a5e91c9d,has_body
science,00340eea543336d54adda18236424de6a5e91c9d,has_body
introduction,00340eea543336d54adda18236424de6a5e91c9d,has_body
wuerttemberg-12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
areas,00340eea543336d54adda18236424de6a5e91c9d,has_body
resamplings,00340eea543336d54adda18236424de6a5e91c9d,has_body
relationships,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410536betacovsingapore52020,00340eea543336d54adda18236424de6a5e91c9d,has_body
comparisons,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412978betacovwuhanhbcdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408488betacovjiangsuivdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl413555,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412912betacovgermanybaden,00340eea543336d54adda18236424de6a5e91c9d,has_body
dynamic,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl404895betacovusawa12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
th,00340eea543336d54adda18236424de6a5e91c9d,has_body
hopkins,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408668betacovvietnamvr03,00340eea543336d54adda18236424de6a5e91c9d,has_body
presence,00340eea543336d54adda18236424de6a5e91c9d,has_body
switzerland,00340eea543336d54adda18236424de6a5e91c9d,has_body
arrows,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410715betacovsingapore92020,00340eea543336d54adda18236424de6a5e91c9d,has_body
reconstruction,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410714betacovsingapore82020,00340eea543336d54adda18236424de6a5e91c9d,has_body
reliability,00340eea543336d54adda18236424de6a5e91c9d,has_body
mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
lack,00340eea543336d54adda18236424de6a5e91c9d,has_body
dots,00340eea543336d54adda18236424de6a5e91c9d,has_body
evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
jx-0022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
license,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408514betacovwuhanivdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410045betacovusail22020,00340eea543336d54adda18236424de6a5e91c9d,has_body
trend,00340eea543336d54adda18236424de6a5e91c9d,has_body
hb-032020,00340eea543336d54adda18236424de6a5e91c9d,has_body
genomes,00340eea543336d54adda18236424de6a5e91c9d,has_body
diversity,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412975betacovaustraliansw052020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408431betacovfranceidf06262020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl405839betacovshenzhenhku,00340eea543336d54adda18236424de6a5e91c9d,has_body
reconstructions,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl413016betacovbrazilspbr-022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl402132betacovwuhanhbcdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
studies,00340eea543336d54adda18236424de6a5e91c9d,has_body
quartet,00340eea543336d54adda18236424de6a5e91c9d,has_body
media,00340eea543336d54adda18236424de6a5e91c9d,has_body
uncertainty,00340eea543336d54adda18236424de6a5e91c9d,has_body
hb-052020,00340eea543336d54adda18236424de6a5e91c9d,has_body
communications,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411220betacovfranceidf0386-islp32020,00340eea543336d54adda18236424de6a5e91c9d,has_body
wales,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412030betacovhongkongvb200265652020,00340eea543336d54adda18236424de6a5e91c9d,has_body
scenarios,00340eea543336d54adda18236424de6a5e91c9d,has_body
divergence,00340eea543336d54adda18236424de6a5e91c9d,has_body
dynamics,00340eea543336d54adda18236424de6a5e91c9d,has_body
gisaid,00340eea543336d54adda18236424de6a5e91c9d,has_body
regression,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl404227betacovzhejiangwz-012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411219betacovfranceidf0386-islp12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
nc,00340eea543336d54adda18236424de6a5e91c9d,has_body
decisions,00340eea543336d54adda18236424de6a5e91c9d,has_body
errors,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407073betacovengland022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
sampling,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407214betacovusawa1-a122020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl403929betacovwuhanipbcams,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl413648,00340eea543336d54adda18236424de6a5e91c9d,has_body
uk,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406798betacovwuhanwh012019,00340eea543336d54adda18236424de6a5e91c9d,has_body
figureb,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412981betacovwuhanhbcdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
js-0012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408484betacovsichuanivdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
evidence,00340eea543336d54adda18236424de6a5e91c9d,has_body
shortness,00340eea543336d54adda18236424de6a5e91c9d,has_body
discussions,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406801betacovwuhanwh042020,00340eea543336d54adda18236424de6a5e91c9d,has_body
arrow,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412965betacovcanadabc370,00340eea543336d54adda18236424de6a5e91c9d,has_body
cov-2,00340eea543336d54adda18236424de6a5e91c9d,has_body
nd0,00340eea543336d54adda18236424de6a5e91c9d,has_body
effort,00340eea543336d54adda18236424de6a5e91c9d,has_body
availability,00340eea543336d54adda18236424de6a5e91c9d,has_body
supplementary,00340eea543336d54adda18236424de6a5e91c9d,has_body
dambe6,00340eea543336d54adda18236424de6a5e91c9d,has_body
community,00340eea543336d54adda18236424de6a5e91c9d,has_body
doi,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl403931betacovwuhanipbcams,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl413017betacovsouthkoreakumc012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408669betacovjapanky,00340eea543336d54adda18236424de6a5e91c9d,has_body
lazio,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408665betacovjapanty,00340eea543336d54adda18236424de6a5e91c9d,has_body
phylogenetic,00340eea543336d54adda18236424de6a5e91c9d,has_body
debates,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411954betacovusaca72020,00340eea543336d54adda18236424de6a5e91c9d,has_body
glasgow,00340eea543336d54adda18236424de6a5e91c9d,has_body
sequence,00340eea543336d54adda18236424de6a5e91c9d,has_body
phl24452020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl403932betacovguangdong20sf0122020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411915betacovtaiwancgmh,00340eea543336d54adda18236424de6a5e91c9d,has_body
transmission,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406597betacovfranceidf03732020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412980betacovwuhanhbcdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412973betacovitalycdg12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl402129betacovwuhanwiv062019,00340eea543336d54adda18236424de6a5e91c9d,has_body
discussion,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407313betacovhangzhouhzcdc00012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
patterns,00340eea543336d54adda18236424de6a5e91c9d,has_body
branches,00340eea543336d54adda18236424de6a5e91c9d,has_body
humanity,00340eea543336d54adda18236424de6a5e91c9d,has_body
debate,00340eea543336d54adda18236424de6a5e91c9d,has_body
glut,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411060betacovfujian82020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408489betacovtaiwanntu012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
edinburgh,00340eea543336d54adda18236424de6a5e91c9d,has_body
wk-0122020,00340eea543336d54adda18236424de6a5e91c9d,has_body
international,00340eea543336d54adda18236424de6a5e91c9d,has_body
transitions,00340eea543336d54adda18236424de6a5e91c9d,has_body
parsimony,00340eea543336d54adda18236424de6a5e91c9d,has_body
wk-5212020,00340eea543336d54adda18236424de6a5e91c9d,has_body
breath,00340eea543336d54adda18236424de6a5e91c9d,has_body
analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
evaluation,00340eea543336d54adda18236424de6a5e91c9d,has_body
outbreak,00340eea543336d54adda18236424de6a5e91c9d,has_body
tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
beginning,00340eea543336d54adda18236424de6a5e91c9d,has_body
hype,00340eea543336d54adda18236424de6a5e91c9d,has_body
vehicle,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410301betacovnepal612020,00340eea543336d54adda18236424de6a5e91c9d,has_body
fever,00340eea543336d54adda18236424de6a5e91c9d,has_body
wh-032019,00340eea543336d54adda18236424de6a5e91c9d,has_body
medrxiv,00340eea543336d54adda18236424de6a5e91c9d,has_body
tip,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410718betacovaustraliaqld042020,00340eea543336d54adda18236424de6a5e91c9d,has_body
subclade,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412982betacovwuhanhbcdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411956betacovusatx12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
preprint,00340eea543336d54adda18236424de6a5e91c9d,has_body
httpsdoiorg10110120200320034470,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412869betacovkoreakcdc052020,00340eea543336d54adda18236424de6a5e91c9d,has_body
cough,00340eea543336d54adda18236424de6a5e91c9d,has_body
distance,00340eea543336d54adda18236424de6a5e91c9d,has_body
results,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406594betacovshenzhenszth-0032020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl402125betacovwuhan,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl413019betacovswitzerland10004771022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410535betacovsingapore42020,00340eea543336d54adda18236424de6a5e91c9d,has_body
brazil,00340eea543336d54adda18236424de6a5e91c9d,has_body
analyses,00340eea543336d54adda18236424de6a5e91c9d,has_body
figurea,00340eea543336d54adda18236424de6a5e91c9d,has_body
topologies,00340eea543336d54adda18236424de6a5e91c9d,has_body
news,00340eea543336d54adda18236424de6a5e91c9d,has_body
south,00340eea543336d54adda18236424de6a5e91c9d,has_body
sars,00340eea543336d54adda18236424de6a5e91c9d,has_body
perpetuity,00340eea543336d54adda18236424de6a5e91c9d,has_body
wk-5012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
forums,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406593betacovshenzhenszth-0022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
disease,00340eea543336d54adda18236424de6a5e91c9d,has_body
lineages,00340eea543336d54adda18236424de6a5e91c9d,has_body
proxy,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl403934betacovguangdong20sf0142020,00340eea543336d54adda18236424de6a5e91c9d,has_body
dashboard,00340eea543336d54adda18236424de6a5e91c9d,has_body
korea,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412973,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410545betacovitalyinmi1-isl2020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412871betacovkoreakcdc072020,00340eea543336d54adda18236424de6a5e91c9d,has_body
audience,00340eea543336d54adda18236424de6a5e91c9d,has_body
symptoms,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412873betacovkoreakcdc242020,00340eea543336d54adda18236424de6a5e91c9d,has_body
claims,00340eea543336d54adda18236424de6a5e91c9d,has_body
makers,00340eea543336d54adda18236424de6a5e91c9d,has_body
-such,00340eea543336d54adda18236424de6a5e91c9d,has_body
yn-0032020,00340eea543336d54adda18236424de6a5e91c9d,has_body
papers,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410716betacovsingapore102020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408010betacovusaca52020,00340eea543336d54adda18236424de6a5e91c9d,has_body
italy,00340eea543336d54adda18236424de6a5e91c9d,has_body
march,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412966betacovchinaiqtc012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
wh-022019,00340eea543336d54adda18236424de6a5e91c9d,has_body
signals,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412967betacovchinaiqtc022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406717betacovchinawhu022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
plots,00340eea543336d54adda18236424de6a5e91c9d,has_body
evaluations,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406030betacovshenzhenhku,00340eea543336d54adda18236424de6a5e91c9d,has_body
dataset,00340eea543336d54adda18236424de6a5e91c9d,has_body
december,00340eea543336d54adda18236424de6a5e91c9d,has_body
ie,00340eea543336d54adda18236424de6a5e91c9d,has_body
clustering,00340eea543336d54adda18236424de6a5e91c9d,has_body
nucleotides,00340eea543336d54adda18236424de6a5e91c9d,has_body
hasgawa,00340eea543336d54adda18236424de6a5e91c9d,has_body
hb-012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
stigmatization,00340eea543336d54adda18236424de6a5e91c9d,has_body
sides,00340eea543336d54adda18236424de6a5e91c9d,has_body
clades,00340eea543336d54adda18236424de6a5e91c9d,has_body
possibility,00340eea543336d54adda18236424de6a5e91c9d,has_body
pneumonia,00340eea543336d54adda18236424de6a5e91c9d,has_body
wh-012019,00340eea543336d54adda18236424de6a5e91c9d,has_body
phylogeography,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406533betacovguangzhou20sf2062020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411066betacovfujian132020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411218betacovfranceidf05712020,00340eea543336d54adda18236424de6a5e91c9d,has_body
methods,00340eea543336d54adda18236424de6a5e91c9d,has_body
bayesian,00340eea543336d54adda18236424de6a5e91c9d,has_body
hotspots,00340eea543336d54adda18236424de6a5e91c9d,has_body
web,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412970betacovusawa22020,00340eea543336d54adda18236424de6a5e91c9d,has_body
values,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412972betacovmexicocdmxindre012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
gaps,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411927betacovtaiwan42020,00340eea543336d54adda18236424de6a5e91c9d,has_body
netherlands,00340eea543336d54adda18236424de6a5e91c9d,has_body
rna,00340eea543336d54adda18236424de6a5e91c9d,has_body
software,00340eea543336d54adda18236424de6a5e91c9d,has_body
hb,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406536betacovfoshan20sf2112020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl413015betacovcanadaonvido-012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
plot,00340eea543336d54adda18236424de6a5e91c9d,has_body
sites,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407894betacovaustraliaqld012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
articles,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl403962betacovnonthaburi612020,00340eea543336d54adda18236424de6a5e91c9d,has_body
words,00340eea543336d54adda18236424de6a5e91c9d,has_body
population,00340eea543336d54adda18236424de6a5e91c9d,has_body
sequencing,00340eea543336d54adda18236424de6a5e91c9d,has_body
hb-022019,00340eea543336d54adda18236424de6a5e91c9d,has_body
hb-042020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epidemic,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412870betacovkoreakcdc062020,00340eea543336d54adda18236424de6a5e91c9d,has_body
interpretation,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl403930betacovwuhanipbcams,00340eea543336d54adda18236424de6a5e91c9d,has_body
tracing,00340eea543336d54adda18236424de6a5e91c9d,has_body
observations,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412964,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411951betacovsweden012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408670betacovusawi12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
pandemic,00340eea543336d54adda18236424de6a5e91c9d,has_body
peer,00340eea543336d54adda18236424de6a5e91c9d,has_body
likelihood,00340eea543336d54adda18236424de6a5e91c9d,has_body
likelihoods,00340eea543336d54adda18236424de6a5e91c9d,has_body
hb-032019,00340eea543336d54adda18236424de6a5e91c9d,has_body
treetime,00340eea543336d54adda18236424de6a5e91c9d,has_body
hypotheses,00340eea543336d54adda18236424de6a5e91c9d,has_body
diversification,00340eea543336d54adda18236424de6a5e91c9d,has_body
table,00340eea543336d54adda18236424de6a5e91c9d,has_body
stretches,00340eea543336d54adda18236424de6a5e91c9d,has_body
ones,00340eea543336d54adda18236424de6a5e91c9d,has_body
lombardy,00340eea543336d54adda18236424de6a5e91c9d,has_body
wh-052020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412872betacovkoreakcdc122020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408008betacovusaca32020,00340eea543336d54adda18236424de6a5e91c9d,has_body
spearman,00340eea543336d54adda18236424de6a5e91c9d,has_body
dissemination,00340eea543336d54adda18236424de6a5e91c9d,has_body
months,00340eea543336d54adda18236424de6a5e91c9d,has_body
regions,00340eea543336d54adda18236424de6a5e91c9d,has_body
trees,00340eea543336d54adda18236424de6a5e91c9d,has_body
infection,00340eea543336d54adda18236424de6a5e91c9d,has_body
agent,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410713betacovsingapore72020,00340eea543336d54adda18236424de6a5e91c9d,has_body
beast,00340eea543336d54adda18236424de6a5e91c9d,has_body
tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
algorithm,00340eea543336d54adda18236424de6a5e91c9d,has_body
reality,00340eea543336d54adda18236424de6a5e91c9d,has_body
civile,00340eea543336d54adda18236424de6a5e91c9d,has_body
origin,00340eea543336d54adda18236424de6a5e91c9d,has_body
package,00340eea543336d54adda18236424de6a5e91c9d,has_body
covid-19,00340eea543336d54adda18236424de6a5e91c9d,has_body
bayesian,00340eea543336d54adda18236424de6a5e91c9d,has_body
web,00340eea543336d54adda18236424de6a5e91c9d,has_body
cov-2,00340eea543336d54adda18236424de6a5e91c9d,has_body
coronavirus,00340eea543336d54adda18236424de6a5e91c9d,has_body
content,00340eea543336d54adda18236424de6a5e91c9d,has_body
-43,00340eea543336d54adda18236424de6a5e91c9d,has_body
puzzle,00340eea543336d54adda18236424de6a5e91c9d,has_body
phylogeny,00340eea543336d54adda18236424de6a5e91c9d,has_body
quartets,00340eea543336d54adda18236424de6a5e91c9d,has_body
structure,00340eea543336d54adda18236424de6a5e91c9d,has_body
sars,00340eea543336d54adda18236424de6a5e91c9d,has_body
handbook,00340eea543336d54adda18236424de6a5e91c9d,has_body
likelihood,00340eea543336d54adda18236424de6a5e91c9d,has_body
del,00340eea543336d54adda18236424de6a5e91c9d,has_body
software,00340eea543336d54adda18236424de6a5e91c9d,has_body
mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
likelihoods,00340eea543336d54adda18236424de6a5e91c9d,has_body
situation,00340eea543336d54adda18236424de6a5e91c9d,has_body
sito,00340eea543336d54adda18236424de6a5e91c9d,has_body
phylogenies,00340eea543336d54adda18236424de6a5e91c9d,has_body
hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_body
w,00340eea543336d54adda18236424de6a5e91c9d,has_body
alignment,00340eea543336d54adda18236424de6a5e91c9d,has_body
datafrom,00340eea543336d54adda18236424de6a5e91c9d,has_body
protezione,00340eea543336d54adda18236424de6a5e91c9d,has_body
evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
protein,00340eea543336d54adda18236424de6a5e91c9d,has_body
sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
inference,00340eea543336d54adda18236424de6a5e91c9d,has_body
comparisons,00340eea543336d54adda18236424de6a5e91c9d,has_body
della,00340eea543336d54adda18236424de6a5e91c9d,has_body
emergence,00340eea543336d54adda18236424de6a5e91c9d,has_body
chloroplasts,00340eea543336d54adda18236424de6a5e91c9d,has_body
iq,00340eea543336d54adda18236424de6a5e91c9d,has_body
health,00340eea543336d54adda18236424de6a5e91c9d,has_body
analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
biology,00340eea543336d54adda18236424de6a5e91c9d,has_body
dashboard,00340eea543336d54adda18236424de6a5e91c9d,has_body
tracking,00340eea543336d54adda18236424de6a5e91c9d,has_body
data,00340eea543336d54adda18236424de6a5e91c9d,has_body
applications,00340eea543336d54adda18236424de6a5e91c9d,has_body
path,00340eea543336d54adda18236424de6a5e91c9d,has_body
phylodynamic,00340eea543336d54adda18236424de6a5e91c9d,has_body
report,00340eea543336d54adda18236424de6a5e91c9d,has_body
tempest,00340eea543336d54adda18236424de6a5e91c9d,has_body
dambe,00340eea543336d54adda18236424de6a5e91c9d,has_body
vision,00340eea543336d54adda18236424de6a5e91c9d,has_body
phylogenetic,00340eea543336d54adda18236424de6a5e91c9d,has_body
mutations,00340eea543336d54adda18236424de6a5e91c9d,has_body
o,00340eea543336d54adda18236424de6a5e91c9d,has_body
nextstrain,00340eea543336d54adda18236424de6a5e91c9d,has_body
maximum,00340eea543336d54adda18236424de6a5e91c9d,has_body
dipartimento,00340eea543336d54adda18236424de6a5e91c9d,has_body
approach,00340eea543336d54adda18236424de6a5e91c9d,has_body
sequence,00340eea543336d54adda18236424de6a5e91c9d,has_body
influenza,00340eea543336d54adda18236424de6a5e91c9d,has_body
-emergenza,00340eea543336d54adda18236424de6a5e91c9d,has_body
nazionale,00340eea543336d54adda18236424de6a5e91c9d,has_body
pathogen,00340eea543336d54adda18236424de6a5e91c9d,has_body
trees,00340eea543336d54adda18236424de6a5e91c9d,has_body
initiative,00340eea543336d54adda18236424de6a5e91c9d,has_body
joseph ward,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
oluwapelumi adeyemi,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
niall mclean,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
stonehouse a#,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
chris neil,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
tobias tuthill,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
lidia lasecka-dykes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
david kealy,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
morgan herod,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
emma ,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
warner ,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
 gold,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
caroline wright,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
sarah ,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
nicola ,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
david rowlands,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
donald king,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
virus,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
disease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
pseudoknots,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
production,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
rna,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
replication,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
loop,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
importance,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
genome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
function,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
translation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
frame,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
presence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
text,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
authorfunder,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
nucleotide,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
pseudoknots,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
disease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
kb,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
foot,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
ires,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
rna,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
shape,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
deletion,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
abstract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
cis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
replicons,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
pk,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
poly,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
series,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
reading,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
utr,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
signals,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
genomes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
stem,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
entry,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
site,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
contribution,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
hydroxyl,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
mutation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
initiation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
picornaviruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
replication,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
c,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
tandemly,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
acetylation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
permission,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
experiments,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
virus,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
report,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
fmdv,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
extension,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
cre,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
reuse,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
pks,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
domains,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
advantage,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
packaging,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
ribosome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
authorfunder,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pk4,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
primers,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
decrease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
neb,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
fastqc,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ligation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
basic,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
blast,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
error,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
experiments,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
elements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
hindrance,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
vp2,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
features,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
construct,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
truncation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
repeats,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
effects,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pairing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
loops,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
nmia,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
sem,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
construction,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pk1,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
hybridisation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
insertion,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
reporter,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
report,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
kpni,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
reverse,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
reactivity,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
hindiii,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
a5,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
library,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
linearised,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
localisation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
plasmids,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
interaction,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
aatii,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
deletion,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
proteinsb,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
introduction,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
figurea,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
treatment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
copies,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
mutagenesis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
kit,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
fmdv-,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
idba,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
potential,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
s,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
sickle,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
genes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
importance,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
vp4,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
replication,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
containment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
picornaviruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
c,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
stems,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
prep,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
from-4,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
yeast,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
numbers,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
novo,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
absence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
culture,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
levels,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
trna,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
aflii,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
assays,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pks,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
evidence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
spei,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
preprint,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
passaging,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
stem,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
picornavirus,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
genomes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
dnase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
lifecycle,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
t7,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
requirements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
holder,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
passage,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
differences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
series,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
role,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
g,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
addition,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
p2,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
amplification,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
c0,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
httpsdoiorg10110120200110901801,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
recombination,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
competition,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
transcription,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
reactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
shape,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
presence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
lasergene,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
co-467,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
polymerase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
poly,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ud,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
formation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
utr,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
signals,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
hiscribe,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
package,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
requirement,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
rna,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
assembly,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
lines,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
files,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
structure,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pk,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
seqman,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
packaging,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
reads,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
downstream,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
local,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
host,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
copyright,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
disadvantage,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
figureb,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
observation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
kpni-131,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
mengo,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
p3,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
biorxiv,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
synthesis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pcr,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
date,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
bars,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
replicons,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
sub,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
algorithm,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
star,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
removal,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
fmdv-1311,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
vectors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
screen,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
n,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
sequence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
loop,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
vector,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
impact,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
mutations,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
strain,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
search,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
dna,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
data,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
fmdv,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
digestion,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
heterogeneity,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
vp0,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
reduction,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ptgfp,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
software,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
forward,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
upstream,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
cells,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
fastq,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
findings,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
tool,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
protein,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
doi,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
transfection,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
alighnment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
significance,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
tandem,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
wt,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
contigs,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
mapping,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
orientation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
purification,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
vpgc,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
duplication,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
peer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
tissue,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
plasmid,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
advantage,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
aii,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pbluescript,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
similarity,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
fragment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
site,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
reuse,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
function,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
events,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
p,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
controld,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
quality,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
virus,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pro,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
figurec,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
amounts,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
c11,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
hf,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
purelink,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
variation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
gnn,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
isolates,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
plaques,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
permission,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
nhei,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
replicon,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
cycle,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
residues,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
aspects,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
consensus,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
decline,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
authorfunder,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ud,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
polymerase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
miseq,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
poly,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
wt,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
assembler,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
idba,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
rna,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
peer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
mice,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
virusd,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
metagenomic,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
error,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
trans,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pk,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
replication,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
picornaviruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
c,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
novo,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
tracts,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
copyright,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
mouth,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
reuse,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
preparation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
genome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
sequencing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pks,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
assays,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
bars,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
cis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
replicons,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
virus,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
figure,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
preprint,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
c11,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
disease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
sem,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
gnn,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
c0,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
activities,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
population,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
protocol,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
viral,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
gfp,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pathways,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
n,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
holder,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
precursor,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
permission,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
b,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
data,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
alignment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
polyc,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
library,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
depth,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
economy,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
mutational,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
cleavage,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
replicon,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
bhk-21,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
bhk,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
foot,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
consensus,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
cells,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
and-613,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
illumina,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
carla mavian,00340eea543336d54adda18236424de6a5e91c9d,has_author
costanza manes,00340eea543336d54adda18236424de6a5e91c9d,has_author
ilaria capua,00340eea543336d54adda18236424de6a5e91c9d,has_author
marco salemi,00340eea543336d54adda18236424de6a5e91c9d,has_author
mattia prosperi,00340eea543336d54adda18236424de6a5e91c9d,has_author
simone marini,00340eea543336d54adda18236424de6a5e91c9d,has_author
tracing,00340eea543336d54adda18236424de6a5e91c9d,has_title
sars,00340eea543336d54adda18236424de6a5e91c9d,has_title
perspective,00340eea543336d54adda18236424de6a5e91c9d,has_title
implications,00340eea543336d54adda18236424de6a5e91c9d,has_title
cov-2,00340eea543336d54adda18236424de6a5e91c9d,has_title
title,00340eea543336d54adda18236424de6a5e91c9d,has_title
analysis,00340eea543336d54adda18236424de6a5e91c9d,has_title
peer,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
heterogeneity,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
analysis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
months,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
holder,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
international,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
nd0,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
tracing,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
sequences,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
authorfunder,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
countries,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
sars,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
perpetuity,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
preprint,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
dissemination,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
cc,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
quality,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
economies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
cov-2,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
copyright,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
channels,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
finding,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
analyses,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
limitations,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
data,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
coronavirus,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
epidemic,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
information,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
stigmatization,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
phylogenetic,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
nc,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
studies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
plethora,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
efforts,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
distress,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
presence,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
license,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
societies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
genome,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
journals,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
calibrations,00340eea543336d54adda18236424de6a5e91c9d,has_body
s2,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408480betacovyunnanivdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
date,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406031betacovtaiwan22020,00340eea543336d54adda18236424de6a5e91c9d,has_body
absence,00340eea543336d54adda18236424de6a5e91c9d,has_body
bic,00340eea543336d54adda18236424de6a5e91c9d,has_body
singapore,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407893betacovaustraliansw012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
research,00340eea543336d54adda18236424de6a5e91c9d,has_body
structure,00340eea543336d54adda18236424de6a5e91c9d,has_body
cases,00340eea543336d54adda18236424de6a5e91c9d,has_body
topology,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407084betacovjapanaii-0042020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl409067betacovusama12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
infections,00340eea543336d54adda18236424de6a5e91c9d,has_body
figures,00340eea543336d54adda18236424de6a5e91c9d,has_body
corners,00340eea543336d54adda18236424de6a5e91c9d,has_body
cluster,00340eea543336d54adda18236424de6a5e91c9d,has_body
iq,00340eea543336d54adda18236424de6a5e91c9d,has_body
scattering,00340eea543336d54adda18236424de6a5e91c9d,has_body
simulation,00340eea543336d54adda18236424de6a5e91c9d,has_body
tempest,00340eea543336d54adda18236424de6a5e91c9d,has_body
cq-0012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411955betacovusaca82020,00340eea543336d54adda18236424de6a5e91c9d,has_body
resolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
s1,00340eea543336d54adda18236424de6a5e91c9d,has_body
model,00340eea543336d54adda18236424de6a5e91c9d,has_body
samples,00340eea543336d54adda18236424de6a5e91c9d,has_body
rate,00340eea543336d54adda18236424de6a5e91c9d,has_body
sz-0052020,00340eea543336d54adda18236424de6a5e91c9d,has_body
criterion,00340eea543336d54adda18236424de6a5e91c9d,has_body
exploration,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406862betacovgermanybavpat12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
routes,00340eea543336d54adda18236424de6a5e91c9d,has_body
conclusion,00340eea543336d54adda18236424de6a5e91c9d,has_body
university,00340eea543336d54adda18236424de6a5e91c9d,has_body
coronavirus,00340eea543336d54adda18236424de6a5e91c9d,has_body
policy,00340eea543336d54adda18236424de6a5e91c9d,has_body
hb-022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406534betacovfoshan20sf2072020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406036betacovusaca22020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408976betacovsydney22020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408666betacovjapanty,00340eea543336d54adda18236424de6a5e91c9d,has_body
hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412029betacovhongkongvm200019882020,00340eea543336d54adda18236424de6a5e91c9d,has_body
quality,00340eea543336d54adda18236424de6a5e91c9d,has_body
position,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411926betacovtaiwan32020,00340eea543336d54adda18236424de6a5e91c9d,has_body
genome,00340eea543336d54adda18236424de6a5e91c9d,has_body
approximation,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407071betacovengland012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
datasets,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl404228betacovzhejiangwz-022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
assessment,00340eea543336d54adda18236424de6a5e91c9d,has_body
portugal,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407896betacovaustraliaqld022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410531betacovjapanna-20,00340eea543336d54adda18236424de6a5e91c9d,has_body
netherland,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407987betacovsingapore22020,00340eea543336d54adda18236424de6a5e91c9d,has_body
countries,00340eea543336d54adda18236424de6a5e91c9d,has_body
httpswwwgisaidorg,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl403933betacovguangdong20sf0132020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl403963betacovnonthaburi742020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406862,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl413014betacovcanadaon,00340eea543336d54adda18236424de6a5e91c9d,has_body
copyright,00340eea543336d54adda18236424de6a5e91c9d,has_body
phylogeny,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410720betacovfranceidf0372-isl2020,00340eea543336d54adda18236424de6a5e91c9d,has_body
wuhan,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408977betacovsydney32020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412969betacovjapanhudpkng19,00340eea543336d54adda18236424de6a5e91c9d,has_body
distribution,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408486betacovjiangxiivdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
authorfunder,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411952betacovjiangsujs022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
terms,00340eea543336d54adda18236424de6a5e91c9d,has_body
data,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407079betacovfinland12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
australia,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406716betacovchinawhu012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
figure,00340eea543336d54adda18236424de6a5e91c9d,has_body
johns,00340eea543336d54adda18236424de6a5e91c9d,has_body
direction,00340eea543336d54adda18236424de6a5e91c9d,has_body
updates,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406535betacovfoshan20sf2102020,00340eea543336d54adda18236424de6a5e91c9d,has_body
v-0292020,00340eea543336d54adda18236424de6a5e91c9d,has_body
virus,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406538betacovguangdong20sf2012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
mexico,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412971betacovfinlandfin-252020,00340eea543336d54adda18236424de6a5e91c9d,has_body
hb-072020,00340eea543336d54adda18236424de6a5e91c9d,has_body
finland,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412983betacovtianmenhbcdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
lineage,00340eea543336d54adda18236424de6a5e91c9d,has_body
usa,00340eea543336d54adda18236424de6a5e91c9d,has_body
link,00340eea543336d54adda18236424de6a5e91c9d,has_body
phylogenies,00340eea543336d54adda18236424de6a5e91c9d,has_body
hb-062020,00340eea543336d54adda18236424de6a5e91c9d,has_body
alignment,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl402120betacovwuhanivdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
envf13,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406034betacovusaca12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411902betacovcambodia00122020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408430betacovfranceidf05152020,00340eea543336d54adda18236424de6a5e91c9d,has_body
mitigation,00340eea543336d54adda18236424de6a5e91c9d,has_body
inference,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412898betacovwuhanhbcdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
wh-042019,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408481betacovchongqingivdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412899betacovwuhanhbcdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
-root,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410546betacovitalyinmi1-cs2020,00340eea543336d54adda18236424de6a5e91c9d,has_body
oxford,00340eea543336d54adda18236424de6a5e91c9d,has_body
epidemiology,00340eea543336d54adda18236424de6a5e91c9d,has_body
hasegawa,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410537betacovsingapore62020,00340eea543336d54adda18236424de6a5e91c9d,has_body
transversions,00340eea543336d54adda18236424de6a5e91c9d,has_body
germany,00340eea543336d54adda18236424de6a5e91c9d,has_body
option,00340eea543336d54adda18236424de6a5e91c9d,has_body
shimodaira,00340eea543336d54adda18236424de6a5e91c9d,has_body
figurec,00340eea543336d54adda18236424de6a5e91c9d,has_body
groups,00340eea543336d54adda18236424de6a5e91c9d,has_body
performed000,00340eea543336d54adda18236424de6a5e91c9d,has_body
transitiontransversions,00340eea543336d54adda18236424de6a5e91c9d,has_body
china,00340eea543336d54adda18236424de6a5e91c9d,has_body
implications,00340eea543336d54adda18236424de6a5e91c9d,has_body
rell,00340eea543336d54adda18236424de6a5e91c9d,has_body
correlation,00340eea543336d54adda18236424de6a5e91c9d,has_body
transitionstransversions,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl403928betacovwuhanipbcams,00340eea543336d54adda18236424de6a5e91c9d,has_body
quartets,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406844betacovaustraliavic012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410044betacovusaca62020,00340eea543336d54adda18236424de6a5e91c9d,has_body
bootstrap,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407988betacovsingapore32020,00340eea543336d54adda18236424de6a5e91c9d,has_body
contagion,00340eea543336d54adda18236424de6a5e91c9d,has_body
editorial,00340eea543336d54adda18236424de6a5e91c9d,has_body
hu-12019,00340eea543336d54adda18236424de6a5e91c9d,has_body
caution,00340eea543336d54adda18236424de6a5e91c9d,has_body
ml,00340eea543336d54adda18236424de6a5e91c9d,has_body
signal,00340eea543336d54adda18236424de6a5e91c9d,has_body
rd,00340eea543336d54adda18236424de6a5e91c9d,has_body
cgu-012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410984betacovfranceidf0515-isl2020,00340eea543336d54adda18236424de6a5e91c9d,has_body
distress,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406531betacovguangdong20sf1742020,00340eea543336d54adda18236424de6a5e91c9d,has_body
information,00340eea543336d54adda18236424de6a5e91c9d,has_body
sc-0012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412026betacovhefei22020,00340eea543336d54adda18236424de6a5e91c9d,has_body
discrimination,00340eea543336d54adda18236424de6a5e91c9d,has_body
sz-0022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412862betacovusaca92020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412459betacovjingzhouhbcdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl403935betacovguangdong20sf0252020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412974betacovitalyspl12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412028betacovhongkongvm200010612020,00340eea543336d54adda18236424de6a5e91c9d,has_body
observation,00340eea543336d54adda18236424de6a5e91c9d,has_body
points,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412968betacovjapanhudpkng19,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl413020betacovswitzerland10004773772020,00340eea543336d54adda18236424de6a5e91c9d,has_body
testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408515betacovwuhanivdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
measures,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412979betacovwuhanhbcdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
cc,00340eea543336d54adda18236424de6a5e91c9d,has_body
holder,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl403936betacovguangdong20sf0282020,00340eea543336d54adda18236424de6a5e91c9d,has_body
substitution,00340eea543336d54adda18236424de6a5e91c9d,has_body
cladograms,00340eea543336d54adda18236424de6a5e91c9d,has_body
sidecenter,00340eea543336d54adda18236424de6a5e91c9d,has_body
models,00340eea543336d54adda18236424de6a5e91c9d,has_body
assumptions,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl404253betacovusail12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl402127betacovwuhanwiv022019,00340eea543336d54adda18236424de6a5e91c9d,has_body
nextstrain,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406970betacovhangzhouhz-12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406973betacovsingapore12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
answers,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl413018betacovsouthkoreakumc022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411957betacovchinawh-092020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl402119betacovwuhanivdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
urgency,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408667betacovjapanty,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408009betacovusaca42020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407215betacovusawa1-f62020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl402123betacovwuhanipbcams,00340eea543336d54adda18236424de6a5e91c9d,has_body
hb-012019,00340eea543336d54adda18236424de6a5e91c9d,has_body
science,00340eea543336d54adda18236424de6a5e91c9d,has_body
introduction,00340eea543336d54adda18236424de6a5e91c9d,has_body
wuerttemberg-12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
areas,00340eea543336d54adda18236424de6a5e91c9d,has_body
resamplings,00340eea543336d54adda18236424de6a5e91c9d,has_body
relationships,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410536betacovsingapore52020,00340eea543336d54adda18236424de6a5e91c9d,has_body
comparisons,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412978betacovwuhanhbcdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408488betacovjiangsuivdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl413555,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412912betacovgermanybaden,00340eea543336d54adda18236424de6a5e91c9d,has_body
dynamic,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl404895betacovusawa12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
th,00340eea543336d54adda18236424de6a5e91c9d,has_body
hopkins,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408668betacovvietnamvr03,00340eea543336d54adda18236424de6a5e91c9d,has_body
presence,00340eea543336d54adda18236424de6a5e91c9d,has_body
switzerland,00340eea543336d54adda18236424de6a5e91c9d,has_body
arrows,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410715betacovsingapore92020,00340eea543336d54adda18236424de6a5e91c9d,has_body
reconstruction,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410714betacovsingapore82020,00340eea543336d54adda18236424de6a5e91c9d,has_body
reliability,00340eea543336d54adda18236424de6a5e91c9d,has_body
mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
lack,00340eea543336d54adda18236424de6a5e91c9d,has_body
dots,00340eea543336d54adda18236424de6a5e91c9d,has_body
evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
jx-0022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
license,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408514betacovwuhanivdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410045betacovusail22020,00340eea543336d54adda18236424de6a5e91c9d,has_body
trend,00340eea543336d54adda18236424de6a5e91c9d,has_body
hb-032020,00340eea543336d54adda18236424de6a5e91c9d,has_body
genomes,00340eea543336d54adda18236424de6a5e91c9d,has_body
diversity,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412975betacovaustraliansw052020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408431betacovfranceidf06262020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl405839betacovshenzhenhku,00340eea543336d54adda18236424de6a5e91c9d,has_body
reconstructions,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl413016betacovbrazilspbr-022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl402132betacovwuhanhbcdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
studies,00340eea543336d54adda18236424de6a5e91c9d,has_body
quartet,00340eea543336d54adda18236424de6a5e91c9d,has_body
media,00340eea543336d54adda18236424de6a5e91c9d,has_body
uncertainty,00340eea543336d54adda18236424de6a5e91c9d,has_body
hb-052020,00340eea543336d54adda18236424de6a5e91c9d,has_body
communications,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411220betacovfranceidf0386-islp32020,00340eea543336d54adda18236424de6a5e91c9d,has_body
wales,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412030betacovhongkongvb200265652020,00340eea543336d54adda18236424de6a5e91c9d,has_body
scenarios,00340eea543336d54adda18236424de6a5e91c9d,has_body
divergence,00340eea543336d54adda18236424de6a5e91c9d,has_body
dynamics,00340eea543336d54adda18236424de6a5e91c9d,has_body
gisaid,00340eea543336d54adda18236424de6a5e91c9d,has_body
regression,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl404227betacovzhejiangwz-012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411219betacovfranceidf0386-islp12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
nc,00340eea543336d54adda18236424de6a5e91c9d,has_body
decisions,00340eea543336d54adda18236424de6a5e91c9d,has_body
errors,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407073betacovengland022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
sampling,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407214betacovusawa1-a122020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl403929betacovwuhanipbcams,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl413648,00340eea543336d54adda18236424de6a5e91c9d,has_body
uk,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406798betacovwuhanwh012019,00340eea543336d54adda18236424de6a5e91c9d,has_body
figureb,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412981betacovwuhanhbcdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
js-0012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408484betacovsichuanivdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
evidence,00340eea543336d54adda18236424de6a5e91c9d,has_body
shortness,00340eea543336d54adda18236424de6a5e91c9d,has_body
discussions,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406801betacovwuhanwh042020,00340eea543336d54adda18236424de6a5e91c9d,has_body
arrow,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412965betacovcanadabc370,00340eea543336d54adda18236424de6a5e91c9d,has_body
cov-2,00340eea543336d54adda18236424de6a5e91c9d,has_body
nd0,00340eea543336d54adda18236424de6a5e91c9d,has_body
effort,00340eea543336d54adda18236424de6a5e91c9d,has_body
availability,00340eea543336d54adda18236424de6a5e91c9d,has_body
supplementary,00340eea543336d54adda18236424de6a5e91c9d,has_body
dambe6,00340eea543336d54adda18236424de6a5e91c9d,has_body
community,00340eea543336d54adda18236424de6a5e91c9d,has_body
doi,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl403931betacovwuhanipbcams,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl413017betacovsouthkoreakumc012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408669betacovjapanky,00340eea543336d54adda18236424de6a5e91c9d,has_body
lazio,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408665betacovjapanty,00340eea543336d54adda18236424de6a5e91c9d,has_body
phylogenetic,00340eea543336d54adda18236424de6a5e91c9d,has_body
debates,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411954betacovusaca72020,00340eea543336d54adda18236424de6a5e91c9d,has_body
glasgow,00340eea543336d54adda18236424de6a5e91c9d,has_body
sequence,00340eea543336d54adda18236424de6a5e91c9d,has_body
phl24452020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl403932betacovguangdong20sf0122020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411915betacovtaiwancgmh,00340eea543336d54adda18236424de6a5e91c9d,has_body
transmission,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406597betacovfranceidf03732020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412980betacovwuhanhbcdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412973betacovitalycdg12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl402129betacovwuhanwiv062019,00340eea543336d54adda18236424de6a5e91c9d,has_body
discussion,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407313betacovhangzhouhzcdc00012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
patterns,00340eea543336d54adda18236424de6a5e91c9d,has_body
branches,00340eea543336d54adda18236424de6a5e91c9d,has_body
humanity,00340eea543336d54adda18236424de6a5e91c9d,has_body
debate,00340eea543336d54adda18236424de6a5e91c9d,has_body
glut,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411060betacovfujian82020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408489betacovtaiwanntu012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
edinburgh,00340eea543336d54adda18236424de6a5e91c9d,has_body
wk-0122020,00340eea543336d54adda18236424de6a5e91c9d,has_body
international,00340eea543336d54adda18236424de6a5e91c9d,has_body
transitions,00340eea543336d54adda18236424de6a5e91c9d,has_body
parsimony,00340eea543336d54adda18236424de6a5e91c9d,has_body
wk-5212020,00340eea543336d54adda18236424de6a5e91c9d,has_body
breath,00340eea543336d54adda18236424de6a5e91c9d,has_body
analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
evaluation,00340eea543336d54adda18236424de6a5e91c9d,has_body
outbreak,00340eea543336d54adda18236424de6a5e91c9d,has_body
tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
beginning,00340eea543336d54adda18236424de6a5e91c9d,has_body
hype,00340eea543336d54adda18236424de6a5e91c9d,has_body
vehicle,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410301betacovnepal612020,00340eea543336d54adda18236424de6a5e91c9d,has_body
fever,00340eea543336d54adda18236424de6a5e91c9d,has_body
wh-032019,00340eea543336d54adda18236424de6a5e91c9d,has_body
medrxiv,00340eea543336d54adda18236424de6a5e91c9d,has_body
tip,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410718betacovaustraliaqld042020,00340eea543336d54adda18236424de6a5e91c9d,has_body
subclade,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412982betacovwuhanhbcdc,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411956betacovusatx12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
preprint,00340eea543336d54adda18236424de6a5e91c9d,has_body
httpsdoiorg10110120200320034470,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412869betacovkoreakcdc052020,00340eea543336d54adda18236424de6a5e91c9d,has_body
cough,00340eea543336d54adda18236424de6a5e91c9d,has_body
distance,00340eea543336d54adda18236424de6a5e91c9d,has_body
results,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406594betacovshenzhenszth-0032020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl402125betacovwuhan,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl413019betacovswitzerland10004771022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410535betacovsingapore42020,00340eea543336d54adda18236424de6a5e91c9d,has_body
brazil,00340eea543336d54adda18236424de6a5e91c9d,has_body
analyses,00340eea543336d54adda18236424de6a5e91c9d,has_body
figurea,00340eea543336d54adda18236424de6a5e91c9d,has_body
topologies,00340eea543336d54adda18236424de6a5e91c9d,has_body
news,00340eea543336d54adda18236424de6a5e91c9d,has_body
south,00340eea543336d54adda18236424de6a5e91c9d,has_body
sars,00340eea543336d54adda18236424de6a5e91c9d,has_body
perpetuity,00340eea543336d54adda18236424de6a5e91c9d,has_body
wk-5012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
forums,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406593betacovshenzhenszth-0022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
disease,00340eea543336d54adda18236424de6a5e91c9d,has_body
lineages,00340eea543336d54adda18236424de6a5e91c9d,has_body
proxy,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl403934betacovguangdong20sf0142020,00340eea543336d54adda18236424de6a5e91c9d,has_body
dashboard,00340eea543336d54adda18236424de6a5e91c9d,has_body
korea,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412973,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410545betacovitalyinmi1-isl2020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412871betacovkoreakcdc072020,00340eea543336d54adda18236424de6a5e91c9d,has_body
audience,00340eea543336d54adda18236424de6a5e91c9d,has_body
symptoms,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412873betacovkoreakcdc242020,00340eea543336d54adda18236424de6a5e91c9d,has_body
claims,00340eea543336d54adda18236424de6a5e91c9d,has_body
makers,00340eea543336d54adda18236424de6a5e91c9d,has_body
-such,00340eea543336d54adda18236424de6a5e91c9d,has_body
yn-0032020,00340eea543336d54adda18236424de6a5e91c9d,has_body
papers,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410716betacovsingapore102020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408010betacovusaca52020,00340eea543336d54adda18236424de6a5e91c9d,has_body
italy,00340eea543336d54adda18236424de6a5e91c9d,has_body
march,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412966betacovchinaiqtc012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
wh-022019,00340eea543336d54adda18236424de6a5e91c9d,has_body
signals,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412967betacovchinaiqtc022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406717betacovchinawhu022020,00340eea543336d54adda18236424de6a5e91c9d,has_body
plots,00340eea543336d54adda18236424de6a5e91c9d,has_body
evaluations,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406030betacovshenzhenhku,00340eea543336d54adda18236424de6a5e91c9d,has_body
dataset,00340eea543336d54adda18236424de6a5e91c9d,has_body
december,00340eea543336d54adda18236424de6a5e91c9d,has_body
ie,00340eea543336d54adda18236424de6a5e91c9d,has_body
clustering,00340eea543336d54adda18236424de6a5e91c9d,has_body
nucleotides,00340eea543336d54adda18236424de6a5e91c9d,has_body
hasgawa,00340eea543336d54adda18236424de6a5e91c9d,has_body
hb-012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
stigmatization,00340eea543336d54adda18236424de6a5e91c9d,has_body
sides,00340eea543336d54adda18236424de6a5e91c9d,has_body
clades,00340eea543336d54adda18236424de6a5e91c9d,has_body
possibility,00340eea543336d54adda18236424de6a5e91c9d,has_body
pneumonia,00340eea543336d54adda18236424de6a5e91c9d,has_body
wh-012019,00340eea543336d54adda18236424de6a5e91c9d,has_body
phylogeography,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406533betacovguangzhou20sf2062020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411066betacovfujian132020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411218betacovfranceidf05712020,00340eea543336d54adda18236424de6a5e91c9d,has_body
methods,00340eea543336d54adda18236424de6a5e91c9d,has_body
bayesian,00340eea543336d54adda18236424de6a5e91c9d,has_body
hotspots,00340eea543336d54adda18236424de6a5e91c9d,has_body
web,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412970betacovusawa22020,00340eea543336d54adda18236424de6a5e91c9d,has_body
values,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412972betacovmexicocdmxindre012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
gaps,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411927betacovtaiwan42020,00340eea543336d54adda18236424de6a5e91c9d,has_body
netherlands,00340eea543336d54adda18236424de6a5e91c9d,has_body
rna,00340eea543336d54adda18236424de6a5e91c9d,has_body
software,00340eea543336d54adda18236424de6a5e91c9d,has_body
hb,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl406536betacovfoshan20sf2112020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl413015betacovcanadaonvido-012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
plot,00340eea543336d54adda18236424de6a5e91c9d,has_body
sites,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl407894betacovaustraliaqld012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
articles,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl403962betacovnonthaburi612020,00340eea543336d54adda18236424de6a5e91c9d,has_body
words,00340eea543336d54adda18236424de6a5e91c9d,has_body
population,00340eea543336d54adda18236424de6a5e91c9d,has_body
sequencing,00340eea543336d54adda18236424de6a5e91c9d,has_body
hb-022019,00340eea543336d54adda18236424de6a5e91c9d,has_body
hb-042020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epidemic,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412870betacovkoreakcdc062020,00340eea543336d54adda18236424de6a5e91c9d,has_body
interpretation,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl403930betacovwuhanipbcams,00340eea543336d54adda18236424de6a5e91c9d,has_body
tracing,00340eea543336d54adda18236424de6a5e91c9d,has_body
observations,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412964,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl411951betacovsweden012020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408670betacovusawi12020,00340eea543336d54adda18236424de6a5e91c9d,has_body
pandemic,00340eea543336d54adda18236424de6a5e91c9d,has_body
peer,00340eea543336d54adda18236424de6a5e91c9d,has_body
likelihood,00340eea543336d54adda18236424de6a5e91c9d,has_body
likelihoods,00340eea543336d54adda18236424de6a5e91c9d,has_body
hb-032019,00340eea543336d54adda18236424de6a5e91c9d,has_body
treetime,00340eea543336d54adda18236424de6a5e91c9d,has_body
hypotheses,00340eea543336d54adda18236424de6a5e91c9d,has_body
diversification,00340eea543336d54adda18236424de6a5e91c9d,has_body
table,00340eea543336d54adda18236424de6a5e91c9d,has_body
stretches,00340eea543336d54adda18236424de6a5e91c9d,has_body
ones,00340eea543336d54adda18236424de6a5e91c9d,has_body
lombardy,00340eea543336d54adda18236424de6a5e91c9d,has_body
wh-052020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl412872betacovkoreakcdc122020,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl408008betacovusaca32020,00340eea543336d54adda18236424de6a5e91c9d,has_body
spearman,00340eea543336d54adda18236424de6a5e91c9d,has_body
dissemination,00340eea543336d54adda18236424de6a5e91c9d,has_body
months,00340eea543336d54adda18236424de6a5e91c9d,has_body
regions,00340eea543336d54adda18236424de6a5e91c9d,has_body
trees,00340eea543336d54adda18236424de6a5e91c9d,has_body
infection,00340eea543336d54adda18236424de6a5e91c9d,has_body
agent,00340eea543336d54adda18236424de6a5e91c9d,has_body
epiisl410713betacovsingapore72020,00340eea543336d54adda18236424de6a5e91c9d,has_body
beast,00340eea543336d54adda18236424de6a5e91c9d,has_body
tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
algorithm,00340eea543336d54adda18236424de6a5e91c9d,has_body
reality,00340eea543336d54adda18236424de6a5e91c9d,has_body
civile,00340eea543336d54adda18236424de6a5e91c9d,has_body
origin,00340eea543336d54adda18236424de6a5e91c9d,has_body
package,00340eea543336d54adda18236424de6a5e91c9d,has_body
covid-19,00340eea543336d54adda18236424de6a5e91c9d,has_body
bayesian,00340eea543336d54adda18236424de6a5e91c9d,has_body
web,00340eea543336d54adda18236424de6a5e91c9d,has_body
cov-2,00340eea543336d54adda18236424de6a5e91c9d,has_body
coronavirus,00340eea543336d54adda18236424de6a5e91c9d,has_body
content,00340eea543336d54adda18236424de6a5e91c9d,has_body
-43,00340eea543336d54adda18236424de6a5e91c9d,has_body
puzzle,00340eea543336d54adda18236424de6a5e91c9d,has_body
phylogeny,00340eea543336d54adda18236424de6a5e91c9d,has_body
quartets,00340eea543336d54adda18236424de6a5e91c9d,has_body
structure,00340eea543336d54adda18236424de6a5e91c9d,has_body
sars,00340eea543336d54adda18236424de6a5e91c9d,has_body
handbook,00340eea543336d54adda18236424de6a5e91c9d,has_body
likelihood,00340eea543336d54adda18236424de6a5e91c9d,has_body
del,00340eea543336d54adda18236424de6a5e91c9d,has_body
software,00340eea543336d54adda18236424de6a5e91c9d,has_body
mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
likelihoods,00340eea543336d54adda18236424de6a5e91c9d,has_body
situation,00340eea543336d54adda18236424de6a5e91c9d,has_body
sito,00340eea543336d54adda18236424de6a5e91c9d,has_body
phylogenies,00340eea543336d54adda18236424de6a5e91c9d,has_body
hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_body
w,00340eea543336d54adda18236424de6a5e91c9d,has_body
alignment,00340eea543336d54adda18236424de6a5e91c9d,has_body
datafrom,00340eea543336d54adda18236424de6a5e91c9d,has_body
protezione,00340eea543336d54adda18236424de6a5e91c9d,has_body
evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
protein,00340eea543336d54adda18236424de6a5e91c9d,has_body
sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
inference,00340eea543336d54adda18236424de6a5e91c9d,has_body
comparisons,00340eea543336d54adda18236424de6a5e91c9d,has_body
della,00340eea543336d54adda18236424de6a5e91c9d,has_body
emergence,00340eea543336d54adda18236424de6a5e91c9d,has_body
chloroplasts,00340eea543336d54adda18236424de6a5e91c9d,has_body
iq,00340eea543336d54adda18236424de6a5e91c9d,has_body
health,00340eea543336d54adda18236424de6a5e91c9d,has_body
analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
biology,00340eea543336d54adda18236424de6a5e91c9d,has_body
dashboard,00340eea543336d54adda18236424de6a5e91c9d,has_body
tracking,00340eea543336d54adda18236424de6a5e91c9d,has_body
data,00340eea543336d54adda18236424de6a5e91c9d,has_body
applications,00340eea543336d54adda18236424de6a5e91c9d,has_body
path,00340eea543336d54adda18236424de6a5e91c9d,has_body
phylodynamic,00340eea543336d54adda18236424de6a5e91c9d,has_body
report,00340eea543336d54adda18236424de6a5e91c9d,has_body
tempest,00340eea543336d54adda18236424de6a5e91c9d,has_body
dambe,00340eea543336d54adda18236424de6a5e91c9d,has_body
vision,00340eea543336d54adda18236424de6a5e91c9d,has_body
phylogenetic,00340eea543336d54adda18236424de6a5e91c9d,has_body
mutations,00340eea543336d54adda18236424de6a5e91c9d,has_body
o,00340eea543336d54adda18236424de6a5e91c9d,has_body
nextstrain,00340eea543336d54adda18236424de6a5e91c9d,has_body
maximum,00340eea543336d54adda18236424de6a5e91c9d,has_body
dipartimento,00340eea543336d54adda18236424de6a5e91c9d,has_body
approach,00340eea543336d54adda18236424de6a5e91c9d,has_body
sequence,00340eea543336d54adda18236424de6a5e91c9d,has_body
influenza,00340eea543336d54adda18236424de6a5e91c9d,has_body
-emergenza,00340eea543336d54adda18236424de6a5e91c9d,has_body
nazionale,00340eea543336d54adda18236424de6a5e91c9d,has_body
pathogen,00340eea543336d54adda18236424de6a5e91c9d,has_body
trees,00340eea543336d54adda18236424de6a5e91c9d,has_body
initiative,00340eea543336d54adda18236424de6a5e91c9d,has_body
Staphylococcus warneri,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
Warnerin,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
"lipase 2, Staphylococcus warneri",0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
"warnericin RB4, Staphylococcus warneri",0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
"warnericin RK, Staphylococcus warneri",0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
"((1-phenyl-2,5-di-(2-pyridyl)phosphole)gold(I)) chloride",0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
(2-benzoxazolethiolato)(triphenylphosphine)gold(I),0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
(2-naphthyl)(triphenylphosphine)gold(I),0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
"(5,10,15-tris(N-methylpyridinium-4-yl)-20-(1-pyrenyl)-porphyrinato)gold(III)",0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
"(5,10,15-tris(N-methylpyridinium-4-yl)-20-(1-pyrenyl)-porphyrinato)gold(III) chloride",0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
SARAH antigen,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
"sarah protein, Drosophila",0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
Nicolaides Baraitser syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
Nicolaides-Baraitser Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
Nicolar,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
Nicolau Livedoid Dermatitis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
Nicolau Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
"11kDa protein synthesis inhibitor, Vaccinia virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"12-kDa protein, potato virus M",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"126-kDa protein, Tobacco mosaic virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"12K late protein, Vaccinia virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"130k protein, Tobacco mosaic virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"14K protein, Borna disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"18K glycoprotein, Borna disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"1D protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
2019 novel coronavirus disease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
2019 novel coronavirus disease testing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
Antibody Production,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
Crop Production,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
Heat Production,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
Orphan Drug Production,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"PGK promoter directed over production protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"00261 long non coding RNA, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
10Sa RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
15S RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"16S RNA pseudouridine 516 synthase, E coli",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
16S Ribosomal RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"ARABIDOPSIS THALIANA REPLICATION PROTEIN A 1A protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
Autonomous Replication,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"Chromosome Replication Order, Temporal",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"Chromosome Replication Pattern, Temporal",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
Chromosome Replication Timing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
A-Loop,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Afferent Loop Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Ascending Limb of Loop of Henle,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Basic Helix-Loop-Helix Transcription Factors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Achaete-Scute Complex Genome Region,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Bacterial Genome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Bacterial Genomes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Chloroplast Genome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Chloroplast Genome-Encoded Proteins,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ANTI-SILENCING FUNCTION 1A protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ANTI-SILENCING FUNCTION 1B protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ASF1 anti-silencing function 1 homolog A (S. cerevisiae) protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ASF1 anti-silencing function 1 homolog B (S. cerevisiae) protein, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Adrenal Cortex Function Tests,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Amino Acid Activation, Translational",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Amino Acid Modification, Co-Translational",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Amino Acid Modification, Post-Translational",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Amino Acid Modification, Pre-Translational",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Amino Acid Modification, Translational",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Chromosome 6 open reading frame 106, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Chromosome 9 Open Reading Frame 72 Protein,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Covalent Organic Framework,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Frame Shift Mutation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Frameless Stereotaxy,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Sickness Presence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ACV1, Conus textile",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Conus textile toxin,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Industry, Textile",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Q8009 protease, Pseudonaja textilis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Text Messages,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"2',3'-Cyclic Nucleotide 3'-Phosphodiesterase",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"2',3'-Cyclic Nucleotide 3'-Phosphodiesterases",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"2',3'-Cyclic Nucleotide Phosphodiesterase",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"2',3'-Cyclic Nucleotide Phosphodiesterases",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"2',3'-Cyclic-Nucleotide Phosphodiesterases",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"14K protein, Borna disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"18K glycoprotein, Borna disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"1D protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
2019 novel coronavirus disease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
2019 novel coronavirus disease testing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Belofor KB,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Belofor KB, disodium salt",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"CLC-Kb channel, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Chromosome 1q21.1 Deletion Syndrome, 200-Kb",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Clearfil KB 1300,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"1D protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"3ABC protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"3C protease, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"3D protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Anus, Imperforate, with Hand, Foot, and Ear Anomalies",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Iressa,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
iresin,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"00261 long non coding RNA, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
10Sa RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
15S RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"16S RNA pseudouridine 516 synthase, E coli",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
16S Ribosomal RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ABERRANT TESTA SHAPE protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ABNORMAL LEAF SHAPE 1 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Angel shaped phalangoepiphyseal dysplasia,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Angel-Shaped Phalangoepiphyseal Dysplasia,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Angel-shaped phalango-epiphyseal dysplasia,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
10p Deletion Syndrome (Partial),0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
10q- deletion,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
11p Deletion Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
11q Deletion Disorder,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
11q Deletion Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Abstracting,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Abstracting and Indexing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Abstracting and Indexing as Topic,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Abstracting as Topic,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Abstracts,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"((3alpha,3'alpha,4beta,4'beta)-3,3')-dimethoxy-cis-(4,4'-bis(3,4,5,10-tetrahydro-1H-naphtho(2,3-)pyran))-5,5',10,10'-tetraone",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
((cis-Pt(NH(3))(2))(2)(mu-OH)(mu-pyrazolate))(2+),0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"((cis-Pt(NH3)2Cl)2 4,4'-dipyridyl sulfide(NO3)2)",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
((cis-Pt(NH3)2Cl)2 bpsu(NO3)2),0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
((cis-RuCl2(Me2SO)3)H2N(CH2)4NH2(cis-PtCl2(NH3))),0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
AMP-PK reactivator,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Ac-pk-1 protein, Autographa californica nucleopolyhedrovirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"CRK4 PK, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
CaM PK II,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Calcium-Calmodulin-Dependent PK Type II,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Animal Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Civil Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Collective Human Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Equal Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Health Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
(+)-alpha-polypodatetraene,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
(+)-alpha-tocopheryl polyethylene glycol 1000 succinate,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"(1,4-bis(3-pyridyl)-2,3-diazo-1,3-butadiene)dichlorozinc(II) polymer",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
(2'-5')An Polymerase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
(2'-5')tetraadenylate-polylysine,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Actinoid Series Elements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Fourier Series,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Interrupted Time Series,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Interrupted Time Series Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Lanthanoid Series Elements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Chromosome 6 open reading frame 106, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Chromosome 9 Open Reading Frame 72 Protein,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Compulsive Reading,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Developmental Reading Disorder,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Epilepsy, Reading",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
3' UTR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
3'UTR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
5' UTR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
5'UTR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
COP9 Signalsome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Constitutive Photomorphogenesis 9 Signalsome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Nuclear Export Signals,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Nuclear Localization Signals,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Peroxisomal Targeting Signals,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Bacterial Genomes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Genomes, Bacterial",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Plastid Genomes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
(+)-13-stemarene,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"(-)-9,10-epi-stemoamide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
8-epi-stemoamide,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"9,10-epi-stemoamide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
9a-epi-stemaphylline,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Computerized Physician Order Entry,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Computerized Physician Order Entry System,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Computerized Provider Order Entry,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Computerized Provider Order Entry System,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
DNA entry nuclease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
2 mu circle site-specific recombinase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
3' Splice Site,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
5' Splice Site,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
ARF nucleotide-binding-site opener,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Abelson helper integration site 1 protein, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Financial Contributions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
((17-N-cyclobutylmethyl)morphinan-3-yl-(-14-hydroxyl-17-N-cyclobutylmethyl) morphinan-3-yl) decanedioate,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"(+)-Larreatricin hydroxylase, creosote bush",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"(+)-larreatricin hydroxylase, Larrea tridentata",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
(+-)-E-4-methyl-2-((E)-hydroxylamino)-5-nitro-6-methoxy-3-hexanamide,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"(1R)-(4-hydroxybenzyl)-7-hydroxyl-8-O-beta-D-glucopyranosyl-1,2,3,4-tetrahydroisoquinoline",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ALB protein, human (Kenitra mutation)",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Activation Mutation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Amber Nonsense Mutation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Analysis, DNA Mutational",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Autoimmune Lymphoproliferative Disease without Fas Mutations,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"BRF1 homolog, subunit of RNA polymerase III transcription initiation factor IIIB (S. cerevisiae) protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"BRF2 RNA polymerase III transcription initiation factor subunit protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"BRF2, subunit of RNA polymerase III transcription initiation factor, BRF1-like protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"C2 translation initiation factor, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Adenine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Cytosine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Deoxyadenine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Deoxycytosine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Deoxyguanine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Picornaviruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ARABIDOPSIS THALIANA REPLICATION PROTEIN A 1A protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Autonomous Replication,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Chromosome Replication Order, Temporal",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Chromosome Replication Pattern, Temporal",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Chromosome Replication Timing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"(((12aR)-12-((11S)-7,8-difluoro-6,11-dihydrodibenzo(b,E)thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12ahexahydro-1H-(1,4)oxazino(3,4-C)pyrido(2,1-F)(1,2,4)triazin-7-yl)oxy)methyl methyl carbonate",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
((11)C)(R)-1-(4-(2-(4-methoxyphenyl)phenyl)piperazin-1-yl)-3-(2-pyrazinyloxy)-2-propanol,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
((11)C)1-(7-methoxy- quinolin-4-yl)-3-(6-(trifluoromethyl)pyridin-2-yl)urea,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"((11)C)2-(2',6'-dimethoxy-(1,1'-biphenyl)-3-yl)-N,N-dimethylethanamine",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
((11)C)3'-Me-BTA-1,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Acetylation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"REDUCED WALL ACETYLATION2 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"will decrease acetylation protein, Drosophila",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Animal Experiments,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"11kDa protein synthesis inhibitor, Vaccinia virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"12-kDa protein, potato virus M",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"126-kDa protein, Tobacco mosaic virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"12K late protein, Vaccinia virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"130k protein, Tobacco mosaic virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Abuse Reporting,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Adverse Drug Reaction Reporting Systems,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Age Reporting,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Annual Report,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Annual Reports as Topic,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"3ABC protein, FMDV",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"3D protein, FMDV",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
FMDV 15 peptide,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"FMDV 3C protease, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
FMDV L proteinase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Bilateral, annular limbal dermoids with corneal and conjunctival extension",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Cell Membrane Extensions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Cell Surface Extensions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Extracapsular Extension,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Extranodal Extension,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
AFLP Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Activation Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Activation Analysis, Neutron",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Actuarial Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Amino Acid Sequence Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
CRE 1087,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
CRE 10904,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
CRE 223,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
CRE-1087,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
CRE-10904,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Equipment Reuse,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
3' Untranslated Regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
5' Untranslated Regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Antarctic Regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Arctic Regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Body Regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
PKS beta-ketoacyl synthase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
PKS ketoreductase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
AAA Domains,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
ANK Repeat Domains,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ARF-GAP with GTP-binding protein-like, ankyrin repeat and pleckstrin homology domains 1, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ARF-GAP with GTP-binding protein-like, ankyrin repeat and pleckstrin homology domains 1, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ARF-GAP with GTP-binding protein-like, ankyrin repeat and pleckstrin homology domains 1, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Advantage adhesive,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Advantage-S,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Medicare Advantage,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
DNA Packaging,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"DNA cleavage and packaging proteins, Herpesvirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Drug Packaging,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Edible Food Packaging Materials,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Edible Packaging,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"A-T tract-binding protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Atrio-Hisian Bypass Tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Atriohisian Tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Biliary Tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Biliary Tract Cancer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"30S Ribosome Subunits, Archaeal",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"30S Ribosome Subunits, Bacterial",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
40S Ribosome Subunits,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"50S Ribosome Subunits, Archaeal",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"50S Ribosome Subunits, Bacterial",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
ABC primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Alloy Primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Angel I Self-Etch Primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Cesead Opaque Primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Clearfil Ceramic Primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Animal Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Bacterial Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Cell Membrane Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Cell Nucleus Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Cellular Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Alu Repetitive Sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amino Acid Sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
CRISPR Sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
CRISPR Spacer Sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA Sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA Primers,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Oligodeoxyribonucleotide Primers,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Oligonucleotide Primers,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
RNA primers,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amenorrhea-Galactorrhea-FSH Decrease Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Brittle Hair-Intellectual Impairment-Decreased Fertility-Short Stature Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Bulbocavernosus Reflex, Decreased",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"DECREASE WAX BIOSYNTHESIS2 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"DECREASED DNA METHYLATION 1 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
68Ga-NEB,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
7-C-NEB cpd,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"NEB protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
NEB-LFamide,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Neb protein, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Ligation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Ligation, Tubal",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Multiplex Ligation-Dependent Probe Amplification,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Tubal Ligation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Vas Ligation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(Hse lactone-52)-52,53-seco-bovine basic pancreatic trypsin inhibitor",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(Myelin Basic Protein)-Arginine N-Methyltransferase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"119-Gly-131-Gly-dansyl myelin basic protein, synthetic",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ARABIDOPSIS THALIANA BASIC LEUCINE ZIPPER 10 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Amino Acid Transport Systems, Basic",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5-hydroxymethyl(blasticidin S),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Anemia, Refractory, with Excess of Blasts",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
B-Cell Blast-2 Antigen,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
B-Lymphocyte Activation Marker BLAST-1,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"BLAST1 protein, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Amino Acid Metabolism, Inborn Error",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Amino Acid Metabolism, Inborn Errors",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Carbohydrate Metabolism, Inborn Error",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Carbohydrate Metabolism, Inborn Errors",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Congenital Errors of Steroid Metabolism,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Animal Experiments,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AU Rich Elements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Actinoid Series Elements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Alu Elements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Anti-Oxidant Response Elements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Anti-Sense Elements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
BTV 17 VP2,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bluetongue virus VP2,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Chicken anemia virus capsid protein VP2,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Rhinovirus VP2,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"SVDV VP2 protein, Swine vesicular disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Acromegaloid features, overgrowth, cleft palate, and hernia",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Autosomal dominant partial epilepsy with auditory features,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bird-headed dwarfism with features of premature senility,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
CMT with Pyramidal Features,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cerebellar Vermis Aplasia with Associated Features suggesting Smith-Lemli-Opitz Syndrome and Meckel Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Bond Issues, Construction",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Construction Industry,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Construction Loans,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Construction Materials,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Construction Trades,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Truncation Bias,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Truncation Biases,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"truncation of C-mip protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Ankyrin Repeats,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Ankyrin-Like Repeats,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"B cell scaffold protein with ankyrin repeats 1 protein, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"B-cell scaffold protein with ankyrin repeats 1 protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Clustered Regularly Interspaced Short Palindromic Repeats,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Abortifacient Effects,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adrenergic Effects,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Adverse Effects, Long Term",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Anabolic Effects,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Androgen Effects,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Base Pairing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Chromosome Pairing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"homologous pairing protein 2, S cerevisiae",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Prepapillary Vascular Loops,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Preretinal Vascular Loops,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
R-Loops,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
NMIA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
SEM-76,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"SeM protein, Streptococcus equi",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Sem D,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Sem-2 protein, C elegans",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Sem-5 protein, C elegans",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Bond Issues, Construction",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Construction Industry,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Construction Loans,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Construction Materials,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Construction Trades,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
LLC-PK1 Cells,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
PK1 compound,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"PK1 protein, Toxoplasma gondii",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"B lymphoma Mo-MLV insertion region (mouse) protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"B lymphoma Mo-MLV insertion region 1 homolog (mouse) protein, zebrafish",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"B lymphoma Mo-MLV insertion region 1 protein, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"B lymphoma Mo-MLV insertion region 1 protein, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA Insertion Elements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Genes, Reporter",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Reporter Genes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
reporter RNA-biotin-avidin,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Abuse Reporting,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adverse Drug Reaction Reporting Systems,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Age Reporting,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Annual Report,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Annual Reports as Topic,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA modification methylase KpnI,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
KpnI endonuclease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
KpnI methylase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
endodeoxyribonuclease KpnI,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Chromatography, Reverse-Phase",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Chromatography, Reversed-Phase Liquid",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA reverse gyrase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
HIV Reverse Transcriptase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
HIV-1 Reverse Transcriptase p51,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Physiological Stress Reactivity,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA Restriction Enzyme HindIII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA modification methylase HindIII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Deoxyribonuclease HindIII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Endonuclease HindIII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
HindIII methylase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(99)mTc-(CO)(3) His-annexin A5,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(99m)Tc (CO)3 His-ann A5,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3''-O-propionylleucomycin A5,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
99m-Tc-HYNIC-annexin A5,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
99mTc-Cys-annexin A5,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Administration, Library",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Associations, Library",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Catalogs, Library",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA Library,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Dental Library,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AFLP Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Activation Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Activation Analysis, Neutron",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Actuarial Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amino Acid Sequence Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ABC primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Alloy Primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Angel I Self-Etch Primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cesead Opaque Primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Clearfil Ceramic Primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"SAM domain, SH3 domain and nuclear localisation signals, 1 protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacteriocin Plasmids,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Colicin Plasmids,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
F Plasmids,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Plant Tumor-Inducing Plasmids,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Plasmids,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adverse Herb-Drug Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"AtSR1-interaction protein 1, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacteria Host Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterial-Host Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterium-Host Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AatII endonuclease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
endodeoxyribonuclease AatII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
endonuclease AatII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
10p Deletion Syndrome (Partial),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
10q- deletion,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
11p Deletion Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
11q Deletion Disorder,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
11q Deletion Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adverse Herb-Drug Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacteria Host Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterial-Host Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterium-Host Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Beneficial Herb-Drug Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Acupuncture Treatment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
After-Treatment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Assertive Community Treatment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Atraumatic Restorative Treatment, Dental",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Boots Threadworm Treatment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"multiple copies in T-cell malignancy protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
In Vitro Gene Fusion Mutagenesis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Insertional Mutagenesis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Linker-Insertion Mutagenesis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"MucA mutagenesis protein, Bacteria",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Mutagenesis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"C-Kit protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
CHMFL-ABL KIT-155,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
CHMFL-KIT-110,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"KIT ligand protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"KIT protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3ABC protein, FMDV",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3D protein, FMDV",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
FMDV 15 peptide,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"FMDV 3C protease, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
FMDV L proteinase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Acoustic Evoked Brain Stem Potential,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Acoustic Evoked Brain Stem Potentials,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Acoustic Evoked Brainstem Potential,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Acoustic Evoked Brainstem Potentials,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Action Potential Optical Mapping,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"( R)-6-(( S)-2-hydroxy-4-(4-hydroxyphenyl)butyl)-5,6-dihydropyran-2-one",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((-)-7-(3-(R)-amino-2-(S)-methyl-1-azetidinyl)-8-chloro-1-cyclopropyl-1,4-dihydro-6-fluoro-4-oxo-3-quinolinecarboxylic acid)",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((1-methyl)ethoxycarbonyloxy)-ethyl 7-(2-(2-amino-4-thiazole)-2-methoxyaminoacetamido)-3-(2-propenyl)-3-cephem-4-carboxylate, (6R-(2(S*)),6alpha,7beta(Z)) isomer",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((123)I)-16-iodo-3R,S-methylhexadecanoic acid",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((1R,5S,6S)-6((R))-1-hydroxyethyl-2-((3S,5S)-5(S-methyl-4-thiomorpholin ylcarbonyl)pyrrolidin-3-thio))-l-methylcarbapen-2-em-3- carboxylic acid",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Anemia, Sickle Cell",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Deoxygenated Sickle Hemoglobin,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Hb sickle D-Iran,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Hb sickle-Lepore,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Hemoglobin, Sickle",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Animal Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterial Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cell Membrane Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cell Nucleus Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cellular Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(-)-O-((2'-ethylphenyl)carbamoyl)geneseroline hydrochloride,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amber Suppressor Genes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Archaeal Genes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Artificial Genes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterial Genes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
FM-VP4 compound,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
FM-VP4 cpd,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
IBDVP2 VP4,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"VP4 protease, IPNV",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"VP4 protease, birnavirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Animal Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Civil Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Collective Human Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Equal Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Health Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ARABIDOPSIS THALIANA REPLICATION PROTEIN A 1A protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Autonomous Replication,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Chromosome Replication Order, Temporal",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Chromosome Replication Pattern, Temporal",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Chromosome Replication Timing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Biohazard Containment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Biohazards Containment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Biological Containment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Containment of Biohazards,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Containment, Biologic",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Picornaviruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(((12aR)-12-((11S)-7,8-difluoro-6,11-dihydrodibenzo(b,E)thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12ahexahydro-1H-(1,4)oxazino(3,4-C)pyrido(2,1-F)(1,2,4)triazin-7-yl)oxy)methyl methyl carbonate",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((11)C)(R)-1-(4-(2-(4-methoxyphenyl)phenyl)piperazin-1-yl)-3-(2-pyrazinyloxy)-2-propanol,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((11)C)1-(7-methoxy- quinolin-4-yl)-3-(6-(trifluoromethyl)pyridin-2-yl)urea,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((11)C)2-(2',6'-dimethoxy-(1,1'-biphenyl)-3-yl)-N,N-dimethylethanamine",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((11)C)3'-Me-BTA-1,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"GLABROUS INFLORESCENCE STEMS protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"GLABROUS INFLORESCENCE STEMS3 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Plant Stems,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
26RFa prepro-neuropeptide,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"8-Quinolinol, 5-chloro-7-iodo-, mixt. with calamine (pharmaceutical preparation) and zinc oxide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AMT preparation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Analytic Sample Preparation Methods,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Aqua-Prep,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"AFG3 ATPase family gene 3-like 1 (yeast) protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"AHA1, activator of heat shock 90kDa protein ATPase homolog 1 (yeast), human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"APC11 anaphase promoting complex subunit 11 homolog (yeast) protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ARP1 actin-related protein 1 homolog A (yeast), mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ARP2 actin-related protein 2 homolog (yeast), human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Numbers Needed To Treat,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"COL1 protein, Ophiostoma novo-ulmi",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"CYP108D1, Novosphingobium aromaticivorans",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Ildamen-Novodigal,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Insulin Novo Monotard,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Mycobacterium novocastrense,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Absence Seizure Disorder,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Absence Seizures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Absence Status,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Absence defect of limbs, scalp, and skull",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Absence of Brain, Congenital",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Axenic Culture,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Axenic Cultures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
BGJ culture medium,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Batch Cell Culture Techniques,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Batch Culture,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
High Cholesterol Levels,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
urinary levels,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
2-isopentenyl tRNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2-methylthio-N6-isopentenyl-adenosine(37)-tRNA monooxygenase, Salmonella typhimurium",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
2-nitro-4-azidobenzoyl-Phe-tRNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
2-nitro-4-azidobenzoyl-phenylalanine-tRNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
2-nitro-4-azidobenzoyl-phenylalanyl-tRNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3' Untranslated Regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5' Untranslated Regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Antarctic Regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Arctic Regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Body Regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AflII endonuclease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AflIII endonuclease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
endodeoxyribonuclease AflII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
endodeoxyribonuclease AflIII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
endonuclease AflII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Antitumor Assays, Xenograft Model",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Antitumor Drug Screening Assays,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Assays, Biological",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Biologic Assays,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bioluminescent Assays,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
PKS beta-ketoacyl synthase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
PKS ketoreductase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Dentistry, Evidence-Based",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Emergency Medicine, Evidence-Based",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Evidence Based Health Care Management,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Evidence Based Healthcare Management,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Evidence Based Management, Health Care",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amycolatopsis speibonae,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
SpeI endonuclease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Streptomyces speibonae,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
endodeoxyribonuclease SpeI,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Preprint,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Preprints,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Preprints as Topic,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(+)-13-stemarene,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(-)-9,10-epi-stemoamide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
8-epi-stemoamide,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"9,10-epi-stemoamide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
9a-epi-stemaphylline,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Infections, Picornavirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Picornavirus Infections,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Picornaviruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"picornain 2A, Picornavirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"proteinase 2A, Picornavirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterial Genomes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Genomes, Bacterial",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Plastid Genomes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ATP-Dependent DNase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Acid DNase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Alkaline DNase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"CAD DNase, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Ca Mg DNASE,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"0.3 protein, Enterobacteria phage T7",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"0.7 protein, Enterobacteria phage T7",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacteriophage T7,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacteriophage T7 Gene 4 Protein,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Coliphage T7,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Dietary Requirements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Nutrition Requirements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Nutritional Requirements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Serial Passage,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Individual Differences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Sex Differences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Actinoid Series Elements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Fourier Series,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Interrupted Time Series,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Interrupted Time Series Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Lanthanoid Series Elements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Gender Role,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Judicial Role,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Man's Role,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Men's Role,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Nurse's Role,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((4aR)-1-(4-Fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-1,4,5,6,7,8-hexahydro-4aH-pyrazolo(3,4-g)isoquinolin-4a-yl)(4-(trifluoromethyl)-2-pyridinyl)methanone",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(+)-sarcodonin G,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(-)-sarcodonin G,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(1,2,3)triazolo(3,4-g)quinoxaline",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(11,12)-dihydrodibenzo(c,g)(1,2)dithiocine",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Paced Auditory Serial Addition Test,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Terminal Addition Enzyme,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"additional Sex Comb-Like 1 protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"additional Sex Comb-Like 2 protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"additional sex combs like 1 (Drosophila) protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2-DG-1,6-P2",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3'-deoxy-2',3'-didehydrothymidine P2-ethyl 5'-P1-diphosphate",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"60S acidic ribosomal protein P2, Trypanosoma cruzi",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AD-p2,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AZT(p2)AZT,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Amplification Technics, Nucleic Acid",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Amplification Techniques, Nucleic Acid",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bio Amplification,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bio-amplification,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Branched DNA Signal Amplification Assay,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
C0-05 ADP-ribosyltransferase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pneumocandin C0,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"DMC1 dosage suppressor of mck1 homolog, meiosis-specific homologous recombination (yeast) protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA Repair And Recombination Protein RAD52,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Genetic Recombination,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
HIN Recombinational Enhancer Binding Protein,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Homologous Recombination,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Competition, Economic",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Competition, Managed",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Economic Competition,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Managed Competition,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
1-fetoprotein transcription factor,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5S Gene-Specific Transcription Factor,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5S RNA Gene Transcription Factor,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ABA-INDUCIBLE BHLH-TYPE TRANSCRIPTION FACTOR, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ABFI transcription factor, S cerevisiae",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Antigen-Antibody Reactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Blood Transfusion-Associated Adverse Reactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Click Chemical Reactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cross Reactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Dark Reactions of Photosynthesis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ABERRANT TESTA SHAPE protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ABNORMAL LEAF SHAPE 1 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Angel shaped phalangoepiphyseal dysplasia,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Angel-Shaped Phalangoepiphyseal Dysplasia,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Angel-shaped phalango-epiphyseal dysplasia,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Sickness Presence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(2'-5')An Polymerase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2',5'-Oligo(A) Polymerase",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2',5'-Oligoadenylate Polymerase",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2,3,7,8-tetrachlorodibenzo-p-dioxin poly(ADP-ribose) polymerase, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2,3,7,8-tetrachlorodibenzo-p-dioxin poly(ADP-ribose) polymerase, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(+)-alpha-polypodatetraene,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(+)-alpha-tocopheryl polyethylene glycol 1000 succinate,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(1,4-bis(3-pyridyl)-2,3-diazo-1,3-butadiene)dichlorozinc(II) polymer",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(2'-5')An Polymerase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(2'-5')tetraadenylate-polylysine,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
UD CG 115,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
UD CG 212 Cl,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
UD-170A,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
UD-CG 115,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
UD-CG-212-Cl,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ABERRANT LATERAL ROOT FORMATION 5 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Acrosome formation associated factor, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Antibody Formation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Body Pattern Formation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bone Formation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3' UTR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3'UTR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5' UTR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5'UTR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
COP9 Signalsome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Constitutive Photomorphogenesis 9 Signalsome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Nuclear Export Signals,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Nuclear Localization Signals,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Peroxisomal Targeting Signals,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Hospitals, Packaged",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Package Inserts,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Package Inserts, Drug",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Packaged Hospitals,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Dietary Requirements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
High-Temperature Requirement A Serine Peptidase 1,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
High-Temperature Requirement A Serine Peptidase 2,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"N REQUIREMENT GENE 1.1 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"N REQUIREMENT GENE 1.2 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"00261 long non coding RNA, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
10Sa RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
15S RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"16S RNA pseudouridine 516 synthase, E coli",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
16S Ribosomal RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ATP synthase mitochondrial F1 complex assembly factor 1 protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ATP synthase mitochondrial F1 complex assembly factor 1, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ATP synthase mitochondrial F1 complex assembly factor 2 protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ATP synthase mitochondrial F1 complex assembly factor 2, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ATP-dependent chromatin assembly factor large subunit protein, Drosophila",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Arterial Lines,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Intra-Arterial Lines,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Linesterol,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Linestrenol,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Teosyal 27G Deep Lines,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Data Files,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Machine-Readable Data Files,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3D Molecular Structure,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5' mRNA Cap Structure,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Animal Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterial Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cell Membrane Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AMP-PK reactivator,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Ac-pk-1 protein, Autographa californica nucleopolyhedrovirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"CRK4 PK, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
CaM PK II,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Calcium-Calmodulin-Dependent PK Type II,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA Packaging,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"DNA cleavage and packaging proteins, Herpesvirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Drug Packaging,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Edible Food Packaging Materials,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Edible Packaging,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"BCR downstream signaling 1 protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"CEP DOWNSTREAM 1 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"CEP DOWNSTREAM 2 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Downstream Regulatory Element Antagonist Modulator,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Downstream of raf1 protein, Drosophila",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"60 kDa nuclear localization signal binding protein, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"AT-HOOK MOTIF NUCLEAR LOCALIZED protein 3, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"AT-HOOK MOTIF NUCLEAR LOCALIZED protein 4, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"AT-hook motif nuclear localized 22 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"AT-hook motif nuclear localized protein 1, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacteria Host Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterial-Host Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterium-Host Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
C1 Host Cell Factor,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"C2 host cell factor, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Copyright,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cultural Disadvantagement,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Disadvantaged,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Behavior Observation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Behavior Observation Techniques,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Behavioral Observation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Behavioral Observation Techniques,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Clinical Observation Units,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2A protease, mengovirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2A protein, mengovirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2A proteinase, Mengovirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Mengo Virus,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Mengovirus,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(2'-5')ppp3'dA(p3'dA),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
1-O-OHTHFGlc P3,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
15-MA-P3,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3-amino-3-deoxy-Ins(1,4,5)P3",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3-deoxy-3-fluoro-Ins(1,4,5)P3",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"11kDa protein synthesis inhibitor, Vaccinia virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adrenal Steroid Synthesis Inhibitors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adrenergic Synthesis Inhibitors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Androgen Synthesis Inhibitors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Bile Acid Synthesis Defect, Congenital, 3",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Anchored PCR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Arbitrarily Primed PCR Reaction,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DISC-PCR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Direct In Situ Copy PCR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"GIP (G-PCR interacting protein), human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Date Fruit,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Date Palm Fruit,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Date Palm Trees,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Date Palms,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Dates,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"BARS protein, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"BARS50 protein, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
De Barsy Moens Diercks syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
De Barsy syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Progeroid syndrome of De Barsy,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
68Ga-DOTAGA-(3-iodo-y)fk(Sub-KuE),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
68Ga-DOTAGA-(I-y)fk(Sub-KuE),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ATP Binding Cassette Transporter, Sub-Family A",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ATP Binding Cassette Transporter, Sub-Family A, Member 4",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ATP Binding Cassette Transporter, Sub-Family B",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Algorithms,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2,3,5-triiodobenzoyl potato starch",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2,3,5-triiodobenzoyl starch",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
2-hydroxypropyl starch,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
2-hydroxypropyl starch ether,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ADP Glucose Starch Glucosyltransferase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Blood Component Removal,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Device Removal,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Hair Removal,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Leukocyte Removal Procedures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
mycoplasma removal agent,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"A-T tract-binding protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Atrio-Hisian Bypass Tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Atriohisian Tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Biliary Tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Biliary Tract Cancer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Arachnid Vectors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Arthropod Vectors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cloning Vectors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Disease Vectors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Genetic Vectors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Antenatal Screening,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Anti-Cancer Drug Screens,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Antitumor Drug Screening Assays,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Antitumor Drug Screens,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cancer Screening,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(((1,2-dihydro-2-oxo-4-quinolinyl)methyl)thio)-N-(((4-(1-piperidinylmethyl)-2-pyridinyl)oxy)-2-butenyl)acetamide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(((2-(2-(2,4-dichlorophenyl)-4-(2-methyl-3-chlorophenyl)-1-ylmethyl)carbamoyl)methyl)-5-oxopyrrole-1-yl)-N-(3-piperidinylpropyl)acetamide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(((4-(4-amidino-N-methylbenzamido)acetyl)-1,2-phenylene)dioxy)diacetic acid",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(((5-(6-(oxolan-3-yl)amino)purin-9-yl)-3,4-dihydroxyoxolan-2-yl)methoxy)-N-methylcarboxamide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((+)-4-((alphaR)-alpha-((2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl)-(3-phenyl)methyl)-N,N-diethylbenzamide)",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
111In-nuclear translocation sequence-7G3,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3' Flanking Sequence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5' Flanking Sequence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5' TOP Sequence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AAUAAA RNA Sequence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
A-Loop,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Afferent Loop Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Ascending Limb of Loop of Henle,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Basic Helix-Loop-Helix Transcription Factors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Arachnid Vectors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Arthropod Vectors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cloning Vectors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Coxiella burnetii Vector-Borne Disease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Disease Vectors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Demographic Impact,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Demographic Impacts,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Environmental Impact,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Environmental Impacts,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Fecal Impaction,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Autoimmune Lymphoproliferative Disease without Fas Mutations,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Autoimmune lymphoproliferative syndrome without FAS mutations,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Encephalopathy, Neonatal Severe, Due To Mecp2 Mutations",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Lipodystrophy, Familial Partial, Associated With PPARg Mutations",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Mutations, Silent",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"1-H-2-NADO, Pseudomonas sp. strain PP2",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"1-hydroxy-2-naphthoic acid dioxygenase, Pseudomonas sp. strain PP2",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
129 Strain Mice,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
129 Strain Mouse,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Acinetobacter junii strain 65 O-antigen,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Host-Searching Behavior,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Search Engine,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Searching Behavior,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(R)-alpha-(N6-adenyl)styrene oxide-DNA adduct,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"1,2-cyclohexanediamine platinum(II)-DNA complex",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
10-23 DNA enzyme,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
2-AMIQ-DNA adduct,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2-amino-1-methyl-6-phenolimidazo(4,5-b)pyridine-DNA adduct",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
APC Viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adeno-Associated Viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
African Swine Fever-Like Viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Algal Viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Animal Viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"1,17-DATAH",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amino Acid Sequence Databases,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Automatic Data Processing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Big Data,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Clinical Trials Data Monitoring Committees,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3ABC protein, FMDV",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3D protein, FMDV",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
FMDV 15 peptide,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"FMDV 3C protease, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
FMDV L proteinase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Digestion,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Protein Digestion,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Genetic Heterogeneity,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Heterogeneity, Genetic",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Population Heterogeneity,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Poliovirus capsid protein VP0,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"VP0 protein, Poliovirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"viral outer coat protein VP0, Poliovirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Absolute Risk Reduction,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Animal Testing Reduction, Refinement and Replacement",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Annular Reduction, Cardiac Valve",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Annulus Reduction, Cardiac Valve",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"CHLORORESPIRATORY REDUCTION 2 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Computer Applications Software,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Computer Software,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Computer Software Applications,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Portable Software Applications,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Portable Software Apps,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adenine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cytosine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Deoxyadenine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Deoxycytosine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Deoxyguanine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"sperm forward motility protein, Bos taurus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Chicken Ovalbumin Upstream Promoter-Transcription Factor I,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Chicken Ovalbumin Upstream Promoter-Transcription Factor II,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Chicken Ovalbumin Upstream Promoter-Transcription Factors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Far upstream element binding protein 1, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
MAP kinase upstream kinase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
293T Cells,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3T3 Cells,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3T3 Cells, BALB",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3T3 Cells, NIH",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3T3-L1 Cells,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Arthrogryposis multiplex congenita, pulmonary hypoplasia, cryptorchidism, and unusual ophthalmological findings",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Incidental Findings,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Morphological and Microscopic Findings,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Neurologic Findings,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Reproducibility of Findings,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Global Trigger Tool, Healthcare",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Healthcare Global Trigger Tool,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Retained Surgical Tools,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
STOPP (Screening Tool of Older Person's Potentially Inappropriate Prescriptions),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Screening Tool of Older Person's Potentially Inappropriate Prescriptions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(1-6)-beta-D-glucan-protein complex,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(125I)IPOS protein,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(2Fe-2S) protein I,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(3H-MeSO2)2TCB-binding protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(6-4) photolyase protein, Xenopus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
4-DOI,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DOI cpd,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DOI-P,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DOI-aminopropane,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
L-glutamine DOI aminotransferase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Transfection,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Atypical Squamous Cells of Undetermined Significance,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Monoclonal Gammapathy of Undetermined Significance,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Monoclonal Gammopathy of Undetermined Significance,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(N-MeCys(3),N-MeCys(7))TANDEM",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(N-MeCys(3)-N-MeCys(7))TANDEM,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(N-methylcysteinyl(3)-N-methylcysteinyl(7))TANDEM,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ATP-binding cassette, sub-family C (CFTR-MRP), member 6b, tandem duplicate 1 protein, zebrafish",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ATPase Na+-K+ transporting subunit alpha 1a, tandem duplicate 1 protein, zebrafish",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Kathon WT,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Minibody (WT),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
WT Limb-Blood Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
WT limb blood syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"WT-1 protein, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Action Potential Optical Mapping,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Anatomic Electrical Activity Optical Mapping,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Body Surface Mapping,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Body Surface Potential Mapping,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Brain Electrical Activity Mapping,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Ciliary Discoordination Due To Random Ciliary Orientation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cognitive Orientation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Compass Orientation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Employee Orientation Programs,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Mental Orientation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Tandem Affinity Purification,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Water Purification,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
isolation & purification,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
isolation and purification,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
purification,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
10q duplication syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
22q11.2 Duplication,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Aphalangia, Partial, with Syndactyly and Duplication of Metatarsal IV",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Brachydactyly of the hands and feet with duplication of the first toes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Caudal Duplication Anomaly,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Grants, Peer Review",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Organizations, Peer Review",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Peer Group,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Peer Influence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Peer Pressure,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"173-527-plasminogen activator (human tissue-type), 173-L-serine-174-L-tyrosine-175-L-glutamine-",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Abdominal Adipose Tissue,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Abdominal Subcutaneous Adipose Tissue,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Aberrant Tissue,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Acellular Dermal Graft Tissue,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ArdC protein, IncW plasmid pSa",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacteriocin Plasmids,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"CcdB killer protein, Plasmid F",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"CcdB protein, Plasmid F",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Colicin Plasmids,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Advantage adhesive,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Advantage-S,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Medicare Advantage,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(Pro)3 AII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(Sar(1),Ile(5),(4'N3)Phe(8))AII",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(Sar)5 AII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(Sar1)-AII(1-7)-NH2,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
1-Sar-8-Phe-AII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Family with sequence similarity 3 member D protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Family with sequence similarity 3 member D protein, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"family with sequence similarity 101, member A protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"family with sequence similarity 101, member A protein, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"family with sequence similarity 101, member B protein, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(But-Cys18)(19-37)-fragment betaCGRP,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(N-acetyl-tyr1,D-arg2)fragment 1-29 amide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
285-292 IgG fragment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5.2-OKT3 bispecific single-chain antibody fragment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amplified Fragment Length Polymorphism Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
2 mu circle site-specific recombinase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3' Splice Site,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5' Splice Site,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ARF nucleotide-binding-site opener,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Abelson helper integration site 1 protein, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Equipment Reuse,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ANTI-SILENCING FUNCTION 1A protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ANTI-SILENCING FUNCTION 1B protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ASF1 anti-silencing function 1 homolog A (S. cerevisiae) protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ASF1 anti-silencing function 1 homolog B (S. cerevisiae) protein, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adrenal Cortex Function Tests,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adult Survivors of Child Adverse Events,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Anniversaries and Special Events,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Der(22) Syndrome Due To 3:1 Meiotic Disjunction Events,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Historical Events, 15th Century",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Historical Events, 16th Century",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((-)-4-(3-3,4-trans-p-menthadien-(1,8)-yl)-orcinol)",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((1-(N-(p-(amidinobenzoyl)tyrosyl)-4-piperidinyl)oxy))acetic acid,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((C6H6)Ru(m-OH-p-OMPIP)Cl)Cl,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((eta6-p-cymene)Ru(4,4,4-trifluoro-1-(4-chlorophenyl)-1,3-butanedione)-1,3,5-triaza-7-phosphaadamantane)",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((p-(N-acrylamino)phenyl)mercuric chloride),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Agency for Healthcare Research and Quality (U.S.),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Air Quality,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Air Quality, Indoor",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Continuous Quality Management,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Data Quality,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"11kDa protein synthesis inhibitor, Vaccinia virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"12-kDa protein, potato virus M",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"126-kDa protein, Tobacco mosaic virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"12K late protein, Vaccinia virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"130k protein, Tobacco mosaic virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((des-NH2)Phe(19)-D-Ala(24)-D-Pro(26)psi(CH2NH)Phe(27))-GRP(19-27),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((im bzl)-D-His(6), Pro(9)-NEt)LHRH",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(-2)pro-PSA, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(-2)pro-prostate-specific antigen, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(111)In-DTPA-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(4-methoxy-C11)DNR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(4-methoxy-C11)daunorubicin,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(C11)-GB67,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(C11)GB 67,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"8-chloro-7-hydroxy-5-(2,3-dihydrobenzofuran-7-yl)-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, (S)-isomer, C11-labeled",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(Cp(2)Hf)(2)B(5)H(8))(B(11)H(14),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
2-Me-HMB-HF,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
26-G-HF-TG,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3-BPNP-HF cpd,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
4-(HP-HP-HF),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Anatomic Variation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Antigen Variation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Antigenic Variation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Between-Individual Biological Variation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Between-Person Biological Variation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adhesion Plaques,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Unusual Plaques",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amyloid Plaques,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Atheromatous Plaques,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Atherosclerotic Plaques,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
NheI endonuclease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
endodeoxyribonuclease NheI,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
endonuclease NheI,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
OriC replicon,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Replicon,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"52 kDa protein encoded by a Cell Cycle Switch gene, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"8-benzenesulfonyloxy-5-N,N-dimethylaminosulfonylquinolin-2-ylmethyl-pendant cyclen",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Activity Cycles,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
BS-caged-L4-cyclen,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"CDC10 cell division cycle 10 homolog (S. cerevisiae), human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Drug Residues,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Dvl-associating protein with a high frequency of leucine residues protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Nogo extracellular peptide, residues 1-40, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Nogo extracellular peptide, residues 1-40, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Pesticide Residues,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Aspects, Historical",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Historical Aspects,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
International Aspects,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Legal Aspects,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Multinational Aspects,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Conferences, Consensus Development as Topic",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Consensus,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Consensus Development,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Consensus Development Conference,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Consensus Development Conference, NIH",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cognitive Decline,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Decline, Mortality",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Mortality Decline,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Postoperative Decline,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Alu Repetitive Sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amino Acid Sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
CRISPR Sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
CRISPR Spacer Sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA Sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
UD CG 115,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
UD CG 212 Cl,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
UD-170A,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
UD-CG 115,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
UD-CG-212-Cl,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(2'-5')An Polymerase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2',5'-Oligo(A) Polymerase",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2',5'-Oligoadenylate Polymerase",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2,3,7,8-tetrachlorodibenzo-p-dioxin poly(ADP-ribose) polymerase, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2,3,7,8-tetrachlorodibenzo-p-dioxin poly(ADP-ribose) polymerase, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(+)-alpha-polypodatetraene,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(+)-alpha-tocopheryl polyethylene glycol 1000 succinate,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(1,4-bis(3-pyridyl)-2,3-diazo-1,3-butadiene)dichlorozinc(II) polymer",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(2'-5')An Polymerase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(2'-5')tetraadenylate-polylysine,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Kathon WT,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Minibody (WT),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
WT Limb-Blood Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
WT limb blood syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"WT-1 protein, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"00261 long non coding RNA, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
10Sa RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
15S RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"16S RNA pseudouridine 516 synthase, E coli",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
16S Ribosomal RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Grants, Peer Review",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Organizations, Peer Review",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Peer Group,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Peer Influence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Peer Pressure,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
129 Mice,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
129 Strain Mice,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Apo E Knockout Mice,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ApoE Knockout Mice,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Athymic Mice,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Metagenomics,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
metagenomic acidic lipopeptide antibiotic-cidins,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Amino Acid Metabolism, Inborn Error",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Amino Acid Metabolism, Inborn Errors",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Carbohydrate Metabolism, Inborn Error",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Carbohydrate Metabolism, Inborn Errors",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Congenital Errors of Steroid Metabolism,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((-)-4-(3-3,4-trans-p-menthadien-(1,8)-yl)-orcinol)",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((Pt(NH3)3)-mu-H2N(CH2)(4)NH2-(trans-PtCl(NH3)2))3(+),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((trans-Pt(NH3)2(NH2(CH2)6(NH3+))2-mu-(trans-Pt(NH3)2(NH2(CH2)6NH2)2)),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((trans-PtCl(NH3)2)2(trans-Pt(NH3)2(NH2(CH2)6NH2)2))(NO3)4,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((trans-PtCl(NH3)2)2mu-(trans-Pt(NH3)(2-hydroxypyridine)(H2N(CH2)6NH2)2))Cl4,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AMP-PK reactivator,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Ac-pk-1 protein, Autographa californica nucleopolyhedrovirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"CRK4 PK, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
CaM PK II,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Calcium-Calmodulin-Dependent PK Type II,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ARABIDOPSIS THALIANA REPLICATION PROTEIN A 1A protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Autonomous Replication,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Chromosome Replication Order, Temporal",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Chromosome Replication Pattern, Temporal",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Chromosome Replication Timing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Picornaviruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(((12aR)-12-((11S)-7,8-difluoro-6,11-dihydrodibenzo(b,E)thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12ahexahydro-1H-(1,4)oxazino(3,4-C)pyrido(2,1-F)(1,2,4)triazin-7-yl)oxy)methyl methyl carbonate",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((11)C)(R)-1-(4-(2-(4-methoxyphenyl)phenyl)piperazin-1-yl)-3-(2-pyrazinyloxy)-2-propanol,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((11)C)1-(7-methoxy- quinolin-4-yl)-3-(6-(trifluoromethyl)pyridin-2-yl)urea,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((11)C)2-(2',6'-dimethoxy-(1,1'-biphenyl)-3-yl)-N,N-dimethylethanamine",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((11)C)3'-Me-BTA-1,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Animal Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Civil Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Collective Human Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Equal Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Health Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"COL1 protein, Ophiostoma novo-ulmi",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"CYP108D1, Novosphingobium aromaticivorans",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Ildamen-Novodigal,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Insulin Novo Monotard,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Mycobacterium novocastrense,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Corticobulbar Tracts,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Corticospinal Tracts,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Extrapyramidal Tracts,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Pyramidal Tracts,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Spinocerebellar Tracts,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Copyright,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"1D protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3ABC protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3C protease, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3D protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Abnormalities, Mouth",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Equipment Reuse,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"8-Quinolinol, 5-chloro-7-iodo-, mixt. with calamine (pharmaceutical preparation) and zinc oxide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AMT preparation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Analytic Sample Preparation Methods,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
BDP preparation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
BTK 8L preparation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Achaete-Scute Complex Genome Region,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterial Genome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterial Genomes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Chloroplast Genome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Chloroplast Genome-Encoded Proteins,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amino Acid Sequencing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Assay for Transposase-Accessible Chromatin Using Sequencing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ChIP Sequencing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Chromatin Immuno-precipitation Sequencing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Chromatin Immunoprecipitation Sequencing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
PKS beta-ketoacyl synthase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
PKS ketoreductase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Antitumor Assays, Xenograft Model",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Antitumor Drug Screening Assays,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Assays, Biological",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Biologic Assays,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bioluminescent Assays,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"BARS protein, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"BARS50 protein, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
De Barsy Moens Diercks syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
De Barsy syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Progeroid syndrome of De Barsy,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((3alpha,3'alpha,4beta,4'beta)-3,3')-dimethoxy-cis-(4,4'-bis(3,4,5,10-tetrahydro-1H-naphtho(2,3-)pyran))-5,5',10,10'-tetraone",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((cis-Pt(NH(3))(2))(2)(mu-OH)(mu-pyrazolate))(2+),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((cis-Pt(NH3)2Cl)2 4,4'-dipyridyl sulfide(NO3)2)",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((cis-Pt(NH3)2Cl)2 bpsu(NO3)2),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((cis-RuCl2(Me2SO)3)H2N(CH2)4NH2(cis-PtCl2(NH3))),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"11kDa protein synthesis inhibitor, Vaccinia virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"12-kDa protein, potato virus M",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"126-kDa protein, Tobacco mosaic virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"12K late protein, Vaccinia virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"130k protein, Tobacco mosaic virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Human Figure,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Rey-Osterrieth Complex Figure,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Preprint,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Preprints,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Preprints as Topic,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"A-T tract-binding protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Atrio-Hisian Bypass Tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Atriohisian Tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Biliary Tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Biliary Tract Cancer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(4-methoxy-C11)DNR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(4-methoxy-C11)daunorubicin,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(C11)-GB67,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(C11)GB 67,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"8-chloro-7-hydroxy-5-(2,3-dihydrobenzofuran-7-yl)-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, (S)-isomer, C11-labeled",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"14K protein, Borna disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"18K glycoprotein, Borna disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"1D protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
2019 novel coronavirus disease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
2019 novel coronavirus disease testing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
SEM-76,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"SeM protein, Streptococcus equi",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Sem D,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Sem-2 protein, C elegans",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Sem-5 protein, C elegans",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
C0-05 ADP-ribosyltransferase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pneumocandin C0,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ATPase associated with diverse cellular activities,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ATPases Associated with Diverse Cellular Activities,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Activities of Daily Living,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Activities, Daily Living",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Activities, Educational",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Animal Population Groups,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Biologic Variability, Population",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Biological Variation, Population",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Continental Population Groups,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
General Social Development and Population,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(COMPADRI)-III protocol,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
06-Paris-LA-66 protocol,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
1-UFT protocol,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3M protocol,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5-FU-CDDP protocol,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2C protein, viral",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Antibodies, Viral",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Antigens, Neoplasm, Viral",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Antigens, Viral",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Antigens, Viral, Tumor",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Om45-GFP protein, S cerevisiae",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
cyclo(GP-p(CH2S)-GFP),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
cyclo(GP-psi(CH2SO)-GFP),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"scFV-GFP protein, recombinant",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Accessory Atrioventricular Pathways,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Accessory Conducting Pathways,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adverse Outcome Pathways,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Afferent Pathways,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Auditory Pathways,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(((1,2-dihydro-2-oxo-4-quinolinyl)methyl)thio)-N-(((4-(1-piperidinylmethyl)-2-pyridinyl)oxy)-2-butenyl)acetamide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(((2-(2-(2,4-dichlorophenyl)-4-(2-methyl-3-chlorophenyl)-1-ylmethyl)carbamoyl)methyl)-5-oxopyrrole-1-yl)-N-(3-piperidinylpropyl)acetamide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(((4-(4-amidino-N-methylbenzamido)acetyl)-1,2-phenylene)dioxy)diacetic acid",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(((5-(6-(oxolan-3-yl)amino)purin-9-yl)-3,4-dihydroxyoxolan-2-yl)methoxy)-N-methylcarboxamide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((+)-4-((alphaR)-alpha-((2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl)-(3-phenyl)methyl)-N,N-diethylbenzamide)",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial precursor, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2S albumin precursor protein, Ricinus communis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2S albumin precursor, Bertholletia excelsa",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"78 kDa glucose-regulated protein precursor protein, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ACTH-Endorphin Precursor,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
APC Viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adeno-Associated Viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
African Swine Fever-Like Viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Algal Viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Animal Viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(((12aR)-12-((11S)-7,8-difluoro-6,11-dihydrodibenzo(b,E)thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12ahexahydro-1H-(1,4)oxazino(3,4-C)pyrido(2,1-F)(1,2,4)triazin-7-yl)oxy)methyl methyl carbonate",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((+)-(5S,6R,7R)-2-isopropylamino-7-(4-methoxy-2-(2R))-3-methoxy-2-methylpropyl)-5-(3,4-methylenedioxyphenyl)cyclopenteno(1,2-b)pyridine-6-carboxylic acid",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)(hydroxy)methylidene)azanium chloride",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((1R,2R,3AS,9AS)-2-hydroxy-1-((3S)-3-hydroxyoctyl)-2,3,3A,4,9,9A-hexahydro-1H-cylopent(b)naphthalen-5-yl)oxy)acetate",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((3 alpha-tropanyl)oxy)-5H-benzo(4,5)cyclohepta(1,2-b)pyridine",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"1,17-DATAH",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amino Acid Sequence Databases,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Automatic Data Processing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Big Data,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Clinical Trials Data Monitoring Committees,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Homolog ALignment in meiosis abnormal 3 protein, C elegans",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Radiotherapy Target Organ Alignment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Sequence Alignment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Target Organ Alignment, Radiotherapy",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"centrosome alignment defect 1 protein, Drosophila",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"AM-protein, Physarum polycephalum",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
APL PolyCat57,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Actinomadura polychroma,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adult Polycystic Kidney Disease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adult Polycystic Kidney Disease Type 1,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Administration, Library",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Associations, Library",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Catalogs, Library",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA Library,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Dental Library,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Depth Intoxication,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Depth Perception,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AFLP Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Activation Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Activation Analysis, Neutron",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Actuarial Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amino Acid Sequence Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Economy, Token",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Token Economy,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Analysis, DNA Mutational",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA Mutational Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Mutational Analysis, DNA",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"25-kDa subunit, Im cleavage factor, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"25-kDa subunit, Im cleavage factor, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3-keto-5-aminohexanoate cleavage enzyme,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3-keto-6-acetamidohexanoate cleavage enzyme,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"77-kDa subunit, cleavage stimulation factor, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
OriC replicon,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Replicon,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
bhk (kinase),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"p23 protein, BHK, mammalian",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"1D protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3ABC protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3C protease, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3D protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Anus, Imperforate, with Hand, Foot, and Ear Anomalies",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Conferences, Consensus Development as Topic",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Consensus,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Consensus Development,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Consensus Development Conference,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Consensus Development Conference, NIH",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adenine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cytosine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Deoxyadenine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Deoxycytosine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Deoxyguanine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
293T Cells,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3T3 Cells,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3T3 Cells, BALB",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3T3 Cells, NIH",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3T3-L1 Cells,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Illumina Sequencing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Illuminating Gas Poisoning,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Illumination,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Poisoning, Illuminating Gas",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Communicable Disease Contact Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_title
Contact Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_title
Fluorescent Protein Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_title
Infectious Disease Contact Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_title
Neuroanatomical Tract-Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_title
21-formyl sarsasapogenin,00340eea543336d54adda18236424de6a5e91c9d,has_title
"3C-like protease, SARS coronavirus",00340eea543336d54adda18236424de6a5e91c9d,has_title
"3CL(pro) protein, SARS-CoV",00340eea543336d54adda18236424de6a5e91c9d,has_title
"3a protein, SARS-CoV",00340eea543336d54adda18236424de6a5e91c9d,has_title
"7a protein, SARS virus",00340eea543336d54adda18236424de6a5e91c9d,has_title
International Perspectives,00340eea543336d54adda18236424de6a5e91c9d,has_title
Multinational Perspectives,00340eea543336d54adda18236424de6a5e91c9d,has_title
MNA SARS-CoV-2 S1 subunit vaccines,00340eea543336d54adda18236424de6a5e91c9d,has_title
SARS-CoV-2,00340eea543336d54adda18236424de6a5e91c9d,has_title
SARS-CoV-2 S protein,00340eea543336d54adda18236424de6a5e91c9d,has_title
SARS-CoV-2 convalescent plasma treatment,00340eea543336d54adda18236424de6a5e91c9d,has_title
SARS-CoV-2 convalescent sera treatment,00340eea543336d54adda18236424de6a5e91c9d,has_title
"Health Insurance for Aged and Disabled, Title 18",00340eea543336d54adda18236424de6a5e91c9d,has_title
"Health Insurance for Aged, Disabled, Title 18",00340eea543336d54adda18236424de6a5e91c9d,has_title
"Health Insurance for Aged, Title 18",00340eea543336d54adda18236424de6a5e91c9d,has_title
"Medical Assistance, Title 19",00340eea543336d54adda18236424de6a5e91c9d,has_title
AFLP Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_title
Activation Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_title
"Activation Analysis, Neutron",00340eea543336d54adda18236424de6a5e91c9d,has_title
Actuarial Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_title
Amino Acid Sequence Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_title
"Grants, Peer Review",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Organizations, Peer Review",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Peer Group,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Peer Influence,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Peer Pressure,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Genetic Heterogeneity,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Heterogeneity, Genetic",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Population Heterogeneity,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
AFLP Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Activation Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Activation Analysis, Neutron",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Actuarial Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Amino Acid Sequence Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Agency for International Development,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Educational Exchange, International",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Exchange, International Educational",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
International Agencies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
International Aspects,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Communicable Disease Contact Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Contact Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Fluorescent Protein Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Infectious Disease Contact Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Neuroanatomical Tract-Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Alu Repetitive Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Amino Acid Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
CRISPR Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
CRISPR Spacer Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
DNA Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Developed Countries,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Developing Countries,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Industrialized Countries,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Least Developed Countries,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Less-Developed Countries,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
21-formyl sarsasapogenin,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"3C-like protease, SARS coronavirus",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"3CL(pro) protein, SARS-CoV",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"3a protein, SARS-CoV",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"7a protein, SARS virus",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Preprint,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Preprints,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Preprints as Topic,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Information Dissemination,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
(68Ga)Glu-urea-Lys(Ahx)-HBED-CC,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
2-CC-F-EP cpd,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
4-(2-CC)-2-TFBN cpd,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
5-CC-M-P-O cpd,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"ALP CC chemokine protein, mouse",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Agency for Healthcare Research and Quality (U.S.),00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Air Quality,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Air Quality, Indoor",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Continuous Quality Management,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Data Quality,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Easterlin Hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Hygiene Hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Lyon Hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
MNA SARS-CoV-2 S1 subunit vaccines,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
SARS-CoV-2,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
SARS-CoV-2 S protein,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
SARS-CoV-2 convalescent plasma treatment,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
SARS-CoV-2 convalescent sera treatment,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Copyright,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
ATP-Sensitive Potassium Channels,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Acid Sensing Ion Channels,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Acid-Sensing Ion Channels,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
BK Channels,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Big K Channels,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Arthrogryposis multiplex congenita, pulmonary hypoplasia, cryptorchidism, and unusual ophthalmological findings",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Host-Finding Behavior,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Incidental Findings,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Morphological and Microscopic Findings,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Neurologic Findings,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Amino Acid Sequence Analyses,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Analyses, Demographic",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Analyses, Dental Stress",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Analyses, Multiregional",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Biological Oxygen Demand Analyses,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"1,17-DATAH",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Amino Acid Sequence Databases,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Automatic Data Processing,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Big Data,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Clinical Trials Data Monitoring Committees,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
2019 novel coronavirus,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
2019 novel coronavirus disease,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
2019 novel coronavirus disease testing,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
2019 novel coronavirus infection,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
2019 novel coronavirus testing,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Encephalitis, Epidemic",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Epidemic Acute Poliomyelitis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Epidemic Encephalitis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Epidemic Hemorrhagic Fever Virus,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Epidemic Neurolabyrinthitis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Access to Information,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Ambulatory Care Information Systems,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Ambulatory Information Systems,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Ancillary Information Systems,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Bio-Physical Information Therapy,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Stigmatization,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Phylogenetic Biogeography,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Phylogenetic DNA Barcode,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Phylogenetic DNA Barcoding,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"(Arg(14),Lys(15))NC",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
(DAniF)3Mo2(((m-CF3)C6H5)NC(O)C6H4(O)CN((m-CF3)C6H5))Mo2(DAniF)3,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
(DAniF)3Mo2((C6H5)NC(O)C6H4(O)CN(C6H5))Mo2(DAniF)3,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
(NC)2Cu(I),00340eea543336d54adda18236424de6a5e91c9d,has_abstract
(NC)2Cu(II),00340eea543336d54adda18236424de6a5e91c9d,has_abstract
CBA Studies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Candidate Gene Association Studies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Case Control Studies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Case Studies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Case Studies, Organizational",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"PLETHORA 5 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"PLETHORA 7 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"PLETHORA1 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"PLETHORA2 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"PLETHORA3 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Acute Respiratory Distress Syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Adult Respiratory Distress Syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Choreoathetosis, Hypothyroidism, And Neonatal Respiratory Distress",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Emotional Distress,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Fetal Distress,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Sickness Presence,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Licensed Practical Nurses,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Licensed Vocational Nurses,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Licenses,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Dental Societies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Greek Letter Societies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Greek-Letter Societies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Hospital Societies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
International Federation of Red Cross and Red Crescent Societies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Achaete-Scute Complex Genome Region,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Bacterial Genome,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Bacterial Genomes,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Chloroplast Genome,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Chloroplast Genome-Encoded Proteins,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Journals as Topic,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
((Cu(II)(MePY2)Me2N)2(S2)),00340eea543336d54adda18236424de6a5e91c9d,has_body
(ACADGI)S2,00340eea543336d54adda18236424de6a5e91c9d,has_body
"4-thioanisyl-2-biphenylyl-3-hydroxypropionic acid, (1:S2:R*,R*)-isomer",00340eea543336d54adda18236424de6a5e91c9d,has_body
"4-thioanisyl-2-biphenylyl-3-hydroxypropionic acid, (1:S2:R*,S*)-isomer",00340eea543336d54adda18236424de6a5e91c9d,has_body
"4-trifluoromethylphenyl-2-biphenylyl-3-hydroxypropionic acid, (1:S2:R*,R*)-isomer",00340eea543336d54adda18236424de6a5e91c9d,has_body
Date Fruit,00340eea543336d54adda18236424de6a5e91c9d,has_body
Date Palm Fruit,00340eea543336d54adda18236424de6a5e91c9d,has_body
Date Palm Trees,00340eea543336d54adda18236424de6a5e91c9d,has_body
Date Palms,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dates,00340eea543336d54adda18236424de6a5e91c9d,has_body
Absence Seizure Disorder,00340eea543336d54adda18236424de6a5e91c9d,has_body
Absence Seizures,00340eea543336d54adda18236424de6a5e91c9d,has_body
Absence Status,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Absence defect of limbs, scalp, and skull",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Absence of Brain, Congenital",00340eea543336d54adda18236424de6a5e91c9d,has_body
1-M-D-BIC-CDAA,00340eea543336d54adda18236424de6a5e91c9d,has_body
BIC,00340eea543336d54adda18236424de6a5e91c9d,has_body
BIC mustard,00340eea543336d54adda18236424de6a5e91c9d,has_body
BIC protocol,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Bic-C gprotein, Drosophila",00340eea543336d54adda18236424de6a5e91c9d,has_body
Actinopolymorpha singaporensis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Burkholderia singaporensis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Desulforhopalus singaporensis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Desulfovibrio singaporenus,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hb G-Singapore,00340eea543336d54adda18236424de6a5e91c9d,has_body
Action Research,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Administration Research, Nursing",00340eea543336d54adda18236424de6a5e91c9d,has_body
Administrative Nursing Research,00340eea543336d54adda18236424de6a5e91c9d,has_body
Adult Stem Cell Research,00340eea543336d54adda18236424de6a5e91c9d,has_body
Agency for Health Care Policy and Research,00340eea543336d54adda18236424de6a5e91c9d,has_body
3D Molecular Structure,00340eea543336d54adda18236424de6a5e91c9d,has_body
5' mRNA Cap Structure,00340eea543336d54adda18236424de6a5e91c9d,has_body
Animal Structures,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bacterial Structures,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cell Membrane Structures,00340eea543336d54adda18236424de6a5e91c9d,has_body
Legal Cases,00340eea543336d54adda18236424de6a5e91c9d,has_body
Review of Reported Cases,00340eea543336d54adda18236424de6a5e91c9d,has_body
AIDS-Related Opportunistic Infections,00340eea543336d54adda18236424de6a5e91c9d,has_body
Acinetobacter Infections,00340eea543336d54adda18236424de6a5e91c9d,has_body
Actinobacillus Infections,00340eea543336d54adda18236424de6a5e91c9d,has_body
Actinomyces Infections,00340eea543336d54adda18236424de6a5e91c9d,has_body
Actinomycetales Infections,00340eea543336d54adda18236424de6a5e91c9d,has_body
Four Corners Virus,00340eea543336d54adda18236424de6a5e91c9d,has_body
"(6Fe-6S) prismane-cluster-containing protein, Desulfovibrio vulgaris",00340eea543336d54adda18236424de6a5e91c9d,has_body
Atypical Cluster Headache,00340eea543336d54adda18236424de6a5e91c9d,has_body
Breakpoint Cluster Region Protein,00340eea543336d54adda18236424de6a5e91c9d,has_body
"CD24 antigen (small cell lung carcinoma cluster 4 antigen), human",00340eea543336d54adda18236424de6a5e91c9d,has_body
CRISPR Clusters,00340eea543336d54adda18236424de6a5e91c9d,has_body
2-(2''-DCAB)-3-(IQ),00340eea543336d54adda18236424de6a5e91c9d,has_body
2-(2-BE)NB-IQ cpd,00340eea543336d54adda18236424de6a5e91c9d,has_body
2-A-3M-IQ,00340eea543336d54adda18236424de6a5e91c9d,has_body
2-C-HP-IQ,00340eea543336d54adda18236424de6a5e91c9d,has_body
2-IQ-glucuronide,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dynamic Light Scattering,00340eea543336d54adda18236424de6a5e91c9d,has_body
Low Angle Scattering,00340eea543336d54adda18236424de6a5e91c9d,has_body
Quasi-Elastic Light Scattering (QELS),00340eea543336d54adda18236424de6a5e91c9d,has_body
Radiation Scattering,00340eea543336d54adda18236424de6a5e91c9d,has_body
Raman Scattering,00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Simulation,00340eea543336d54adda18236424de6a5e91c9d,has_body
High Fidelity Simulation Training,00340eea543336d54adda18236424de6a5e91c9d,has_body
Microgravity Simulation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Molecular Docking Simulation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Molecular Docking Simulations,00340eea543336d54adda18236424de6a5e91c9d,has_body
Conflict Resolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Moderate Resolution Imaging Spectroradiometer,00340eea543336d54adda18236424de6a5e91c9d,has_body
4-(4-(Dimethylamino)-N-methyl-L-phenylalanine)virginiamycin S1,00340eea543336d54adda18236424de6a5e91c9d,has_body
"ATPase, Actin-S1",00340eea543336d54adda18236424de6a5e91c9d,has_body
Actin S1 ATPase,00340eea543336d54adda18236424de6a5e91c9d,has_body
Aspergillus Nuclease S1,00340eea543336d54adda18236424de6a5e91c9d,has_body
CD4 S1 peptide,00340eea543336d54adda18236424de6a5e91c9d,has_body
Agent-Based Modeling,00340eea543336d54adda18236424de6a5e91c9d,has_body
Anatomic Models,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Antitumor Assays, Xenograft Model",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Autoimmune Disease Models, Nervous System",00340eea543336d54adda18236424de6a5e91c9d,has_body
Biobehavioral Model,00340eea543336d54adda18236424de6a5e91c9d,has_body
Abortion Rate,00340eea543336d54adda18236424de6a5e91c9d,has_body
Age Specific Death Rate,00340eea543336d54adda18236424de6a5e91c9d,has_body
Age-Specific Birth Rate,00340eea543336d54adda18236424de6a5e91c9d,has_body
Age-Specific Death Rate,00340eea543336d54adda18236424de6a5e91c9d,has_body
Age-Specific Fertility Rate,00340eea543336d54adda18236424de6a5e91c9d,has_body
criterion 424 catalyst,00340eea543336d54adda18236424de6a5e91c9d,has_body
Space Exploration,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Administration Routes, Drug",00340eea543336d54adda18236424de6a5e91c9d,has_body
Drug Administration Routes,00340eea543336d54adda18236424de6a5e91c9d,has_body
Transmucosal Administration Routes,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Center, University Medical",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Centers, University Medical",00340eea543336d54adda18236424de6a5e91c9d,has_body
"DNA segment, Chr 17, Wayne State University 104, expressed protein, mouse",00340eea543336d54adda18236424de6a5e91c9d,has_body
Edinburgh University solution of lime,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Health Services, University",00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus disease,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus disease testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus infection,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Agency for Health Care Policy and Research,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Analysis, Policy",00340eea543336d54adda18236424de6a5e91c9d,has_body
Antinatalist Policy,00340eea543336d54adda18236424de6a5e91c9d,has_body
Economic Policy,00340eea543336d54adda18236424de6a5e91c9d,has_body
Environmental Policy,00340eea543336d54adda18236424de6a5e91c9d,has_body
Easterlin Hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hygiene Hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Lyon Hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Agency for Healthcare Research and Quality (U.S.),00340eea543336d54adda18236424de6a5e91c9d,has_body
Air Quality,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Air Quality, Indoor",00340eea543336d54adda18236424de6a5e91c9d,has_body
Continuous Quality Management,00340eea543336d54adda18236424de6a5e91c9d,has_body
Data Quality,00340eea543336d54adda18236424de6a5e91c9d,has_body
"6,6,16-trifluorohexadecanoic acid, 18F-labeled in position 16",00340eea543336d54adda18236424de6a5e91c9d,has_body
"7,7,16-trifluorohexadecanoic acid, 18F-labeled in position 16",00340eea543336d54adda18236424de6a5e91c9d,has_body
Benign Paroxysmal Positional Vertigo,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chromosomal Position Effect,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chromosomal Position Effects,00340eea543336d54adda18236424de6a5e91c9d,has_body
Achaete-Scute Complex Genome Region,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bacterial Genome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bacterial Genomes,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chloroplast Genome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chloroplast Genome-Encoded Proteins,00340eea543336d54adda18236424de6a5e91c9d,has_body
Datasets as Topic,00340eea543336d54adda18236424de6a5e91c9d,has_body
Assessment of Health Care Needs,00340eea543336d54adda18236424de6a5e91c9d,has_body
Assessment of Healthcare Needs,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Assessment, Biomedical Technology",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Assessment, Educational",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Assessment, Geriatric",00340eea543336d54adda18236424de6a5e91c9d,has_body
Hb D Portugal,00340eea543336d54adda18236424de6a5e91c9d,has_body
Portugal,00340eea543336d54adda18236424de6a5e91c9d,has_body
hemoglobin D Portugal,00340eea543336d54adda18236424de6a5e91c9d,has_body
Caribbean Netherlands,00340eea543336d54adda18236424de6a5e91c9d,has_body
Kingdom of the Netherlands,00340eea543336d54adda18236424de6a5e91c9d,has_body
Netherlands,00340eea543336d54adda18236424de6a5e91c9d,has_body
Netherlands Antilles,00340eea543336d54adda18236424de6a5e91c9d,has_body
Netherlands East Indies,00340eea543336d54adda18236424de6a5e91c9d,has_body
Developed Countries,00340eea543336d54adda18236424de6a5e91c9d,has_body
Developing Countries,00340eea543336d54adda18236424de6a5e91c9d,has_body
Industrialized Countries,00340eea543336d54adda18236424de6a5e91c9d,has_body
Least Developed Countries,00340eea543336d54adda18236424de6a5e91c9d,has_body
Less-Developed Countries,00340eea543336d54adda18236424de6a5e91c9d,has_body
Copyright,00340eea543336d54adda18236424de6a5e91c9d,has_body
Phylogeny,00340eea543336d54adda18236424de6a5e91c9d,has_body
Wuhan coronavirus,00340eea543336d54adda18236424de6a5e91c9d,has_body
Wuhan coronavirus vaccine,00340eea543336d54adda18236424de6a5e91c9d,has_body
Wuhan seafood market pneumonia virus,00340eea543336d54adda18236424de6a5e91c9d,has_body
Age Distribution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Animal Distribution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bernoulli Distribution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Binomial Distribution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Body Fat Distribution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Alu Repetitive Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
Amino Acid Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
CRISPR Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
CRISPR Spacer Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
DNA Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
SNOMED Clinical Terms,00340eea543336d54adda18236424de6a5e91c9d,has_body
"1,17-DATAH",00340eea543336d54adda18236424de6a5e91c9d,has_body
Amino Acid Sequence Databases,00340eea543336d54adda18236424de6a5e91c9d,has_body
Automatic Data Processing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Big Data,00340eea543336d54adda18236424de6a5e91c9d,has_body
Clinical Trials Data Monitoring Committees,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Aborigines, Australian",00340eea543336d54adda18236424de6a5e91c9d,has_body
Anti-Australia Antigens,00340eea543336d54adda18236424de6a5e91c9d,has_body
Australia,00340eea543336d54adda18236424de6a5e91c9d,has_body
Australia Antigen,00340eea543336d54adda18236424de6a5e91c9d,has_body
Australian Capital Territory,00340eea543336d54adda18236424de6a5e91c9d,has_body
Human Figure,00340eea543336d54adda18236424de6a5e91c9d,has_body
Rey-Osterrieth Complex Figure,00340eea543336d54adda18236424de6a5e91c9d,has_body
Acinetobacter johnsonii,00340eea543336d54adda18236424de6a5e91c9d,has_body
Actinomyces johnsonii,00340eea543336d54adda18236424de6a5e91c9d,has_body
Borrelia johnsonii,00340eea543336d54adda18236424de6a5e91c9d,has_body
"CbsT2 protein, Lactobacillus johnsonii",00340eea543336d54adda18236424de6a5e91c9d,has_body
Cytophaga johnsonae,00340eea543336d54adda18236424de6a5e91c9d,has_body
Direction compound,00340eea543336d54adda18236424de6a5e91c9d,has_body
Directional Coronary Atherectomy,00340eea543336d54adda18236424de6a5e91c9d,has_body
"11kDa protein synthesis inhibitor, Vaccinia virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"12-kDa protein, potato virus M",00340eea543336d54adda18236424de6a5e91c9d,has_body
"126-kDa protein, Tobacco mosaic virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"12K late protein, Vaccinia virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"130k protein, Tobacco mosaic virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
Gulf of Mexico,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hb J Mexico,00340eea543336d54adda18236424de6a5e91c9d,has_body
"LPMV P protein, La Piedad Michoacan Mexico virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
Mexico,00340eea543336d54adda18236424de6a5e91c9d,has_body
Mexicor,00340eea543336d54adda18236424de6a5e91c9d,has_body
Aeromonas finlandiensis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Borrelia finlandensis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Borreliella finlandensis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Finland,00340eea543336d54adda18236424de6a5e91c9d,has_body
hemoglobin Finlandia,00340eea543336d54adda18236424de6a5e91c9d,has_body
"B-cell lineage specific activator protein, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
"BREAKING OF ASYMMETRY IN THE STOMATAL LINEAGE protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_body
"CONSERVED ONLY IN THE GREEN LINEAGE160 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_body
Casitas B-Lineage Lymphoma Protein,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Casitas B-lineage lymphoma b protein, rat",00340eea543336d54adda18236424de6a5e91c9d,has_body
Guidor USA,00340eea543336d54adda18236424de6a5e91c9d,has_body
"PRSV-P (USA) protein, Papaya ringspot virus P",00340eea543336d54adda18236424de6a5e91c9d,has_body
"PRSV-W (USA) protein, Papaya ringspot virus W",00340eea543336d54adda18236424de6a5e91c9d,has_body
(1-2)-linked N-3-hydroxypropionyl-alpha-D-perosamine,00340eea543336d54adda18236424de6a5e91c9d,has_body
"1,2-propanediol dehydrogenase (NAD-linked)",00340eea543336d54adda18236424de6a5e91c9d,has_body
"2',5'-linked triadenylic acid",00340eea543336d54adda18236424de6a5e91c9d,has_body
2'-ethylcarbonate-linked paclitaxel,00340eea543336d54adda18236424de6a5e91c9d,has_body
"2,2'-bis(2-oxazoline) linked poly(lactic acid)",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Homolog ALignment in meiosis abnormal 3 protein, C elegans",00340eea543336d54adda18236424de6a5e91c9d,has_body
Radiotherapy Target Organ Alignment,00340eea543336d54adda18236424de6a5e91c9d,has_body
Sequence Alignment,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Target Organ Alignment, Radiotherapy",00340eea543336d54adda18236424de6a5e91c9d,has_body
"centrosome alignment defect 1 protein, Drosophila",00340eea543336d54adda18236424de6a5e91c9d,has_body
Risk Evaluation and Mitigation,00340eea543336d54adda18236424de6a5e91c9d,has_body
"ABERRANT LATERAL ROOT FORMATION 5 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_body
"ALTERED ROOT ARCHITECTURE protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_body
Astragalus membranaceus root,00340eea543336d54adda18236424de6a5e91c9d,has_body
Astragalus membranaceus root extract,00340eea543336d54adda18236424de6a5e91c9d,has_body
Astragalus membranaceus root powder,00340eea543336d54adda18236424de6a5e91c9d,has_body
CA(Oxford) Antigen,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hb J-Oxford,00340eea543336d54adda18236424de6a5e91c9d,has_body
hemoglobin J Oxford,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Confounding Factors, Epidemiology",00340eea543336d54adda18236424de6a5e91c9d,has_body
Epidemiology,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Epidemiology, Molecular",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Epidemiology, Pharmaceutical",00340eea543336d54adda18236424de6a5e91c9d,has_body
Genetic Epidemiology,00340eea543336d54adda18236424de6a5e91c9d,has_body
Democratic Republic of Germany,00340eea543336d54adda18236424de6a5e91c9d,has_body
Federal Republic of Germany,00340eea543336d54adda18236424de6a5e91c9d,has_body
Germany,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Germany, Democratic Republic of",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Germany, East",00340eea543336d54adda18236424de6a5e91c9d,has_body
Age Groups,00340eea543336d54adda18236424de6a5e91c9d,has_body
Animal Population Groups,00340eea543336d54adda18236424de6a5e91c9d,has_body
Anti-Abortion Groups,00340eea543336d54adda18236424de6a5e91c9d,has_body
Anti-Vaccination Groups,00340eea543336d54adda18236424de6a5e91c9d,has_body
Anti-Vaccine Groups,00340eea543336d54adda18236424de6a5e91c9d,has_body
Ageratum yellow vein China virus,00340eea543336d54adda18236424de6a5e91c9d,has_body
China,00340eea543336d54adda18236424de6a5e91c9d,has_body
China-Sumac,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chinaberry Tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
Linmingia china,00340eea543336d54adda18236424de6a5e91c9d,has_body
"RELL1 protein, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
"RELL2 protein, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
rellidep,00340eea543336d54adda18236424de6a5e91c9d,has_body
Correlation Studies,00340eea543336d54adda18236424de6a5e91c9d,has_body
Correlation Study,00340eea543336d54adda18236424de6a5e91c9d,has_body
Correlation of Data,00340eea543336d54adda18236424de6a5e91c9d,has_body
Genotype-Phenotype Correlation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Genotype-Phenotype Correlations,00340eea543336d54adda18236424de6a5e91c9d,has_body
Guanine-Quartets,00340eea543336d54adda18236424de6a5e91c9d,has_body
Editorial,00340eea543336d54adda18236424de6a5e91c9d,has_body
Editorial Comment,00340eea543336d54adda18236424de6a5e91c9d,has_body
Editorial Policies,00340eea543336d54adda18236424de6a5e91c9d,has_body
18F-ML-10 compound,00340eea543336d54adda18236424de6a5e91c9d,has_body
18F-ML-8 compound,00340eea543336d54adda18236424de6a5e91c9d,has_body
"3-hydroxy-3,5-dihydro ML-236C",00340eea543336d54adda18236424de6a5e91c9d,has_body
3-hydroxy-ML-236B,00340eea543336d54adda18236424de6a5e91c9d,has_body
"3alpha-hydroxy-3,5-dihydro-ML-236C sodium salt",00340eea543336d54adda18236424de6a5e91c9d,has_body
3' Polyadenylation Signal,00340eea543336d54adda18236424de6a5e91c9d,has_body
"60 kDa nuclear localization signal binding protein, rat",00340eea543336d54adda18236424de6a5e91c9d,has_body
"7S RNA, signal recogniton particle",00340eea543336d54adda18236424de6a5e91c9d,has_body
"AGS1 - activator of G-protein signalind protein, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
"APC regulator of WNT signaling pathway protein, zebrafish",00340eea543336d54adda18236424de6a5e91c9d,has_body
"CG5445-RD protein, Drosophila",00340eea543336d54adda18236424de6a5e91c9d,has_body
Gelum oral-rd,00340eea543336d54adda18236424de6a5e91c9d,has_body
IgG4-RD,00340eea543336d54adda18236424de6a5e91c9d,has_body
RD 4-2025,00340eea543336d54adda18236424de6a5e91c9d,has_body
RD 4-2217,00340eea543336d54adda18236424de6a5e91c9d,has_body
Acute Respiratory Distress Syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Adult Respiratory Distress Syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Choreoathetosis, Hypothyroidism, And Neonatal Respiratory Distress",00340eea543336d54adda18236424de6a5e91c9d,has_body
Emotional Distress,00340eea543336d54adda18236424de6a5e91c9d,has_body
Fetal Distress,00340eea543336d54adda18236424de6a5e91c9d,has_body
Access to Information,00340eea543336d54adda18236424de6a5e91c9d,has_body
Ambulatory Care Information Systems,00340eea543336d54adda18236424de6a5e91c9d,has_body
Ambulatory Information Systems,00340eea543336d54adda18236424de6a5e91c9d,has_body
Ancillary Information Systems,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bio-Physical Information Therapy,00340eea543336d54adda18236424de6a5e91c9d,has_body
Age Discrimination,00340eea543336d54adda18236424de6a5e91c9d,has_body
Discrimination Learning,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Discrimination, Psychological",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Discrimination, Psychology",00340eea543336d54adda18236424de6a5e91c9d,has_body
Pitch Discrimination,00340eea543336d54adda18236424de6a5e91c9d,has_body
Behavior Observation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Behavior Observation Techniques,00340eea543336d54adda18236424de6a5e91c9d,has_body
Behavioral Observation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Behavioral Observation Techniques,00340eea543336d54adda18236424de6a5e91c9d,has_body
Clinical Observation Units,00340eea543336d54adda18236424de6a5e91c9d,has_body
Acupuncture Points,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cell Cycle Transition Points,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cell Cycle-Transition Points,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hazard Analysis Critical Control Points,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hazard Analysis and Critical Control Points,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus disease testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019-nCoV disease testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019-nCoV infection testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019-nCoV testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Body Measures,00340eea543336d54adda18236424de6a5e91c9d,has_body
Body Weights and Measures,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chemical Safety Measures,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cost Measures,00340eea543336d54adda18236424de6a5e91c9d,has_body
Measures,00340eea543336d54adda18236424de6a5e91c9d,has_body
(68Ga)Glu-urea-Lys(Ahx)-HBED-CC,00340eea543336d54adda18236424de6a5e91c9d,has_body
2-CC-F-EP cpd,00340eea543336d54adda18236424de6a5e91c9d,has_body
4-(2-CC)-2-TFBN cpd,00340eea543336d54adda18236424de6a5e91c9d,has_body
5-CC-M-P-O cpd,00340eea543336d54adda18236424de6a5e91c9d,has_body
"ALP CC chemokine protein, mouse",00340eea543336d54adda18236424de6a5e91c9d,has_body
Amino Acid Substitution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Drug Substitution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Freeze Substitution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Generic Substitution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hydroxyethyl Starch (130 KD-0.4 Substitution),00340eea543336d54adda18236424de6a5e91c9d,has_body
Anatomic Models,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Autoimmune Disease Models, Nervous System",00340eea543336d54adda18236424de6a5e91c9d,has_body
Biological Models,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chemical Models,00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Models,00340eea543336d54adda18236424de6a5e91c9d,has_body
Adolescent Nutrition Sciences,00340eea543336d54adda18236424de6a5e91c9d,has_body
Adolescent Nutritional Sciences,00340eea543336d54adda18236424de6a5e91c9d,has_body
Animal Nutrition Sciences,00340eea543336d54adda18236424de6a5e91c9d,has_body
Animal Nutritional Sciences,00340eea543336d54adda18236424de6a5e91c9d,has_body
Behavioral Sciences,00340eea543336d54adda18236424de6a5e91c9d,has_body
Forested Areas,00340eea543336d54adda18236424de6a5e91c9d,has_body
Laminar Air-Flow Areas,00340eea543336d54adda18236424de6a5e91c9d,has_body
Poverty Areas,00340eea543336d54adda18236424de6a5e91c9d,has_body
Primary Somatosensory Areas,00340eea543336d54adda18236424de6a5e91c9d,has_body
Secondary Motor Areas,00340eea543336d54adda18236424de6a5e91c9d,has_body
Family Relationships,00340eea543336d54adda18236424de6a5e91c9d,has_body
Husband-Wife Comparisons,00340eea543336d54adda18236424de6a5e91c9d,has_body
Paired Comparisons,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Cardiomyoplasty, Dynamic",00340eea543336d54adda18236424de6a5e91c9d,has_body
Dynamic Cardiomyoplasty,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dynamic Electrocardiography,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dynamic Light Scattering,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dynamic Orthoses,00340eea543336d54adda18236424de6a5e91c9d,has_body
(227)Th-DOTA-rituximab,00340eea543336d54adda18236424de6a5e91c9d,has_body
(227)Th-p-isothiocyanato-benzyl-DOTA-trastuzumab,00340eea543336d54adda18236424de6a5e91c9d,has_body
"1,3,5,6-TH-MB-X",00340eea543336d54adda18236424de6a5e91c9d,has_body
"1,3,7-TH-HMB-X",00340eea543336d54adda18236424de6a5e91c9d,has_body
"1-(2,4-D-H-L)-TH",00340eea543336d54adda18236424de6a5e91c9d,has_body
Hb Hopkins-I,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hopkinsiaxanthin,00340eea543336d54adda18236424de6a5e91c9d,has_body
Pitt Hopkins syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Pitt-Hopkins syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Pitt-Hopkins-Like Syndrome 1,00340eea543336d54adda18236424de6a5e91c9d,has_body
Sickness Presence,00340eea543336d54adda18236424de6a5e91c9d,has_body
Switzerland,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cl-diF(arrows)dAdo,00340eea543336d54adda18236424de6a5e91c9d,has_body
Anterior Cruciate Ligament Reconstruction,00340eea543336d54adda18236424de6a5e91c9d,has_body
Breast Reconstruction,00340eea543336d54adda18236424de6a5e91c9d,has_body
Image Reconstruction,00340eea543336d54adda18236424de6a5e91c9d,has_body
Mandibular Reconstruction,00340eea543336d54adda18236424de6a5e91c9d,has_body
Maxillo-Mandibular Reconstruction,00340eea543336d54adda18236424de6a5e91c9d,has_body
Reliability (Epidemiology),00340eea543336d54adda18236424de6a5e91c9d,has_body
Reliability and Validity,00340eea543336d54adda18236424de6a5e91c9d,has_body
Reliability of Results,00340eea543336d54adda18236424de6a5e91c9d,has_body
Test-Retest Reliability,00340eea543336d54adda18236424de6a5e91c9d,has_body
Action Potential Optical Mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
Anatomic Electrical Activity Optical Mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
Body Surface Mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
Body Surface Potential Mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
Brain Electrical Activity Mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
"ETS-domain lacking protein, Drosophila",00340eea543336d54adda18236424de6a5e91c9d,has_body
"LACK antigen, Leishmania",00340eea543336d54adda18236424de6a5e91c9d,has_body
Lack of Coordination,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Megalencephaly, Mega Corpus Callosum, And Complete Lack Of Motor Development",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Slp homolog lacking C2 domains b protein, humam",00340eea543336d54adda18236424de6a5e91c9d,has_body
Quantum Dots,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Reduction in Cnn dots 5 protein, Drosophila",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Xolka dots protein, Xenopus",00340eea543336d54adda18236424de6a5e91c9d,has_body
Biological Co-Evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Biological Evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chemical Evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Clonal Evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cultural Evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Licensed Practical Nurses,00340eea543336d54adda18236424de6a5e91c9d,has_body
Licensed Vocational Nurses,00340eea543336d54adda18236424de6a5e91c9d,has_body
Licenses,00340eea543336d54adda18236424de6a5e91c9d,has_body
Past Trends,00340eea543336d54adda18236424de6a5e91c9d,has_body
Trend HP,00340eea543336d54adda18236424de6a5e91c9d,has_body
Trendelenburg Position,00340eea543336d54adda18236424de6a5e91c9d,has_body
Trendinol,00340eea543336d54adda18236424de6a5e91c9d,has_body
trendione,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bacterial Genomes,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Genomes, Bacterial",00340eea543336d54adda18236424de6a5e91c9d,has_body
Plastid Genomes,00340eea543336d54adda18236424de6a5e91c9d,has_body
Antibody Diversity,00340eea543336d54adda18236424de6a5e91c9d,has_body
Antigenic Diversity,00340eea543336d54adda18236424de6a5e91c9d,has_body
Biological Diversity,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cultural Diversity,00340eea543336d54adda18236424de6a5e91c9d,has_body
Diversity Outbred Mice,00340eea543336d54adda18236424de6a5e91c9d,has_body
CBA Studies,00340eea543336d54adda18236424de6a5e91c9d,has_body
Candidate Gene Association Studies,00340eea543336d54adda18236424de6a5e91c9d,has_body
Case Control Studies,00340eea543336d54adda18236424de6a5e91c9d,has_body
Case Studies,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Case Studies, Organizational",00340eea543336d54adda18236424de6a5e91c9d,has_body
Guanine-Quartets,00340eea543336d54adda18236424de6a5e91c9d,has_body
"QUARTET 3 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_body
"QUARTET1 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_body
"ARC-mediator transcriptional coactivator subunit protein, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
Aeromonas media,00340eea543336d54adda18236424de6a5e91c9d,has_body
Anterior Median Oculomotor Nucleus,00340eea543336d54adda18236424de6a5e91c9d,has_body
Antigen-Mediated Clonal Selection,00340eea543336d54adda18236424de6a5e91c9d,has_body
Arterial Media,00340eea543336d54adda18236424de6a5e91c9d,has_body
Uncertainty,00340eea543336d54adda18236424de6a5e91c9d,has_body
Augmentative and Alternative Communications Systems,00340eea543336d54adda18236424de6a5e91c9d,has_body
Communications Media,00340eea543336d54adda18236424de6a5e91c9d,has_body
Communications Personnel,00340eea543336d54adda18236424de6a5e91c9d,has_body
Median-Ulnar Nerve Communications,00340eea543336d54adda18236424de6a5e91c9d,has_body
Satellite Communications,00340eea543336d54adda18236424de6a5e91c9d,has_body
New South Wales,00340eea543336d54adda18236424de6a5e91c9d,has_body
Wales,00340eea543336d54adda18236424de6a5e91c9d,has_body
Congenital Fibrosis Syndrome with Synergistic Divergence,00340eea543336d54adda18236424de6a5e91c9d,has_body
External Ophthalmoplegia with Synergistic Divergence,00340eea543336d54adda18236424de6a5e91c9d,has_body
"External Ophthalmoplegia, Synergistic Divergence, Jaw Winking, and Oculocutaneous Hypopigmentation",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Fibrosis of Extraocular Muscles, Congenital, with Synergistic Divergence",00340eea543336d54adda18236424de6a5e91c9d,has_body
Family Dynamics,00340eea543336d54adda18236424de6a5e91c9d,has_body
Fluid Dynamics,00340eea543336d54adda18236424de6a5e91c9d,has_body
Mitochondrial Dynamics,00340eea543336d54adda18236424de6a5e91c9d,has_body
Molecular Dynamics,00340eea543336d54adda18236424de6a5e91c9d,has_body
Molecular Dynamics Simulation,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Analysis, Regression",00340eea543336d54adda18236424de6a5e91c9d,has_body
Corpus Luteum Regression,00340eea543336d54adda18236424de6a5e91c9d,has_body
Geographically Weighted Regression,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hearing loss ankle anomalies and neurological regression-dementia,00340eea543336d54adda18236424de6a5e91c9d,has_body
Linear Regression,00340eea543336d54adda18236424de6a5e91c9d,has_body
"(Arg(14),Lys(15))NC",00340eea543336d54adda18236424de6a5e91c9d,has_body
(DAniF)3Mo2(((m-CF3)C6H5)NC(O)C6H4(O)CN((m-CF3)C6H5))Mo2(DAniF)3,00340eea543336d54adda18236424de6a5e91c9d,has_body
(DAniF)3Mo2((C6H5)NC(O)C6H4(O)CN(C6H5))Mo2(DAniF)3,00340eea543336d54adda18236424de6a5e91c9d,has_body
(NC)2Cu(I),00340eea543336d54adda18236424de6a5e91c9d,has_body
(NC)2Cu(II),00340eea543336d54adda18236424de6a5e91c9d,has_body
Resuscitation Decisions,00340eea543336d54adda18236424de6a5e91c9d,has_body
Supreme Court Decisions,00340eea543336d54adda18236424de6a5e91c9d,has_body
United States Supreme Court Decisions,00340eea543336d54adda18236424de6a5e91c9d,has_body
court decisions,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Amino Acid Metabolism, Inborn Errors",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Carbohydrate Metabolism, Inborn Errors",00340eea543336d54adda18236424de6a5e91c9d,has_body
Congenital Errors of Steroid Metabolism,00340eea543336d54adda18236424de6a5e91c9d,has_body
Diagnostic Errors,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Errors, Diagnostic",00340eea543336d54adda18236424de6a5e91c9d,has_body
Bilateral Synchronous Inferior Petrosal Sinus Sampling,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chorionic Villi Sampling,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chorionic Villus Sampling,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cord Blood Sampling,00340eea543336d54adda18236424de6a5e91c9d,has_body
Experience Sampling,00340eea543336d54adda18236424de6a5e91c9d,has_body
C10-UK-2A antibiotic,00340eea543336d54adda18236424de6a5e91c9d,has_body
C9-UK-2A antibiotic,00340eea543336d54adda18236424de6a5e91c9d,has_body
PHC-UK,00340eea543336d54adda18236424de6a5e91c9d,has_body
STX-uk,00340eea543336d54adda18236424de6a5e91c9d,has_body
UK 1,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Dentistry, Evidence-Based",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Emergency Medicine, Evidence-Based",00340eea543336d54adda18236424de6a5e91c9d,has_body
Evidence Based Health Care Management,00340eea543336d54adda18236424de6a5e91c9d,has_body
Evidence Based Healthcare Management,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Evidence Based Management, Health Care",00340eea543336d54adda18236424de6a5e91c9d,has_body
Congenital shortness of the costocoracoid ligament,00340eea543336d54adda18236424de6a5e91c9d,has_body
Congenital shortness with mild spondylorhizomelic dwarfism,00340eea543336d54adda18236424de6a5e91c9d,has_body
Glaucoma-Lens Ectopia-Microspherophakia-Stiffness-Shortness Syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Hyperostosis frontalis interna, obesity, shortness and cognitive impairment",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Mental retardation with pterygia, shortness and distinct facial appearance",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Arrow protein, Drosophila",00340eea543336d54adda18236424de6a5e91c9d,has_body
Arrowhead,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Arrowhead protein, Drosophila",00340eea543336d54adda18236424de6a5e91c9d,has_body
Arrowroot,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Arrowroot, Brazilian",00340eea543336d54adda18236424de6a5e91c9d,has_body
MNA SARS-CoV-2 S1 subunit vaccines,00340eea543336d54adda18236424de6a5e91c9d,has_body
SARS-CoV-2,00340eea543336d54adda18236424de6a5e91c9d,has_body
SARS-CoV-2 S protein,00340eea543336d54adda18236424de6a5e91c9d,has_body
SARS-CoV-2 convalescent plasma treatment,00340eea543336d54adda18236424de6a5e91c9d,has_body
SARS-CoV-2 convalescent sera treatment,00340eea543336d54adda18236424de6a5e91c9d,has_body
Effort Syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Effort-Induced Upper Extremity Deep Vein Thrombosis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Effort-Related Upper Extremity Deep Vein Thrombosis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Effortil,00340eea543336d54adda18236424de6a5e91c9d,has_body
Physical Effort,00340eea543336d54adda18236424de6a5e91c9d,has_body
Availability Equivalency,00340eea543336d54adda18236424de6a5e91c9d,has_body
Availability of Health Services,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Availability, Biologic",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Availability, Biological",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Availability, Biological Nutritional",00340eea543336d54adda18236424de6a5e91c9d,has_body
Electronic Supplementary Material,00340eea543336d54adda18236424de6a5e91c9d,has_body
Electronic Supplementary Materials,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Epilepsy, Supplementary Motor",00340eea543336d54adda18236424de6a5e91c9d,has_body
Medicare Supplementary Medical Insurance Program,00340eea543336d54adda18236424de6a5e91c9d,has_body
Supplementary Eye Field,00340eea543336d54adda18236424de6a5e91c9d,has_body
Assertive Community Treatment,00340eea543336d54adda18236424de6a5e91c9d,has_body
Biological Community,00340eea543336d54adda18236424de6a5e91c9d,has_body
Biotic Community,00340eea543336d54adda18236424de6a5e91c9d,has_body
Community,00340eea543336d54adda18236424de6a5e91c9d,has_body
Community Action,00340eea543336d54adda18236424de6a5e91c9d,has_body
4-DOI,00340eea543336d54adda18236424de6a5e91c9d,has_body
DOI cpd,00340eea543336d54adda18236424de6a5e91c9d,has_body
DOI-P,00340eea543336d54adda18236424de6a5e91c9d,has_body
DOI-aminopropane,00340eea543336d54adda18236424de6a5e91c9d,has_body
L-glutamine DOI aminotransferase,00340eea543336d54adda18236424de6a5e91c9d,has_body
Phylogenetic Biogeography,00340eea543336d54adda18236424de6a5e91c9d,has_body
Phylogenetic DNA Barcode,00340eea543336d54adda18236424de6a5e91c9d,has_body
Phylogenetic DNA Barcoding,00340eea543336d54adda18236424de6a5e91c9d,has_body
AT III Glasgow,00340eea543336d54adda18236424de6a5e91c9d,has_body
Glasgow Coma Scale,00340eea543336d54adda18236424de6a5e91c9d,has_body
Glasgow Outcome Scale,00340eea543336d54adda18236424de6a5e91c9d,has_body
Glasgow antithrombin III,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Neonatally lethal short-limb skeletal dysplasia, glasgow type",00340eea543336d54adda18236424de6a5e91c9d,has_body
111In-nuclear translocation sequence-7G3,00340eea543336d54adda18236424de6a5e91c9d,has_body
3' Flanking Sequence,00340eea543336d54adda18236424de6a5e91c9d,has_body
5' Flanking Sequence,00340eea543336d54adda18236424de6a5e91c9d,has_body
5' TOP Sequence,00340eea543336d54adda18236424de6a5e91c9d,has_body
AAUAAA RNA Sequence,00340eea543336d54adda18236424de6a5e91c9d,has_body
Autochthonous Transmission,00340eea543336d54adda18236424de6a5e91c9d,has_body
"CTF8, chromosome transmission fidelity factor 8 homolog protein, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
Communicable Disease Transmission,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dentist-Patient Transmission,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Disease Transmission, Infectious",00340eea543336d54adda18236424de6a5e91c9d,has_body
Clinical Practice Patterns,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dental Practice Patterns,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dentist's Practice Patterns,00340eea543336d54adda18236424de6a5e91c9d,has_body
Feeding Patterns,00340eea543336d54adda18236424de6a5e91c9d,has_body
Inheritance Patterns,00340eea543336d54adda18236424de6a5e91c9d,has_body
"EXCESSIVE BRANCHES1 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_body
"MORE AXILLARY BRANCHES 2 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_body
(((4-(bis(2-iodoethyl)amino)phenyl)oxy)carbonyl)glutamic acid,00340eea543336d54adda18236424de6a5e91c9d,has_body
(((amino-2-ethyl)-2-aminomethyl)-2-pyridine-6-carboxylhistidyl-gamma-(2-amino-2-deoxyglucosyl)glutamylglycylamino)-4-phenyl-1-aminoacridine,00340eea543336d54adda18236424de6a5e91c9d,has_body
"((7-methoxycoumarin-4-yl)acetyl)arginyl-prolyl-lysyl-prolyl-valyl-glutamyl-norvalyl-tryptophyl-arginyl-(2,4-dinitrophenyl)lysinamide",00340eea543336d54adda18236424de6a5e91c9d,has_body
"((S)-2-(5-(1,2-dihydro-3-methyl-1-oxobenzo(f)-quinazoline-9-yl)methyl)amino-1-oxo-2-isoindolynyl)-glutaric acid",00340eea543336d54adda18236424de6a5e91c9d,has_body
"(1'-deoxy-D-mannitol-1'-yl)-L-glutamine,1',2'-lactone",00340eea543336d54adda18236424de6a5e91c9d,has_body
Edinburgh Malformation Syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Edinburgh Postnatal Depression Scale,00340eea543336d54adda18236424de6a5e91c9d,has_body
Edinburgh University solution of lime,00340eea543336d54adda18236424de6a5e91c9d,has_body
Agency for International Development,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Educational Exchange, International",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Exchange, International Educational",00340eea543336d54adda18236424de6a5e91c9d,has_body
International Agencies,00340eea543336d54adda18236424de6a5e91c9d,has_body
International Aspects,00340eea543336d54adda18236424de6a5e91c9d,has_body
Gas-Liquid-Solid Phase Transitions,00340eea543336d54adda18236424de6a5e91c9d,has_body
Beclazone Easy Breathe,00340eea543336d54adda18236424de6a5e91c9d,has_body
Breath Holding,00340eea543336d54adda18236424de6a5e91c9d,has_body
Breath Tests,00340eea543336d54adda18236424de6a5e91c9d,has_body
Breathalyzer Tests,00340eea543336d54adda18236424de6a5e91c9d,has_body
Breathing,00340eea543336d54adda18236424de6a5e91c9d,has_body
AFLP Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Activation Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Activation Analysis, Neutron",00340eea543336d54adda18236424de6a5e91c9d,has_body
Actuarial Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Amino Acid Sequence Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Acute Physiology and Chronic Health Evaluation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Systems Evaluation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Diagnostic Self Evaluation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Disability Evaluation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Drug Evaluation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Disease Outbreaks,00340eea543336d54adda18236424de6a5e91c9d,has_body
Infectious Disease Outbreaks,00340eea543336d54adda18236424de6a5e91c9d,has_body
Outbreaks,00340eea543336d54adda18236424de6a5e91c9d,has_body
outbreaks,00340eea543336d54adda18236424de6a5e91c9d,has_body
Almond Tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
Apple Tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
Apricot Tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
Arjun Tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
Arjuna Tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
Beginning of Human Life,00340eea543336d54adda18236424de6a5e91c9d,has_body
Beginning of Life,00340eea543336d54adda18236424de6a5e91c9d,has_body
(64)Cu-bis-DOTA-hypericin,00340eea543336d54adda18236424de6a5e91c9d,has_body
"35-kDa hypertonic stress protein, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
3beta-Hsd Deficiency Congenital Adrenal Hyperplasia,00340eea543336d54adda18236424de6a5e91c9d,has_body
"5-Prime-Deiodinase Deficiency, Generalized, Causing Euthyroid Hyperthyroxinemia",00340eea543336d54adda18236424de6a5e91c9d,has_body
64Cu-bis-DOTA-hypericin,00340eea543336d54adda18236424de6a5e91c9d,has_body
All-Terrain Vehicles,00340eea543336d54adda18236424de6a5e91c9d,has_body
Armored Vehicles,00340eea543336d54adda18236424de6a5e91c9d,has_body
Halobacterium gas vehicle proteins,00340eea543336d54adda18236424de6a5e91c9d,has_body
Launch Vehicle,00340eea543336d54adda18236424de6a5e91c9d,has_body
Motor Vehicles,00340eea543336d54adda18236424de6a5e91c9d,has_body
"5-HL protein, African swine fever virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"5EL protein, African swine fever virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"9-RL protein, African swine fever virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"9GL protein, African swine fever virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"A224L protein, African swine fever virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
1-TIP-4-FEP,00340eea543336d54adda18236424de6a5e91c9d,has_body
"2,4,6-TIP",00340eea543336d54adda18236424de6a5e91c9d,has_body
"3,4-DP-TIP",00340eea543336d54adda18236424de6a5e91c9d,has_body
4-DMS-TIP cpd,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hairy nose tip,00340eea543336d54adda18236424de6a5e91c9d,has_body
Preprint,00340eea543336d54adda18236424de6a5e91c9d,has_body
Preprints,00340eea543336d54adda18236424de6a5e91c9d,has_body
Preprints as Topic,00340eea543336d54adda18236424de6a5e91c9d,has_body
Benign Cough Headache,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cough,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cough Headache,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cough Suppressants,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Neuropathy, Hereditary Sensory And Autonomic, Type I, With Cough And Gastroesophageal Reflux",00340eea543336d54adda18236424de6a5e91c9d,has_body
Distance Counseling,00340eea543336d54adda18236424de6a5e91c9d,has_body
Distance Education,00340eea543336d54adda18236424de6a5e91c9d,has_body
Distance Learning,00340eea543336d54adda18236424de6a5e91c9d,has_body
Distance Perception,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Education, Distance",00340eea543336d54adda18236424de6a5e91c9d,has_body
Knowledge of Results (Psychology),00340eea543336d54adda18236424de6a5e91c9d,has_body
"Knowledge of Results, Psychological",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Knowledge of Results, Psychology",00340eea543336d54adda18236424de6a5e91c9d,has_body
Negative Results,00340eea543336d54adda18236424de6a5e91c9d,has_body
Null Results,00340eea543336d54adda18236424de6a5e91c9d,has_body
"2S albumin, brazil nut",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Acheiropody, Brazilian type",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Achondrogenesis, Brazilian",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Arrowroot, Brazilian",00340eea543336d54adda18236424de6a5e91c9d,has_body
"BbTX-II, Bothrops brazili",00340eea543336d54adda18236424de6a5e91c9d,has_body
Amino Acid Sequence Analyses,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Analyses, Demographic",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Analyses, Dental Stress",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Analyses, Multiregional",00340eea543336d54adda18236424de6a5e91c9d,has_body
Biological Oxygen Demand Analyses,00340eea543336d54adda18236424de6a5e91c9d,has_body
News,00340eea543336d54adda18236424de6a5e91c9d,has_body
Newsletters,00340eea543336d54adda18236424de6a5e91c9d,has_body
Newspaper Article,00340eea543336d54adda18236424de6a5e91c9d,has_body
Newspapers,00340eea543336d54adda18236424de6a5e91c9d,has_body
Newspapers as Topic,00340eea543336d54adda18236424de6a5e91c9d,has_body
Africa South of the Sahara,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Africa, Southern",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Amerinds, South American",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Asia, Southeastern",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Blastomycosis, South American",00340eea543336d54adda18236424de6a5e91c9d,has_body
21-formyl sarsasapogenin,00340eea543336d54adda18236424de6a5e91c9d,has_body
"3C-like protease, SARS coronavirus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"3CL(pro) protein, SARS-CoV",00340eea543336d54adda18236424de6a5e91c9d,has_body
"3a protein, SARS-CoV",00340eea543336d54adda18236424de6a5e91c9d,has_body
"7a protein, SARS virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"14K protein, Borna disease virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"18K glycoprotein, Borna disease virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"1D protein, Foot-and-mouth disease virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus disease,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus disease testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
"differentially expressed in hematopoietic lineages protein, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
(iodoacetamido)proxyl,00340eea543336d54adda18236424de6a5e91c9d,has_body
1-palmitoyl-2-(14-proxylstearoyl)glycero-3-phospho-N-(4-azido-3-nitrophenyl)ethanolamine,00340eea543336d54adda18236424de6a5e91c9d,has_body
"1-palmitoyl-2-(14-proxylstearoyl)glycero-3-phospho-N-(4-azido-3-nitrophenyl)ethanolamine, (3)H-labeled",00340eea543336d54adda18236424de6a5e91c9d,has_body
3-(2-iodoacetamido)proxyl,00340eea543336d54adda18236424de6a5e91c9d,has_body
3-aminomethyl-proxyl,00340eea543336d54adda18236424de6a5e91c9d,has_body
Democratic People's Republic of Korea,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Hemorrhagic Fever Virus, Korean",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Hemorrhagic Fever, Korean",00340eea543336d54adda18236424de6a5e91c9d,has_body
Korea,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Korea, Democratic People's Republic of",00340eea543336d54adda18236424de6a5e91c9d,has_body
Audience Research,00340eea543336d54adda18236424de6a5e91c9d,has_body
Affective Symptoms,00340eea543336d54adda18236424de6a5e91c9d,has_body
Behavioral Symptoms,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cognitive Symptoms,00340eea543336d54adda18236424de6a5e91c9d,has_body
Depressive Symptoms,00340eea543336d54adda18236424de6a5e91c9d,has_body
Drug Reaction with Eosinophilia and Systemic Symptoms,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Administrative Claims, Healthcare",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Analysis, Claims",00340eea543336d54adda18236424de6a5e91c9d,has_body
Claims Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Claims Review,00340eea543336d54adda18236424de6a5e91c9d,has_body
Insurance Claims Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Policy Makers,00340eea543336d54adda18236424de6a5e91c9d,has_body
suchengbeisine,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hb Southern Italy,00340eea543336d54adda18236424de6a5e91c9d,has_body
Italy,00340eea543336d54adda18236424de6a5e91c9d,has_body
hemoglobin Southern Italy,00340eea543336d54adda18236424de6a5e91c9d,has_body
Calothrix marchica,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cylindrospermum marchicum,00340eea543336d54adda18236424de6a5e91c9d,has_body
"E3 ubiquitin-protein ligase MARCH11, mouse",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Fractures, March",00340eea543336d54adda18236424de6a5e91c9d,has_body
"MARCH I protein, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
COP9 Signalsome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Constitutive Photomorphogenesis 9 Signalsome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Nuclear Export Signals,00340eea543336d54adda18236424de6a5e91c9d,has_body
Nuclear Localization Signals,00340eea543336d54adda18236424de6a5e91c9d,has_body
Peroxisomal Targeting Signals,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Drug Evaluations, Preclinical",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Evaluations, Preclinical Drug",00340eea543336d54adda18236424de6a5e91c9d,has_body
Preclinical Drug Evaluations,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dataset,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dataset as Topic,00340eea543336d54adda18236424de6a5e91c9d,has_body
Datasets as Topic,00340eea543336d54adda18236424de6a5e91c9d,has_body
1-D-IE-P,00340eea543336d54adda18236424de6a5e91c9d,has_body
15-prop-PGF2alpha-IE,00340eea543336d54adda18236424de6a5e91c9d,has_body
17-IE-ADOO,00340eea543336d54adda18236424de6a5e91c9d,has_body
2-(MNPSM)IE,00340eea543336d54adda18236424de6a5e91c9d,has_body
"5,6-epoxymogroside IE",00340eea543336d54adda18236424de6a5e91c9d,has_body
Clustering,00340eea543336d54adda18236424de6a5e91c9d,has_body
Disease Clustering,00340eea543336d54adda18236424de6a5e91c9d,has_body
Space-Time Clustering,00340eea543336d54adda18236424de6a5e91c9d,has_body
Adenine Nucleotides,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cytosine Nucleotides,00340eea543336d54adda18236424de6a5e91c9d,has_body
Deoxyadenine Nucleotides,00340eea543336d54adda18236424de6a5e91c9d,has_body
Deoxycytosine Nucleotides,00340eea543336d54adda18236424de6a5e91c9d,has_body
Deoxyguanine Nucleotides,00340eea543336d54adda18236424de6a5e91c9d,has_body
Stigmatization,00340eea543336d54adda18236424de6a5e91c9d,has_body
"sidestep protein, Drosophila",00340eea543336d54adda18236424de6a5e91c9d,has_body
"12F polysaccharide, Streptococcus pneumoniae",00340eea543336d54adda18236424de6a5e91c9d,has_body
"2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase, Klebsiella pneumoniae",00340eea543336d54adda18236424de6a5e91c9d,has_body
"ATP-dependent Clp protease proteolytic subunit, Streptococcus pneumoniae",00340eea543336d54adda18236424de6a5e91c9d,has_body
"AcoK protein, Klebsiella pneumoniae",00340eea543336d54adda18236424de6a5e91c9d,has_body
"AcrR protein, Klebsiella pneumoniae",00340eea543336d54adda18236424de6a5e91c9d,has_body
Phylogeography,00340eea543336d54adda18236424de6a5e91c9d,has_body
Analytic Sample Preparation Methods,00340eea543336d54adda18236424de6a5e91c9d,has_body
Analytical Chemistry Methods,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Barrier Methods, Contraceptive",00340eea543336d54adda18236424de6a5e91c9d,has_body
Census Methods,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Communication Methods, Total",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Analysis, Bayesian",00340eea543336d54adda18236424de6a5e91c9d,has_body
Bayesian Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bayesian Approach,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bayesian Forecast,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bayesian Method,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Emphysema, Congenital, With Deafness, Penoscrotal Web, And Mental Retardation",00340eea543336d54adda18236424de6a5e91c9d,has_body
Food Web,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Glottic Web, Congenital Anterior",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Laryngeal Web, Familial",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Laryngeal web, congenital heart disease and low stature",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Economic Values, Life",00340eea543336d54adda18236424de6a5e91c9d,has_body
Laboratory Alert Values,00340eea543336d54adda18236424de6a5e91c9d,has_body
Laboratory Critical Values,00340eea543336d54adda18236424de6a5e91c9d,has_body
Life Economic Values,00340eea543336d54adda18236424de6a5e91c9d,has_body
Normal Values,00340eea543336d54adda18236424de6a5e91c9d,has_body
Practice Gaps,00340eea543336d54adda18236424de6a5e91c9d,has_body
Professional Practice Gaps,00340eea543336d54adda18236424de6a5e91c9d,has_body
"gapstatin protein, Actinobacillus",00340eea543336d54adda18236424de6a5e91c9d,has_body
ras-GAPs,00340eea543336d54adda18236424de6a5e91c9d,has_body
Caribbean Netherlands,00340eea543336d54adda18236424de6a5e91c9d,has_body
Kingdom of the Netherlands,00340eea543336d54adda18236424de6a5e91c9d,has_body
Netherlands,00340eea543336d54adda18236424de6a5e91c9d,has_body
Netherlands Antilles,00340eea543336d54adda18236424de6a5e91c9d,has_body
Netherlands East Indies,00340eea543336d54adda18236424de6a5e91c9d,has_body
"00261 long non coding RNA, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
10Sa RNA,00340eea543336d54adda18236424de6a5e91c9d,has_body
15S RNA,00340eea543336d54adda18236424de6a5e91c9d,has_body
"16S RNA pseudouridine 516 synthase, E coli",00340eea543336d54adda18236424de6a5e91c9d,has_body
16S Ribosomal RNA,00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Applications Software,00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Software,00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Software Applications,00340eea543336d54adda18236424de6a5e91c9d,has_body
Portable Software Applications,00340eea543336d54adda18236424de6a5e91c9d,has_body
Portable Software Apps,00340eea543336d54adda18236424de6a5e91c9d,has_body
(2-HB)(2-MP)A,00340eea543336d54adda18236424de6a5e91c9d,has_body
"1,3,6,-HB-MDP",00340eea543336d54adda18236424de6a5e91c9d,has_body
"1,5-HB-PMA-P",00340eea543336d54adda18236424de6a5e91c9d,has_body
1-(4-HB)-DDP,00340eea543336d54adda18236424de6a5e91c9d,has_body
1-O-(HP)-(HB)-G,00340eea543336d54adda18236424de6a5e91c9d,has_body
Plotosus,00340eea543336d54adda18236424de6a5e91c9d,has_body
Plott syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Allosteric Sites,00340eea543336d54adda18236424de6a5e91c9d,has_body
Alternative Splice Sites,00340eea543336d54adda18236424de6a5e91c9d,has_body
Antibody Binding Sites,00340eea543336d54adda18236424de6a5e91c9d,has_body
Att Attachment Sites,00340eea543336d54adda18236424de6a5e91c9d,has_body
AttB Attachment Sites,00340eea543336d54adda18236424de6a5e91c9d,has_body
Household Articles,00340eea543336d54adda18236424de6a5e91c9d,has_body
Speech disturbance - use of faulty phrasing and unrelated words,00340eea543336d54adda18236424de6a5e91c9d,has_body
Animal Population Groups,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Biologic Variability, Population",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Biological Variation, Population",00340eea543336d54adda18236424de6a5e91c9d,has_body
Continental Population Groups,00340eea543336d54adda18236424de6a5e91c9d,has_body
General Social Development and Population,00340eea543336d54adda18236424de6a5e91c9d,has_body
Amino Acid Sequencing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Assay for Transposase-Accessible Chromatin Using Sequencing,00340eea543336d54adda18236424de6a5e91c9d,has_body
ChIP Sequencing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chromatin Immuno-precipitation Sequencing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chromatin Immunoprecipitation Sequencing,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Encephalitis, Epidemic",00340eea543336d54adda18236424de6a5e91c9d,has_body
Epidemic Acute Poliomyelitis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Epidemic Encephalitis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Epidemic Hemorrhagic Fever Virus,00340eea543336d54adda18236424de6a5e91c9d,has_body
Epidemic Neurolabyrinthitis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Assisted Radiographic Image Interpretation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer-Assisted Radiographic Image Interpretation,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Data Interpretation, Statistical",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Data Interpretations, Statistical",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Image Interpretation, Computer Assisted",00340eea543336d54adda18236424de6a5e91c9d,has_body
Communicable Disease Contact Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Contact Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Fluorescent Protein Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Infectious Disease Contact Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Neuroanatomical Tract-Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_body
COVID-19 pandemic,00340eea543336d54adda18236424de6a5e91c9d,has_body
"H1N1 Influenza Pandemic, 1918-1919",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Influenza Pandemic, 1918-1919",00340eea543336d54adda18236424de6a5e91c9d,has_body
Pandemics,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Spanish Flu Pandemic, 1918-1919",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Grants, Peer Review",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Organizations, Peer Review",00340eea543336d54adda18236424de6a5e91c9d,has_body
Peer Group,00340eea543336d54adda18236424de6a5e91c9d,has_body
Peer Influence,00340eea543336d54adda18236424de6a5e91c9d,has_body
Peer Pressure,00340eea543336d54adda18236424de6a5e91c9d,has_body
Likelihood Functions,00340eea543336d54adda18236424de6a5e91c9d,has_body
Maximum Likelihood Estimates,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Diversification, Hospital",00340eea543336d54adda18236424de6a5e91c9d,has_body
Hospital Diversification,00340eea543336d54adda18236424de6a5e91c9d,has_body
300IR 5-grass pollen sublingual tablet,00340eea543336d54adda18236424de6a5e91c9d,has_body
Anginol-tablets,00340eea543336d54adda18236424de6a5e91c9d,has_body
Examination Tables,00340eea543336d54adda18236424de6a5e91c9d,has_body
Kohle-Tabletten Boxo-Pharm,00340eea543336d54adda18236424de6a5e91c9d,has_body
Life Table Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
1-Isochromen-1-ones,00340eea543336d54adda18236424de6a5e91c9d,has_body
1H-2-Benzopyran-1-ones,00340eea543336d54adda18236424de6a5e91c9d,has_body
"2,3-dihydro-7H-thiazolo(3,2,a)pyrimidin-7-ones",00340eea543336d54adda18236424de6a5e91c9d,has_body
2-Phenyl-3-Hydroxy-Benzopyran-4-Ones,00340eea543336d54adda18236424de6a5e91c9d,has_body
2-Phenyl-Benzopyran-4-Ones,00340eea543336d54adda18236424de6a5e91c9d,has_body
Spearman Rank Correlation Coefficient,00340eea543336d54adda18236424de6a5e91c9d,has_body
Information Dissemination,00340eea543336d54adda18236424de6a5e91c9d,has_body
3' Untranslated Regions,00340eea543336d54adda18236424de6a5e91c9d,has_body
5' Untranslated Regions,00340eea543336d54adda18236424de6a5e91c9d,has_body
Antarctic Regions,00340eea543336d54adda18236424de6a5e91c9d,has_body
Arctic Regions,00340eea543336d54adda18236424de6a5e91c9d,has_body
Body Regions,00340eea543336d54adda18236424de6a5e91c9d,has_body
Date Palm Trees,00340eea543336d54adda18236424de6a5e91c9d,has_body
Decision Trees,00340eea543336d54adda18236424de6a5e91c9d,has_body
Sweet Gum Trees,00340eea543336d54adda18236424de6a5e91c9d,has_body
Trees,00340eea543336d54adda18236424de6a5e91c9d,has_body
Treeshrews,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus infection,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019-nCoV infection,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019-nCoV infection testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
AIDS-Related Opportunistic Infections,00340eea543336d54adda18236424de6a5e91c9d,has_body
Absidia corymbifera Infection,00340eea543336d54adda18236424de6a5e91c9d,has_body
A1120 agent,00340eea543336d54adda18236424de6a5e91c9d,has_body
A15 imaging agent,00340eea543336d54adda18236424de6a5e91c9d,has_body
AF 2 (cross-linking agent),00340eea543336d54adda18236424de6a5e91c9d,has_body
AR-1 (antiarrhythmia agent),00340eea543336d54adda18236424de6a5e91c9d,has_body
Abortifacient Agents,00340eea543336d54adda18236424de6a5e91c9d,has_body
Almond Tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
Apple Tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
Apricot Tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
Arjun Tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
Arjuna Tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
Algorithms,00340eea543336d54adda18236424de6a5e91c9d,has_body
Augmented Reality,00340eea543336d54adda18236424de6a5e91c9d,has_body
Mixed Reality,00340eea543336d54adda18236424de6a5e91c9d,has_body
Reality Testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Reality Therapy,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Therapy, Reality",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Amyotrophy, Thenar, Of Carpal Origin",00340eea543336d54adda18236424de6a5e91c9d,has_body
CNS Origin Vertigo,00340eea543336d54adda18236424de6a5e91c9d,has_body
Central Nervous System Origin Vertigo,00340eea543336d54adda18236424de6a5e91c9d,has_body
Congenital Amaurosis of Retinal Origin,00340eea543336d54adda18236424de6a5e91c9d,has_body
Delirium of Mixed Origin,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Hospitals, Packaged",00340eea543336d54adda18236424de6a5e91c9d,has_body
Package Inserts,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Package Inserts, Drug",00340eea543336d54adda18236424de6a5e91c9d,has_body
Packaged Hospitals,00340eea543336d54adda18236424de6a5e91c9d,has_body
Ad5-nCoV COVID-19 vaccine,00340eea543336d54adda18236424de6a5e91c9d,has_body
COVID-19,00340eea543336d54adda18236424de6a5e91c9d,has_body
COVID-19 artificial antigen presenting cells vaccine,00340eea543336d54adda18236424de6a5e91c9d,has_body
COVID-19 convalescent plasma treatment,00340eea543336d54adda18236424de6a5e91c9d,has_body
COVID-19 convalescent serum treatment,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Analysis, Bayesian",00340eea543336d54adda18236424de6a5e91c9d,has_body
Bayesian Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bayesian Approach,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bayesian Forecast,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bayesian Method,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Emphysema, Congenital, With Deafness, Penoscrotal Web, And Mental Retardation",00340eea543336d54adda18236424de6a5e91c9d,has_body
Food Web,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Glottic Web, Congenital Anterior",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Laryngeal Web, Familial",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Laryngeal web, congenital heart disease and low stature",00340eea543336d54adda18236424de6a5e91c9d,has_body
MNA SARS-CoV-2 S1 subunit vaccines,00340eea543336d54adda18236424de6a5e91c9d,has_body
SARS-CoV-2,00340eea543336d54adda18236424de6a5e91c9d,has_body
SARS-CoV-2 S protein,00340eea543336d54adda18236424de6a5e91c9d,has_body
SARS-CoV-2 convalescent plasma treatment,00340eea543336d54adda18236424de6a5e91c9d,has_body
SARS-CoV-2 convalescent sera treatment,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus disease,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus disease testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus infection,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Blood Alcohol Content,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bone Mineral Content,00340eea543336d54adda18236424de6a5e91c9d,has_body
Digestive Tract Contents,00340eea543336d54adda18236424de6a5e91c9d,has_body
G+C Content,00340eea543336d54adda18236424de6a5e91c9d,has_body
GC Content,00340eea543336d54adda18236424de6a5e91c9d,has_body
((OC-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV)),00340eea543336d54adda18236424de6a5e91c9d,has_body
"(2S,3R,6R,7R)-7- (4-hydroxy-3-methoxyphenyl)-2,6-bis(hydroxymethyl)-15,43-dimethoxy-5,8-dioxa-1(1,3),4(1,4)-dibenzenacycloundecaphane-16,3-diol",00340eea543336d54adda18236424de6a5e91c9d,has_body
"42,43,44,45,46,47,55-heptanor-41-oxohomoyessotoxin",00340eea543336d54adda18236424de6a5e91c9d,has_body
"42,43,44,45,46,47,55-heptanor-41-oxoyessotoxin",00340eea543336d54adda18236424de6a5e91c9d,has_body
43 kDA-heparin binding protein (brain),00340eea543336d54adda18236424de6a5e91c9d,has_body
Phylogeny,00340eea543336d54adda18236424de6a5e91c9d,has_body
Guanine-Quartets,00340eea543336d54adda18236424de6a5e91c9d,has_body
3D Molecular Structure,00340eea543336d54adda18236424de6a5e91c9d,has_body
5' mRNA Cap Structure,00340eea543336d54adda18236424de6a5e91c9d,has_body
Animal Structures,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bacterial Structures,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cell Membrane Structures,00340eea543336d54adda18236424de6a5e91c9d,has_body
21-formyl sarsasapogenin,00340eea543336d54adda18236424de6a5e91c9d,has_body
"3C-like protease, SARS coronavirus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"3CL(pro) protein, SARS-CoV",00340eea543336d54adda18236424de6a5e91c9d,has_body
"3a protein, SARS-CoV",00340eea543336d54adda18236424de6a5e91c9d,has_body
"7a protein, SARS virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
Handbook,00340eea543336d54adda18236424de6a5e91c9d,has_body
Handbooks,00340eea543336d54adda18236424de6a5e91c9d,has_body
Likelihood Functions,00340eea543336d54adda18236424de6a5e91c9d,has_body
Maximum Likelihood Estimates,00340eea543336d54adda18236424de6a5e91c9d,has_body
Ahumada-Del Castillo syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Argonz-Ahumada-Del Castillo syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Argonz-Del Castillo Syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chitayat Moore Del Bigio syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Chromosome 7, terminal 7p deletion (del 7p21-p22)",00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Applications Software,00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Software,00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Software Applications,00340eea543336d54adda18236424de6a5e91c9d,has_body
Portable Software Applications,00340eea543336d54adda18236424de6a5e91c9d,has_body
Portable Software Apps,00340eea543336d54adda18236424de6a5e91c9d,has_body
Action Potential Optical Mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
Anatomic Electrical Activity Optical Mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
Body Surface Mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
Body Surface Potential Mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
Brain Electrical Activity Mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
Situation Awareness,00340eea543336d54adda18236424de6a5e91c9d,has_body
Situational Awareness,00340eea543336d54adda18236424de6a5e91c9d,has_body
Situational Ethics,00340eea543336d54adda18236424de6a5e91c9d,has_body
Situational Therapy,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Syncope, Situational",00340eea543336d54adda18236424de6a5e91c9d,has_body
3-(2''-O-palmitoyl-myo-inosityl-(1''-6')-glucopyranoside)sitosterol,00340eea543336d54adda18236424de6a5e91c9d,has_body
3-O-(4'-hydroxybenzyl)-beta-sitosterol,00340eea543336d54adda18236424de6a5e91c9d,has_body
3-O-(4-feruloyl)sitostanol,00340eea543336d54adda18236424de6a5e91c9d,has_body
3-O-HOBz-sitosterol,00340eea543336d54adda18236424de6a5e91c9d,has_body
3beta-sitosterol,00340eea543336d54adda18236424de6a5e91c9d,has_body
Easterlin Hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hygiene Hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Lyon Hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_body
(C(2)H(10)N(2))(5)(NH(4))(4)H(2)(Se(2)W(10)V(8)O(62)).9H(2)O,00340eea543336d54adda18236424de6a5e91c9d,has_body
1400 W,00340eea543336d54adda18236424de6a5e91c9d,has_body
2N(w)OHC2-Arg,00340eea543336d54adda18236424de6a5e91c9d,has_body
31-homorifamycin W,00340eea543336d54adda18236424de6a5e91c9d,has_body
3744 W,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Homolog ALignment in meiosis abnormal 3 protein, C elegans",00340eea543336d54adda18236424de6a5e91c9d,has_body
Radiotherapy Target Organ Alignment,00340eea543336d54adda18236424de6a5e91c9d,has_body
Sequence Alignment,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Target Organ Alignment, Radiotherapy",00340eea543336d54adda18236424de6a5e91c9d,has_body
"centrosome alignment defect 1 protein, Drosophila",00340eea543336d54adda18236424de6a5e91c9d,has_body
Biological Co-Evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Biological Evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chemical Evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Clonal Evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cultural Evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
(1-6)-beta-D-glucan-protein complex,00340eea543336d54adda18236424de6a5e91c9d,has_body
(125I)IPOS protein,00340eea543336d54adda18236424de6a5e91c9d,has_body
(2Fe-2S) protein I,00340eea543336d54adda18236424de6a5e91c9d,has_body
"(3H-MeSO2)2TCB-binding protein, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
"(6-4) photolyase protein, Xenopus",00340eea543336d54adda18236424de6a5e91c9d,has_body
Alu Repetitive Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
Amino Acid Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
CRISPR Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
CRISPR Spacer Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
DNA Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
Husband-Wife Comparisons,00340eea543336d54adda18236424de6a5e91c9d,has_body
Paired Comparisons,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Della protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_body
Agitated Emergence,00340eea543336d54adda18236424de6a5e91c9d,has_body
Anesthesia Emergence Delirium,00340eea543336d54adda18236424de6a5e91c9d,has_body
Delayed Emergence from Anesthesia,00340eea543336d54adda18236424de6a5e91c9d,has_body
Emergence Agitation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Emergence Delirium,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chloroplasts,00340eea543336d54adda18236424de6a5e91c9d,has_body
2-(2''-DCAB)-3-(IQ),00340eea543336d54adda18236424de6a5e91c9d,has_body
2-(2-BE)NB-IQ cpd,00340eea543336d54adda18236424de6a5e91c9d,has_body
2-A-3M-IQ,00340eea543336d54adda18236424de6a5e91c9d,has_body
2-C-HP-IQ,00340eea543336d54adda18236424de6a5e91c9d,has_body
2-IQ-glucuronide,00340eea543336d54adda18236424de6a5e91c9d,has_body
Abuse of Health Services,00340eea543336d54adda18236424de6a5e91c9d,has_body
Acceptability of Health Care,00340eea543336d54adda18236424de6a5e91c9d,has_body
Acceptability of Healthcare,00340eea543336d54adda18236424de6a5e91c9d,has_body
Acceptors of Health Care,00340eea543336d54adda18236424de6a5e91c9d,has_body
Access to Health Care,00340eea543336d54adda18236424de6a5e91c9d,has_body
AFLP Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Activation Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Activation Analysis, Neutron",00340eea543336d54adda18236424de6a5e91c9d,has_body
Actuarial Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Amino Acid Sequence Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Aquatic Biology,00340eea543336d54adda18236424de6a5e91c9d,has_body
Biology,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Biology, Computational",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Biology, Developmental",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Biology, Marine",00340eea543336d54adda18236424de6a5e91c9d,has_body
Cell Tracking,00340eea543336d54adda18236424de6a5e91c9d,has_body
"GPT (growing plus-end tracking) 1 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_body
"GPT (growing plus-end tracking) 2 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_body
Patient Tracking,00340eea543336d54adda18236424de6a5e91c9d,has_body
Single Molecule Tracking,00340eea543336d54adda18236424de6a5e91c9d,has_body
"1,17-DATAH",00340eea543336d54adda18236424de6a5e91c9d,has_body
Amino Acid Sequence Databases,00340eea543336d54adda18236424de6a5e91c9d,has_body
Automatic Data Processing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Big Data,00340eea543336d54adda18236424de6a5e91c9d,has_body
Clinical Trials Data Monitoring Committees,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Applications, Medical Informatics",00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Applications Software,00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Software Applications,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Informatics Applications, Medical",00340eea543336d54adda18236424de6a5e91c9d,has_body
Investigational New Drug Applications,00340eea543336d54adda18236424de6a5e91c9d,has_body
(PATH)ZnOH,00340eea543336d54adda18236424de6a5e91c9d,has_body
1-epi-pathylactone A,00340eea543336d54adda18236424de6a5e91c9d,has_body
"APC regulator of WNT signaling pathway protein, zebrafish",00340eea543336d54adda18236424de6a5e91c9d,has_body
Accessory Atrioventricular Pathway,00340eea543336d54adda18236424de6a5e91c9d,has_body
Accessory Atrioventricular Pathways,00340eea543336d54adda18236424de6a5e91c9d,has_body
Abuse Reporting,00340eea543336d54adda18236424de6a5e91c9d,has_body
Adverse Drug Reaction Reporting Systems,00340eea543336d54adda18236424de6a5e91c9d,has_body
Age Reporting,00340eea543336d54adda18236424de6a5e91c9d,has_body
Annual Report,00340eea543336d54adda18236424de6a5e91c9d,has_body
Annual Reports as Topic,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Ataxia, Fatal X-Linked, with Deafness and Loss of Vision",00340eea543336d54adda18236424de6a5e91c9d,has_body
Binocular Vision,00340eea543336d54adda18236424de6a5e91c9d,has_body
"CUG-binding protein and embryonic lethal abnormal vision-type RNA-binding protein 3-like factor 6, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
Color Vision,00340eea543336d54adda18236424de6a5e91c9d,has_body
Color Vision Defects,00340eea543336d54adda18236424de6a5e91c9d,has_body
Phylogenetic Biogeography,00340eea543336d54adda18236424de6a5e91c9d,has_body
Phylogenetic DNA Barcode,00340eea543336d54adda18236424de6a5e91c9d,has_body
Phylogenetic DNA Barcoding,00340eea543336d54adda18236424de6a5e91c9d,has_body
Autoimmune Lymphoproliferative Disease without Fas Mutations,00340eea543336d54adda18236424de6a5e91c9d,has_body
Autoimmune lymphoproliferative syndrome without FAS mutations,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Encephalopathy, Neonatal Severe, Due To Mecp2 Mutations",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Lipodystrophy, Familial Partial, Associated With PPARg Mutations",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Mutations, Silent",00340eea543336d54adda18236424de6a5e91c9d,has_body
"(((1,2-5,6-di-O,O-isopropylideneglucofuranos-3-yl)oxocarbonyl)methyl)cobalt tricarbonyl triphenylphosphine",00340eea543336d54adda18236424de6a5e91c9d,has_body
"((2RS)-2-(4-(4-chlorophenoxy)-alpha,alpha,alpha-trifluoro-o-tolyl)-1-(1H-1,2,4-triazol-1-yl)propan-2-ol",00340eea543336d54adda18236424de6a5e91c9d,has_body
"((2S)-3-cyclohexyl-2-O-1-O-((1R,2R)2-O-(alpha-fucopyranosyl)cyclohexyl)-beta-galactopyrano-3-yl-2-methyl)propanoate",00340eea543336d54adda18236424de6a5e91c9d,has_body
"((3)H)-1-((S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl)-4-(o-tolyl)-piperazine",00340eea543336d54adda18236424de6a5e91c9d,has_body
((9S)-drummondol-9-O-beta-D-glucopyranoside),00340eea543336d54adda18236424de6a5e91c9d,has_body
Clostridium maximum,00340eea543336d54adda18236424de6a5e91c9d,has_body
Maximum Allowable Concentration,00340eea543336d54adda18236424de6a5e91c9d,has_body
Maximum Expiratory Pressure,00340eea543336d54adda18236424de6a5e91c9d,has_body
Maximum Inspiratory Pressure,00340eea543336d54adda18236424de6a5e91c9d,has_body
Maximum Likelihood Estimates,00340eea543336d54adda18236424de6a5e91c9d,has_body
Approach Behavior,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bayesian Approach,00340eea543336d54adda18236424de6a5e91c9d,has_body
Biobehavioral Approach,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dietary Approaches To Stop Hypertension,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dietary Approaches To Stop Hypertension Diet,00340eea543336d54adda18236424de6a5e91c9d,has_body
111In-nuclear translocation sequence-7G3,00340eea543336d54adda18236424de6a5e91c9d,has_body
3' Flanking Sequence,00340eea543336d54adda18236424de6a5e91c9d,has_body
5' Flanking Sequence,00340eea543336d54adda18236424de6a5e91c9d,has_body
5' TOP Sequence,00340eea543336d54adda18236424de6a5e91c9d,has_body
AAUAAA RNA Sequence,00340eea543336d54adda18236424de6a5e91c9d,has_body
"ACS1 protein, Haemophilus influenzae",00340eea543336d54adda18236424de6a5e91c9d,has_body
Avian Influenza,00340eea543336d54adda18236424de6a5e91c9d,has_body
"BM2 polypeptide, influenza B virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"BNP protein, influenza B virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"CM2 protein, Influenza C virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
Blood-Borne Pathogens,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bloodborne Pathogens,00340eea543336d54adda18236424de6a5e91c9d,has_body
Extraintestinal Pathogenic E. coli,00340eea543336d54adda18236424de6a5e91c9d,has_body
Extraintestinal Pathogenic Escherichia coli,00340eea543336d54adda18236424de6a5e91c9d,has_body
"GLI pathogenesis-related 1 (glioma) protein, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
Date Palm Trees,00340eea543336d54adda18236424de6a5e91c9d,has_body
Decision Trees,00340eea543336d54adda18236424de6a5e91c9d,has_body
Sweet Gum Trees,00340eea543336d54adda18236424de6a5e91c9d,has_body
Trees,00340eea543336d54adda18236424de6a5e91c9d,has_body
Treeshrews,00340eea543336d54adda18236424de6a5e91c9d,has_body
One Health Initiative,00340eea543336d54adda18236424de6a5e91c9d,has_body
One Medicine Initiative,00340eea543336d54adda18236424de6a5e91c9d,has_body
Staphylococcus warneri,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
Warnerin,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
"lipase 2, Staphylococcus warneri",0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
"warnericin RB4, Staphylococcus warneri",0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
"warnericin RK, Staphylococcus warneri",0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
"((1-phenyl-2,5-di-(2-pyridyl)phosphole)gold(I)) chloride",0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
(2-benzoxazolethiolato)(triphenylphosphine)gold(I),0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
(2-naphthyl)(triphenylphosphine)gold(I),0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
"(5,10,15-tris(N-methylpyridinium-4-yl)-20-(1-pyrenyl)-porphyrinato)gold(III)",0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
"(5,10,15-tris(N-methylpyridinium-4-yl)-20-(1-pyrenyl)-porphyrinato)gold(III) chloride",0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
SARAH antigen,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
"sarah protein, Drosophila",0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
Nicolaides Baraitser syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
Nicolaides-Baraitser Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
Nicolar,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
Nicolau Livedoid Dermatitis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
Nicolau Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_author
"11kDa protein synthesis inhibitor, Vaccinia virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"12-kDa protein, potato virus M",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"126-kDa protein, Tobacco mosaic virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"12K late protein, Vaccinia virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"130k protein, Tobacco mosaic virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"14K protein, Borna disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"18K glycoprotein, Borna disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"1D protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
2019 novel coronavirus disease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
2019 novel coronavirus disease testing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
Antibody Production,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
Crop Production,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
Heat Production,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
Orphan Drug Production,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"PGK promoter directed over production protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"00261 long non coding RNA, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
10Sa RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
15S RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"16S RNA pseudouridine 516 synthase, E coli",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
16S Ribosomal RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"ARABIDOPSIS THALIANA REPLICATION PROTEIN A 1A protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
Autonomous Replication,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"Chromosome Replication Order, Temporal",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
"Chromosome Replication Pattern, Temporal",0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
Chromosome Replication Timing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_title
A-Loop,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Afferent Loop Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Ascending Limb of Loop of Henle,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Basic Helix-Loop-Helix Transcription Factors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Achaete-Scute Complex Genome Region,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Bacterial Genome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Bacterial Genomes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Chloroplast Genome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Chloroplast Genome-Encoded Proteins,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ANTI-SILENCING FUNCTION 1A protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ANTI-SILENCING FUNCTION 1B protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ASF1 anti-silencing function 1 homolog A (S. cerevisiae) protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ASF1 anti-silencing function 1 homolog B (S. cerevisiae) protein, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Adrenal Cortex Function Tests,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Amino Acid Activation, Translational",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Amino Acid Modification, Co-Translational",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Amino Acid Modification, Post-Translational",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Amino Acid Modification, Pre-Translational",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Amino Acid Modification, Translational",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Chromosome 6 open reading frame 106, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Chromosome 9 Open Reading Frame 72 Protein,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Covalent Organic Framework,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Frame Shift Mutation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Frameless Stereotaxy,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Sickness Presence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ACV1, Conus textile",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Conus textile toxin,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Industry, Textile",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Q8009 protease, Pseudonaja textilis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Text Messages,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"2',3'-Cyclic Nucleotide 3'-Phosphodiesterase",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"2',3'-Cyclic Nucleotide 3'-Phosphodiesterases",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"2',3'-Cyclic Nucleotide Phosphodiesterase",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"2',3'-Cyclic Nucleotide Phosphodiesterases",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"2',3'-Cyclic-Nucleotide Phosphodiesterases",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"14K protein, Borna disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"18K glycoprotein, Borna disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"1D protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
2019 novel coronavirus disease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
2019 novel coronavirus disease testing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Belofor KB,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Belofor KB, disodium salt",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"CLC-Kb channel, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Chromosome 1q21.1 Deletion Syndrome, 200-Kb",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Clearfil KB 1300,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"1D protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"3ABC protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"3C protease, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"3D protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Anus, Imperforate, with Hand, Foot, and Ear Anomalies",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Iressa,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
iresin,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"00261 long non coding RNA, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
10Sa RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
15S RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"16S RNA pseudouridine 516 synthase, E coli",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
16S Ribosomal RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ABERRANT TESTA SHAPE protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ABNORMAL LEAF SHAPE 1 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Angel shaped phalangoepiphyseal dysplasia,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Angel-Shaped Phalangoepiphyseal Dysplasia,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Angel-shaped phalango-epiphyseal dysplasia,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
10p Deletion Syndrome (Partial),0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
10q- deletion,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
11p Deletion Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
11q Deletion Disorder,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
11q Deletion Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Abstracting,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Abstracting and Indexing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Abstracting and Indexing as Topic,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Abstracting as Topic,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Abstracts,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"((3alpha,3'alpha,4beta,4'beta)-3,3')-dimethoxy-cis-(4,4'-bis(3,4,5,10-tetrahydro-1H-naphtho(2,3-)pyran))-5,5',10,10'-tetraone",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
((cis-Pt(NH(3))(2))(2)(mu-OH)(mu-pyrazolate))(2+),0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"((cis-Pt(NH3)2Cl)2 4,4'-dipyridyl sulfide(NO3)2)",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
((cis-Pt(NH3)2Cl)2 bpsu(NO3)2),0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
((cis-RuCl2(Me2SO)3)H2N(CH2)4NH2(cis-PtCl2(NH3))),0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
AMP-PK reactivator,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Ac-pk-1 protein, Autographa californica nucleopolyhedrovirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"CRK4 PK, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
CaM PK II,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Calcium-Calmodulin-Dependent PK Type II,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Animal Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Civil Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Collective Human Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Equal Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Health Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
(+)-alpha-polypodatetraene,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
(+)-alpha-tocopheryl polyethylene glycol 1000 succinate,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"(1,4-bis(3-pyridyl)-2,3-diazo-1,3-butadiene)dichlorozinc(II) polymer",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
(2'-5')An Polymerase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
(2'-5')tetraadenylate-polylysine,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Actinoid Series Elements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Fourier Series,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Interrupted Time Series,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Interrupted Time Series Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Lanthanoid Series Elements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Chromosome 6 open reading frame 106, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Chromosome 9 Open Reading Frame 72 Protein,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Compulsive Reading,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Developmental Reading Disorder,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Epilepsy, Reading",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
3' UTR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
3'UTR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
5' UTR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
5'UTR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
COP9 Signalsome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Constitutive Photomorphogenesis 9 Signalsome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Nuclear Export Signals,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Nuclear Localization Signals,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Peroxisomal Targeting Signals,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Bacterial Genomes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Genomes, Bacterial",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Plastid Genomes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
(+)-13-stemarene,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"(-)-9,10-epi-stemoamide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
8-epi-stemoamide,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"9,10-epi-stemoamide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
9a-epi-stemaphylline,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Computerized Physician Order Entry,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Computerized Physician Order Entry System,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Computerized Provider Order Entry,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Computerized Provider Order Entry System,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
DNA entry nuclease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
2 mu circle site-specific recombinase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
3' Splice Site,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
5' Splice Site,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
ARF nucleotide-binding-site opener,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Abelson helper integration site 1 protein, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Financial Contributions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
((17-N-cyclobutylmethyl)morphinan-3-yl-(-14-hydroxyl-17-N-cyclobutylmethyl) morphinan-3-yl) decanedioate,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"(+)-Larreatricin hydroxylase, creosote bush",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"(+)-larreatricin hydroxylase, Larrea tridentata",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
(+-)-E-4-methyl-2-((E)-hydroxylamino)-5-nitro-6-methoxy-3-hexanamide,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"(1R)-(4-hydroxybenzyl)-7-hydroxyl-8-O-beta-D-glucopyranosyl-1,2,3,4-tetrahydroisoquinoline",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ALB protein, human (Kenitra mutation)",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Activation Mutation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Amber Nonsense Mutation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Analysis, DNA Mutational",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Autoimmune Lymphoproliferative Disease without Fas Mutations,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"BRF1 homolog, subunit of RNA polymerase III transcription initiation factor IIIB (S. cerevisiae) protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"BRF2 RNA polymerase III transcription initiation factor subunit protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"BRF2, subunit of RNA polymerase III transcription initiation factor, BRF1-like protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"C2 translation initiation factor, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Adenine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Cytosine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Deoxyadenine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Deoxycytosine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Deoxyguanine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Picornaviruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ARABIDOPSIS THALIANA REPLICATION PROTEIN A 1A protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Autonomous Replication,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Chromosome Replication Order, Temporal",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Chromosome Replication Pattern, Temporal",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Chromosome Replication Timing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"(((12aR)-12-((11S)-7,8-difluoro-6,11-dihydrodibenzo(b,E)thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12ahexahydro-1H-(1,4)oxazino(3,4-C)pyrido(2,1-F)(1,2,4)triazin-7-yl)oxy)methyl methyl carbonate",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
((11)C)(R)-1-(4-(2-(4-methoxyphenyl)phenyl)piperazin-1-yl)-3-(2-pyrazinyloxy)-2-propanol,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
((11)C)1-(7-methoxy- quinolin-4-yl)-3-(6-(trifluoromethyl)pyridin-2-yl)urea,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"((11)C)2-(2',6'-dimethoxy-(1,1'-biphenyl)-3-yl)-N,N-dimethylethanamine",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
((11)C)3'-Me-BTA-1,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Acetylation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"REDUCED WALL ACETYLATION2 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"will decrease acetylation protein, Drosophila",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Animal Experiments,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"11kDa protein synthesis inhibitor, Vaccinia virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"12-kDa protein, potato virus M",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"126-kDa protein, Tobacco mosaic virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"12K late protein, Vaccinia virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"130k protein, Tobacco mosaic virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Abuse Reporting,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Adverse Drug Reaction Reporting Systems,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Age Reporting,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Annual Report,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Annual Reports as Topic,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"3ABC protein, FMDV",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"3D protein, FMDV",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
FMDV 15 peptide,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"FMDV 3C protease, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
FMDV L proteinase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Bilateral, annular limbal dermoids with corneal and conjunctival extension",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Cell Membrane Extensions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Cell Surface Extensions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Extracapsular Extension,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Extranodal Extension,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
AFLP Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Activation Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"Activation Analysis, Neutron",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Actuarial Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Amino Acid Sequence Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
CRE 1087,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
CRE 10904,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
CRE 223,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
CRE-1087,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
CRE-10904,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Equipment Reuse,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
3' Untranslated Regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
5' Untranslated Regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Antarctic Regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Arctic Regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Body Regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
PKS beta-ketoacyl synthase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
PKS ketoreductase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
AAA Domains,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
ANK Repeat Domains,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ARF-GAP with GTP-binding protein-like, ankyrin repeat and pleckstrin homology domains 1, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ARF-GAP with GTP-binding protein-like, ankyrin repeat and pleckstrin homology domains 1, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"ARF-GAP with GTP-binding protein-like, ankyrin repeat and pleckstrin homology domains 1, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Advantage adhesive,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Advantage-S,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Medicare Advantage,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
DNA Packaging,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"DNA cleavage and packaging proteins, Herpesvirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Drug Packaging,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Edible Food Packaging Materials,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Edible Packaging,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"A-T tract-binding protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Atrio-Hisian Bypass Tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Atriohisian Tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Biliary Tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Biliary Tract Cancer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"30S Ribosome Subunits, Archaeal",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"30S Ribosome Subunits, Bacterial",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
40S Ribosome Subunits,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"50S Ribosome Subunits, Archaeal",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
"50S Ribosome Subunits, Bacterial",0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
ABC primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Alloy Primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Angel I Self-Etch Primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Cesead Opaque Primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Clearfil Ceramic Primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Animal Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Bacterial Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Cell Membrane Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Cell Nucleus Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Cellular Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_abstract
Alu Repetitive Sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amino Acid Sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
CRISPR Sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
CRISPR Spacer Sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA Sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA Primers,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Oligodeoxyribonucleotide Primers,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Oligonucleotide Primers,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
RNA primers,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amenorrhea-Galactorrhea-FSH Decrease Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Brittle Hair-Intellectual Impairment-Decreased Fertility-Short Stature Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Bulbocavernosus Reflex, Decreased",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"DECREASE WAX BIOSYNTHESIS2 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"DECREASED DNA METHYLATION 1 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
68Ga-NEB,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
7-C-NEB cpd,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"NEB protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
NEB-LFamide,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Neb protein, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Ligation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Ligation, Tubal",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Multiplex Ligation-Dependent Probe Amplification,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Tubal Ligation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Vas Ligation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(Hse lactone-52)-52,53-seco-bovine basic pancreatic trypsin inhibitor",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(Myelin Basic Protein)-Arginine N-Methyltransferase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"119-Gly-131-Gly-dansyl myelin basic protein, synthetic",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ARABIDOPSIS THALIANA BASIC LEUCINE ZIPPER 10 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Amino Acid Transport Systems, Basic",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5-hydroxymethyl(blasticidin S),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Anemia, Refractory, with Excess of Blasts",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
B-Cell Blast-2 Antigen,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
B-Lymphocyte Activation Marker BLAST-1,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"BLAST1 protein, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Amino Acid Metabolism, Inborn Error",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Amino Acid Metabolism, Inborn Errors",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Carbohydrate Metabolism, Inborn Error",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Carbohydrate Metabolism, Inborn Errors",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Congenital Errors of Steroid Metabolism,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Animal Experiments,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AU Rich Elements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Actinoid Series Elements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Alu Elements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Anti-Oxidant Response Elements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Anti-Sense Elements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
BTV 17 VP2,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bluetongue virus VP2,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Chicken anemia virus capsid protein VP2,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Rhinovirus VP2,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"SVDV VP2 protein, Swine vesicular disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Acromegaloid features, overgrowth, cleft palate, and hernia",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Autosomal dominant partial epilepsy with auditory features,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bird-headed dwarfism with features of premature senility,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
CMT with Pyramidal Features,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cerebellar Vermis Aplasia with Associated Features suggesting Smith-Lemli-Opitz Syndrome and Meckel Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Bond Issues, Construction",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Construction Industry,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Construction Loans,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Construction Materials,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Construction Trades,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Truncation Bias,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Truncation Biases,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"truncation of C-mip protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Ankyrin Repeats,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Ankyrin-Like Repeats,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"B cell scaffold protein with ankyrin repeats 1 protein, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"B-cell scaffold protein with ankyrin repeats 1 protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Clustered Regularly Interspaced Short Palindromic Repeats,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Abortifacient Effects,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adrenergic Effects,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Adverse Effects, Long Term",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Anabolic Effects,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Androgen Effects,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Base Pairing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Chromosome Pairing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"homologous pairing protein 2, S cerevisiae",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Prepapillary Vascular Loops,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Preretinal Vascular Loops,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
R-Loops,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
NMIA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
SEM-76,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"SeM protein, Streptococcus equi",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Sem D,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Sem-2 protein, C elegans",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Sem-5 protein, C elegans",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Bond Issues, Construction",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Construction Industry,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Construction Loans,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Construction Materials,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Construction Trades,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
LLC-PK1 Cells,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
PK1 compound,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"PK1 protein, Toxoplasma gondii",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"B lymphoma Mo-MLV insertion region (mouse) protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"B lymphoma Mo-MLV insertion region 1 homolog (mouse) protein, zebrafish",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"B lymphoma Mo-MLV insertion region 1 protein, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"B lymphoma Mo-MLV insertion region 1 protein, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA Insertion Elements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Genes, Reporter",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Reporter Genes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
reporter RNA-biotin-avidin,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Abuse Reporting,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adverse Drug Reaction Reporting Systems,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Age Reporting,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Annual Report,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Annual Reports as Topic,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA modification methylase KpnI,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
KpnI endonuclease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
KpnI methylase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
endodeoxyribonuclease KpnI,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Chromatography, Reverse-Phase",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Chromatography, Reversed-Phase Liquid",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA reverse gyrase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
HIV Reverse Transcriptase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
HIV-1 Reverse Transcriptase p51,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Physiological Stress Reactivity,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA Restriction Enzyme HindIII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA modification methylase HindIII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Deoxyribonuclease HindIII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Endonuclease HindIII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
HindIII methylase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(99)mTc-(CO)(3) His-annexin A5,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(99m)Tc (CO)3 His-ann A5,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3''-O-propionylleucomycin A5,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
99m-Tc-HYNIC-annexin A5,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
99mTc-Cys-annexin A5,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Administration, Library",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Associations, Library",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Catalogs, Library",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA Library,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Dental Library,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AFLP Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Activation Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Activation Analysis, Neutron",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Actuarial Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amino Acid Sequence Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ABC primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Alloy Primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Angel I Self-Etch Primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cesead Opaque Primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Clearfil Ceramic Primer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"SAM domain, SH3 domain and nuclear localisation signals, 1 protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacteriocin Plasmids,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Colicin Plasmids,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
F Plasmids,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Plant Tumor-Inducing Plasmids,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Plasmids,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adverse Herb-Drug Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"AtSR1-interaction protein 1, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacteria Host Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterial-Host Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterium-Host Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AatII endonuclease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
endodeoxyribonuclease AatII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
endonuclease AatII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
10p Deletion Syndrome (Partial),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
10q- deletion,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
11p Deletion Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
11q Deletion Disorder,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
11q Deletion Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adverse Herb-Drug Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacteria Host Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterial-Host Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterium-Host Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Beneficial Herb-Drug Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Acupuncture Treatment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
After-Treatment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Assertive Community Treatment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Atraumatic Restorative Treatment, Dental",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Boots Threadworm Treatment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"multiple copies in T-cell malignancy protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
In Vitro Gene Fusion Mutagenesis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Insertional Mutagenesis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Linker-Insertion Mutagenesis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"MucA mutagenesis protein, Bacteria",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Mutagenesis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"C-Kit protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
CHMFL-ABL KIT-155,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
CHMFL-KIT-110,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"KIT ligand protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"KIT protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3ABC protein, FMDV",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3D protein, FMDV",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
FMDV 15 peptide,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"FMDV 3C protease, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
FMDV L proteinase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Acoustic Evoked Brain Stem Potential,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Acoustic Evoked Brain Stem Potentials,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Acoustic Evoked Brainstem Potential,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Acoustic Evoked Brainstem Potentials,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Action Potential Optical Mapping,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"( R)-6-(( S)-2-hydroxy-4-(4-hydroxyphenyl)butyl)-5,6-dihydropyran-2-one",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((-)-7-(3-(R)-amino-2-(S)-methyl-1-azetidinyl)-8-chloro-1-cyclopropyl-1,4-dihydro-6-fluoro-4-oxo-3-quinolinecarboxylic acid)",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((1-methyl)ethoxycarbonyloxy)-ethyl 7-(2-(2-amino-4-thiazole)-2-methoxyaminoacetamido)-3-(2-propenyl)-3-cephem-4-carboxylate, (6R-(2(S*)),6alpha,7beta(Z)) isomer",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((123)I)-16-iodo-3R,S-methylhexadecanoic acid",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((1R,5S,6S)-6((R))-1-hydroxyethyl-2-((3S,5S)-5(S-methyl-4-thiomorpholin ylcarbonyl)pyrrolidin-3-thio))-l-methylcarbapen-2-em-3- carboxylic acid",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Anemia, Sickle Cell",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Deoxygenated Sickle Hemoglobin,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Hb sickle D-Iran,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Hb sickle-Lepore,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Hemoglobin, Sickle",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Animal Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterial Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cell Membrane Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cell Nucleus Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cellular Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(-)-O-((2'-ethylphenyl)carbamoyl)geneseroline hydrochloride,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amber Suppressor Genes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Archaeal Genes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Artificial Genes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterial Genes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
FM-VP4 compound,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
FM-VP4 cpd,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
IBDVP2 VP4,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"VP4 protease, IPNV",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"VP4 protease, birnavirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Animal Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Civil Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Collective Human Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Equal Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Health Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ARABIDOPSIS THALIANA REPLICATION PROTEIN A 1A protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Autonomous Replication,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Chromosome Replication Order, Temporal",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Chromosome Replication Pattern, Temporal",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Chromosome Replication Timing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Biohazard Containment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Biohazards Containment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Biological Containment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Containment of Biohazards,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Containment, Biologic",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Picornaviruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(((12aR)-12-((11S)-7,8-difluoro-6,11-dihydrodibenzo(b,E)thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12ahexahydro-1H-(1,4)oxazino(3,4-C)pyrido(2,1-F)(1,2,4)triazin-7-yl)oxy)methyl methyl carbonate",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((11)C)(R)-1-(4-(2-(4-methoxyphenyl)phenyl)piperazin-1-yl)-3-(2-pyrazinyloxy)-2-propanol,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((11)C)1-(7-methoxy- quinolin-4-yl)-3-(6-(trifluoromethyl)pyridin-2-yl)urea,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((11)C)2-(2',6'-dimethoxy-(1,1'-biphenyl)-3-yl)-N,N-dimethylethanamine",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((11)C)3'-Me-BTA-1,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"GLABROUS INFLORESCENCE STEMS protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"GLABROUS INFLORESCENCE STEMS3 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Plant Stems,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
26RFa prepro-neuropeptide,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"8-Quinolinol, 5-chloro-7-iodo-, mixt. with calamine (pharmaceutical preparation) and zinc oxide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AMT preparation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Analytic Sample Preparation Methods,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Aqua-Prep,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"AFG3 ATPase family gene 3-like 1 (yeast) protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"AHA1, activator of heat shock 90kDa protein ATPase homolog 1 (yeast), human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"APC11 anaphase promoting complex subunit 11 homolog (yeast) protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ARP1 actin-related protein 1 homolog A (yeast), mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ARP2 actin-related protein 2 homolog (yeast), human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Numbers Needed To Treat,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"COL1 protein, Ophiostoma novo-ulmi",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"CYP108D1, Novosphingobium aromaticivorans",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Ildamen-Novodigal,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Insulin Novo Monotard,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Mycobacterium novocastrense,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Absence Seizure Disorder,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Absence Seizures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Absence Status,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Absence defect of limbs, scalp, and skull",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Absence of Brain, Congenital",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Axenic Culture,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Axenic Cultures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
BGJ culture medium,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Batch Cell Culture Techniques,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Batch Culture,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
High Cholesterol Levels,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
urinary levels,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
2-isopentenyl tRNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2-methylthio-N6-isopentenyl-adenosine(37)-tRNA monooxygenase, Salmonella typhimurium",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
2-nitro-4-azidobenzoyl-Phe-tRNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
2-nitro-4-azidobenzoyl-phenylalanine-tRNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
2-nitro-4-azidobenzoyl-phenylalanyl-tRNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3' Untranslated Regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5' Untranslated Regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Antarctic Regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Arctic Regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Body Regions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AflII endonuclease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AflIII endonuclease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
endodeoxyribonuclease AflII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
endodeoxyribonuclease AflIII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
endonuclease AflII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Antitumor Assays, Xenograft Model",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Antitumor Drug Screening Assays,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Assays, Biological",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Biologic Assays,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bioluminescent Assays,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
PKS beta-ketoacyl synthase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
PKS ketoreductase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Dentistry, Evidence-Based",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Emergency Medicine, Evidence-Based",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Evidence Based Health Care Management,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Evidence Based Healthcare Management,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Evidence Based Management, Health Care",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amycolatopsis speibonae,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
SpeI endonuclease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Streptomyces speibonae,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
endodeoxyribonuclease SpeI,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Preprint,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Preprints,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Preprints as Topic,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(+)-13-stemarene,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(-)-9,10-epi-stemoamide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
8-epi-stemoamide,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"9,10-epi-stemoamide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
9a-epi-stemaphylline,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Infections, Picornavirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Picornavirus Infections,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Picornaviruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"picornain 2A, Picornavirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"proteinase 2A, Picornavirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterial Genomes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Genomes, Bacterial",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Plastid Genomes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ATP-Dependent DNase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Acid DNase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Alkaline DNase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"CAD DNase, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Ca Mg DNASE,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"0.3 protein, Enterobacteria phage T7",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"0.7 protein, Enterobacteria phage T7",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacteriophage T7,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacteriophage T7 Gene 4 Protein,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Coliphage T7,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Dietary Requirements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Nutrition Requirements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Nutritional Requirements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Serial Passage,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Individual Differences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Sex Differences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Actinoid Series Elements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Fourier Series,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Interrupted Time Series,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Interrupted Time Series Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Lanthanoid Series Elements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Gender Role,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Judicial Role,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Man's Role,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Men's Role,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Nurse's Role,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((4aR)-1-(4-Fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-1,4,5,6,7,8-hexahydro-4aH-pyrazolo(3,4-g)isoquinolin-4a-yl)(4-(trifluoromethyl)-2-pyridinyl)methanone",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(+)-sarcodonin G,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(-)-sarcodonin G,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(1,2,3)triazolo(3,4-g)quinoxaline",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(11,12)-dihydrodibenzo(c,g)(1,2)dithiocine",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Paced Auditory Serial Addition Test,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Terminal Addition Enzyme,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"additional Sex Comb-Like 1 protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"additional Sex Comb-Like 2 protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"additional sex combs like 1 (Drosophila) protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2-DG-1,6-P2",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3'-deoxy-2',3'-didehydrothymidine P2-ethyl 5'-P1-diphosphate",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"60S acidic ribosomal protein P2, Trypanosoma cruzi",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AD-p2,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AZT(p2)AZT,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Amplification Technics, Nucleic Acid",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Amplification Techniques, Nucleic Acid",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bio Amplification,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bio-amplification,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Branched DNA Signal Amplification Assay,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
C0-05 ADP-ribosyltransferase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pneumocandin C0,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"DMC1 dosage suppressor of mck1 homolog, meiosis-specific homologous recombination (yeast) protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA Repair And Recombination Protein RAD52,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Genetic Recombination,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
HIN Recombinational Enhancer Binding Protein,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Homologous Recombination,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Competition, Economic",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Competition, Managed",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Economic Competition,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Managed Competition,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
1-fetoprotein transcription factor,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5S Gene-Specific Transcription Factor,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5S RNA Gene Transcription Factor,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ABA-INDUCIBLE BHLH-TYPE TRANSCRIPTION FACTOR, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ABFI transcription factor, S cerevisiae",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Antigen-Antibody Reactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Blood Transfusion-Associated Adverse Reactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Click Chemical Reactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cross Reactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Dark Reactions of Photosynthesis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ABERRANT TESTA SHAPE protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ABNORMAL LEAF SHAPE 1 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Angel shaped phalangoepiphyseal dysplasia,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Angel-Shaped Phalangoepiphyseal Dysplasia,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Angel-shaped phalango-epiphyseal dysplasia,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Sickness Presence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(2'-5')An Polymerase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2',5'-Oligo(A) Polymerase",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2',5'-Oligoadenylate Polymerase",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2,3,7,8-tetrachlorodibenzo-p-dioxin poly(ADP-ribose) polymerase, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2,3,7,8-tetrachlorodibenzo-p-dioxin poly(ADP-ribose) polymerase, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(+)-alpha-polypodatetraene,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(+)-alpha-tocopheryl polyethylene glycol 1000 succinate,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(1,4-bis(3-pyridyl)-2,3-diazo-1,3-butadiene)dichlorozinc(II) polymer",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(2'-5')An Polymerase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(2'-5')tetraadenylate-polylysine,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
UD CG 115,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
UD CG 212 Cl,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
UD-170A,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
UD-CG 115,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
UD-CG-212-Cl,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ABERRANT LATERAL ROOT FORMATION 5 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Acrosome formation associated factor, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Antibody Formation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Body Pattern Formation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bone Formation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3' UTR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3'UTR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5' UTR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5'UTR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
COP9 Signalsome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Constitutive Photomorphogenesis 9 Signalsome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Nuclear Export Signals,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Nuclear Localization Signals,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Peroxisomal Targeting Signals,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Hospitals, Packaged",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Package Inserts,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Package Inserts, Drug",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Packaged Hospitals,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Dietary Requirements,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
High-Temperature Requirement A Serine Peptidase 1,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
High-Temperature Requirement A Serine Peptidase 2,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"N REQUIREMENT GENE 1.1 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"N REQUIREMENT GENE 1.2 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"00261 long non coding RNA, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
10Sa RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
15S RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"16S RNA pseudouridine 516 synthase, E coli",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
16S Ribosomal RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ATP synthase mitochondrial F1 complex assembly factor 1 protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ATP synthase mitochondrial F1 complex assembly factor 1, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ATP synthase mitochondrial F1 complex assembly factor 2 protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ATP synthase mitochondrial F1 complex assembly factor 2, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ATP-dependent chromatin assembly factor large subunit protein, Drosophila",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Arterial Lines,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Intra-Arterial Lines,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Linesterol,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Linestrenol,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Teosyal 27G Deep Lines,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Data Files,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Machine-Readable Data Files,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3D Molecular Structure,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5' mRNA Cap Structure,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Animal Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterial Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cell Membrane Structures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AMP-PK reactivator,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Ac-pk-1 protein, Autographa californica nucleopolyhedrovirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"CRK4 PK, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
CaM PK II,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Calcium-Calmodulin-Dependent PK Type II,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA Packaging,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"DNA cleavage and packaging proteins, Herpesvirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Drug Packaging,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Edible Food Packaging Materials,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Edible Packaging,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"BCR downstream signaling 1 protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"CEP DOWNSTREAM 1 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"CEP DOWNSTREAM 2 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Downstream Regulatory Element Antagonist Modulator,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Downstream of raf1 protein, Drosophila",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"60 kDa nuclear localization signal binding protein, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"AT-HOOK MOTIF NUCLEAR LOCALIZED protein 3, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"AT-HOOK MOTIF NUCLEAR LOCALIZED protein 4, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"AT-hook motif nuclear localized 22 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"AT-hook motif nuclear localized protein 1, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacteria Host Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterial-Host Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterium-Host Interactions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
C1 Host Cell Factor,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"C2 host cell factor, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Copyright,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cultural Disadvantagement,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Disadvantaged,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Behavior Observation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Behavior Observation Techniques,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Behavioral Observation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Behavioral Observation Techniques,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Clinical Observation Units,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2A protease, mengovirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2A protein, mengovirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2A proteinase, Mengovirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Mengo Virus,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Mengovirus,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(2'-5')ppp3'dA(p3'dA),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
1-O-OHTHFGlc P3,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
15-MA-P3,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3-amino-3-deoxy-Ins(1,4,5)P3",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3-deoxy-3-fluoro-Ins(1,4,5)P3",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"11kDa protein synthesis inhibitor, Vaccinia virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adrenal Steroid Synthesis Inhibitors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adrenergic Synthesis Inhibitors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Androgen Synthesis Inhibitors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Bile Acid Synthesis Defect, Congenital, 3",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Anchored PCR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Arbitrarily Primed PCR Reaction,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DISC-PCR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Direct In Situ Copy PCR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"GIP (G-PCR interacting protein), human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Date Fruit,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Date Palm Fruit,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Date Palm Trees,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Date Palms,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Dates,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"BARS protein, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"BARS50 protein, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
De Barsy Moens Diercks syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
De Barsy syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Progeroid syndrome of De Barsy,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
68Ga-DOTAGA-(3-iodo-y)fk(Sub-KuE),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
68Ga-DOTAGA-(I-y)fk(Sub-KuE),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ATP Binding Cassette Transporter, Sub-Family A",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ATP Binding Cassette Transporter, Sub-Family A, Member 4",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ATP Binding Cassette Transporter, Sub-Family B",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Algorithms,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2,3,5-triiodobenzoyl potato starch",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2,3,5-triiodobenzoyl starch",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
2-hydroxypropyl starch,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
2-hydroxypropyl starch ether,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ADP Glucose Starch Glucosyltransferase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Blood Component Removal,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Device Removal,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Hair Removal,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Leukocyte Removal Procedures,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
mycoplasma removal agent,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"A-T tract-binding protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Atrio-Hisian Bypass Tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Atriohisian Tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Biliary Tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Biliary Tract Cancer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Arachnid Vectors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Arthropod Vectors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cloning Vectors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Disease Vectors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Genetic Vectors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Antenatal Screening,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Anti-Cancer Drug Screens,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Antitumor Drug Screening Assays,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Antitumor Drug Screens,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cancer Screening,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(((1,2-dihydro-2-oxo-4-quinolinyl)methyl)thio)-N-(((4-(1-piperidinylmethyl)-2-pyridinyl)oxy)-2-butenyl)acetamide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(((2-(2-(2,4-dichlorophenyl)-4-(2-methyl-3-chlorophenyl)-1-ylmethyl)carbamoyl)methyl)-5-oxopyrrole-1-yl)-N-(3-piperidinylpropyl)acetamide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(((4-(4-amidino-N-methylbenzamido)acetyl)-1,2-phenylene)dioxy)diacetic acid",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(((5-(6-(oxolan-3-yl)amino)purin-9-yl)-3,4-dihydroxyoxolan-2-yl)methoxy)-N-methylcarboxamide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((+)-4-((alphaR)-alpha-((2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl)-(3-phenyl)methyl)-N,N-diethylbenzamide)",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
111In-nuclear translocation sequence-7G3,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3' Flanking Sequence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5' Flanking Sequence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5' TOP Sequence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AAUAAA RNA Sequence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
A-Loop,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Afferent Loop Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Ascending Limb of Loop of Henle,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Basic Helix-Loop-Helix Transcription Factors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Arachnid Vectors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Arthropod Vectors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cloning Vectors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Coxiella burnetii Vector-Borne Disease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Disease Vectors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Demographic Impact,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Demographic Impacts,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Environmental Impact,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Environmental Impacts,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Fecal Impaction,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Autoimmune Lymphoproliferative Disease without Fas Mutations,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Autoimmune lymphoproliferative syndrome without FAS mutations,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Encephalopathy, Neonatal Severe, Due To Mecp2 Mutations",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Lipodystrophy, Familial Partial, Associated With PPARg Mutations",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Mutations, Silent",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"1-H-2-NADO, Pseudomonas sp. strain PP2",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"1-hydroxy-2-naphthoic acid dioxygenase, Pseudomonas sp. strain PP2",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
129 Strain Mice,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
129 Strain Mouse,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Acinetobacter junii strain 65 O-antigen,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Host-Searching Behavior,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Search Engine,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Searching Behavior,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(R)-alpha-(N6-adenyl)styrene oxide-DNA adduct,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"1,2-cyclohexanediamine platinum(II)-DNA complex",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
10-23 DNA enzyme,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
2-AMIQ-DNA adduct,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2-amino-1-methyl-6-phenolimidazo(4,5-b)pyridine-DNA adduct",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
APC Viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adeno-Associated Viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
African Swine Fever-Like Viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Algal Viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Animal Viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"1,17-DATAH",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amino Acid Sequence Databases,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Automatic Data Processing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Big Data,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Clinical Trials Data Monitoring Committees,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3ABC protein, FMDV",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3D protein, FMDV",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
FMDV 15 peptide,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"FMDV 3C protease, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
FMDV L proteinase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Digestion,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Protein Digestion,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Genetic Heterogeneity,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Heterogeneity, Genetic",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Population Heterogeneity,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Poliovirus capsid protein VP0,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"VP0 protein, Poliovirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"viral outer coat protein VP0, Poliovirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Absolute Risk Reduction,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Animal Testing Reduction, Refinement and Replacement",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Annular Reduction, Cardiac Valve",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Annulus Reduction, Cardiac Valve",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"CHLORORESPIRATORY REDUCTION 2 protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Computer Applications Software,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Computer Software,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Computer Software Applications,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Portable Software Applications,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Portable Software Apps,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adenine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cytosine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Deoxyadenine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Deoxycytosine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Deoxyguanine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"sperm forward motility protein, Bos taurus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Chicken Ovalbumin Upstream Promoter-Transcription Factor I,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Chicken Ovalbumin Upstream Promoter-Transcription Factor II,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Chicken Ovalbumin Upstream Promoter-Transcription Factors,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Far upstream element binding protein 1, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
MAP kinase upstream kinase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
293T Cells,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3T3 Cells,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3T3 Cells, BALB",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3T3 Cells, NIH",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3T3-L1 Cells,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Arthrogryposis multiplex congenita, pulmonary hypoplasia, cryptorchidism, and unusual ophthalmological findings",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Incidental Findings,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Morphological and Microscopic Findings,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Neurologic Findings,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Reproducibility of Findings,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Global Trigger Tool, Healthcare",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Healthcare Global Trigger Tool,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Retained Surgical Tools,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
STOPP (Screening Tool of Older Person's Potentially Inappropriate Prescriptions),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Screening Tool of Older Person's Potentially Inappropriate Prescriptions,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(1-6)-beta-D-glucan-protein complex,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(125I)IPOS protein,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(2Fe-2S) protein I,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(3H-MeSO2)2TCB-binding protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(6-4) photolyase protein, Xenopus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
4-DOI,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DOI cpd,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DOI-P,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DOI-aminopropane,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
L-glutamine DOI aminotransferase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Transfection,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Atypical Squamous Cells of Undetermined Significance,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Monoclonal Gammapathy of Undetermined Significance,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Monoclonal Gammopathy of Undetermined Significance,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(N-MeCys(3),N-MeCys(7))TANDEM",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(N-MeCys(3)-N-MeCys(7))TANDEM,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(N-methylcysteinyl(3)-N-methylcysteinyl(7))TANDEM,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ATP-binding cassette, sub-family C (CFTR-MRP), member 6b, tandem duplicate 1 protein, zebrafish",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ATPase Na+-K+ transporting subunit alpha 1a, tandem duplicate 1 protein, zebrafish",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Kathon WT,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Minibody (WT),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
WT Limb-Blood Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
WT limb blood syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"WT-1 protein, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Action Potential Optical Mapping,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Anatomic Electrical Activity Optical Mapping,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Body Surface Mapping,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Body Surface Potential Mapping,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Brain Electrical Activity Mapping,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Ciliary Discoordination Due To Random Ciliary Orientation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cognitive Orientation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Compass Orientation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Employee Orientation Programs,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Mental Orientation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Tandem Affinity Purification,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Water Purification,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
isolation & purification,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
isolation and purification,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
purification,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
10q duplication syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
22q11.2 Duplication,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Aphalangia, Partial, with Syndactyly and Duplication of Metatarsal IV",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Brachydactyly of the hands and feet with duplication of the first toes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Caudal Duplication Anomaly,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Grants, Peer Review",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Organizations, Peer Review",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Peer Group,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Peer Influence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Peer Pressure,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"173-527-plasminogen activator (human tissue-type), 173-L-serine-174-L-tyrosine-175-L-glutamine-",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Abdominal Adipose Tissue,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Abdominal Subcutaneous Adipose Tissue,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Aberrant Tissue,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Acellular Dermal Graft Tissue,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ArdC protein, IncW plasmid pSa",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacteriocin Plasmids,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"CcdB killer protein, Plasmid F",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"CcdB protein, Plasmid F",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Colicin Plasmids,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Advantage adhesive,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Advantage-S,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Medicare Advantage,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(Pro)3 AII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(Sar(1),Ile(5),(4'N3)Phe(8))AII",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(Sar)5 AII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(Sar1)-AII(1-7)-NH2,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
1-Sar-8-Phe-AII,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Family with sequence similarity 3 member D protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Family with sequence similarity 3 member D protein, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"family with sequence similarity 101, member A protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"family with sequence similarity 101, member A protein, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"family with sequence similarity 101, member B protein, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(But-Cys18)(19-37)-fragment betaCGRP,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(N-acetyl-tyr1,D-arg2)fragment 1-29 amide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
285-292 IgG fragment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5.2-OKT3 bispecific single-chain antibody fragment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amplified Fragment Length Polymorphism Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
2 mu circle site-specific recombinase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3' Splice Site,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5' Splice Site,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ARF nucleotide-binding-site opener,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Abelson helper integration site 1 protein, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Equipment Reuse,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ANTI-SILENCING FUNCTION 1A protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ANTI-SILENCING FUNCTION 1B protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ASF1 anti-silencing function 1 homolog A (S. cerevisiae) protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ASF1 anti-silencing function 1 homolog B (S. cerevisiae) protein, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adrenal Cortex Function Tests,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adult Survivors of Child Adverse Events,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Anniversaries and Special Events,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Der(22) Syndrome Due To 3:1 Meiotic Disjunction Events,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Historical Events, 15th Century",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Historical Events, 16th Century",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((-)-4-(3-3,4-trans-p-menthadien-(1,8)-yl)-orcinol)",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((1-(N-(p-(amidinobenzoyl)tyrosyl)-4-piperidinyl)oxy))acetic acid,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((C6H6)Ru(m-OH-p-OMPIP)Cl)Cl,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((eta6-p-cymene)Ru(4,4,4-trifluoro-1-(4-chlorophenyl)-1,3-butanedione)-1,3,5-triaza-7-phosphaadamantane)",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((p-(N-acrylamino)phenyl)mercuric chloride),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Agency for Healthcare Research and Quality (U.S.),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Air Quality,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Air Quality, Indoor",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Continuous Quality Management,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Data Quality,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"11kDa protein synthesis inhibitor, Vaccinia virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"12-kDa protein, potato virus M",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"126-kDa protein, Tobacco mosaic virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"12K late protein, Vaccinia virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"130k protein, Tobacco mosaic virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((des-NH2)Phe(19)-D-Ala(24)-D-Pro(26)psi(CH2NH)Phe(27))-GRP(19-27),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((im bzl)-D-His(6), Pro(9)-NEt)LHRH",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(-2)pro-PSA, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(-2)pro-prostate-specific antigen, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(111)In-DTPA-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(4-methoxy-C11)DNR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(4-methoxy-C11)daunorubicin,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(C11)-GB67,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(C11)GB 67,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"8-chloro-7-hydroxy-5-(2,3-dihydrobenzofuran-7-yl)-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, (S)-isomer, C11-labeled",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(Cp(2)Hf)(2)B(5)H(8))(B(11)H(14),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
2-Me-HMB-HF,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
26-G-HF-TG,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3-BPNP-HF cpd,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
4-(HP-HP-HF),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Anatomic Variation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Antigen Variation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Antigenic Variation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Between-Individual Biological Variation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Between-Person Biological Variation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adhesion Plaques,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Unusual Plaques",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amyloid Plaques,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Atheromatous Plaques,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Atherosclerotic Plaques,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
NheI endonuclease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
endodeoxyribonuclease NheI,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
endonuclease NheI,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
OriC replicon,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Replicon,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"52 kDa protein encoded by a Cell Cycle Switch gene, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"8-benzenesulfonyloxy-5-N,N-dimethylaminosulfonylquinolin-2-ylmethyl-pendant cyclen",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Activity Cycles,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
BS-caged-L4-cyclen,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"CDC10 cell division cycle 10 homolog (S. cerevisiae), human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Drug Residues,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Dvl-associating protein with a high frequency of leucine residues protein, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Nogo extracellular peptide, residues 1-40, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Nogo extracellular peptide, residues 1-40, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Pesticide Residues,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Aspects, Historical",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Historical Aspects,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
International Aspects,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Legal Aspects,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Multinational Aspects,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Conferences, Consensus Development as Topic",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Consensus,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Consensus Development,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Consensus Development Conference,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Consensus Development Conference, NIH",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cognitive Decline,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Decline, Mortality",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Mortality Decline,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Postoperative Decline,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Alu Repetitive Sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amino Acid Sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
CRISPR Sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
CRISPR Spacer Sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA Sequences,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
UD CG 115,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
UD CG 212 Cl,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
UD-170A,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
UD-CG 115,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
UD-CG-212-Cl,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(2'-5')An Polymerase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2',5'-Oligo(A) Polymerase",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2',5'-Oligoadenylate Polymerase",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2,3,7,8-tetrachlorodibenzo-p-dioxin poly(ADP-ribose) polymerase, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2,3,7,8-tetrachlorodibenzo-p-dioxin poly(ADP-ribose) polymerase, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(+)-alpha-polypodatetraene,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(+)-alpha-tocopheryl polyethylene glycol 1000 succinate,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(1,4-bis(3-pyridyl)-2,3-diazo-1,3-butadiene)dichlorozinc(II) polymer",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(2'-5')An Polymerase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(2'-5')tetraadenylate-polylysine,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Kathon WT,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Minibody (WT),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
WT Limb-Blood Syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
WT limb blood syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"WT-1 protein, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"00261 long non coding RNA, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
10Sa RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
15S RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"16S RNA pseudouridine 516 synthase, E coli",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
16S Ribosomal RNA,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Grants, Peer Review",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Organizations, Peer Review",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Peer Group,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Peer Influence,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Peer Pressure,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
129 Mice,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
129 Strain Mice,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Apo E Knockout Mice,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ApoE Knockout Mice,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Athymic Mice,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Metagenomics,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
metagenomic acidic lipopeptide antibiotic-cidins,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Amino Acid Metabolism, Inborn Error",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Amino Acid Metabolism, Inborn Errors",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Carbohydrate Metabolism, Inborn Error",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Carbohydrate Metabolism, Inborn Errors",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Congenital Errors of Steroid Metabolism,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((-)-4-(3-3,4-trans-p-menthadien-(1,8)-yl)-orcinol)",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((Pt(NH3)3)-mu-H2N(CH2)(4)NH2-(trans-PtCl(NH3)2))3(+),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((trans-Pt(NH3)2(NH2(CH2)6(NH3+))2-mu-(trans-Pt(NH3)2(NH2(CH2)6NH2)2)),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((trans-PtCl(NH3)2)2(trans-Pt(NH3)2(NH2(CH2)6NH2)2))(NO3)4,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((trans-PtCl(NH3)2)2mu-(trans-Pt(NH3)(2-hydroxypyridine)(H2N(CH2)6NH2)2))Cl4,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AMP-PK reactivator,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Ac-pk-1 protein, Autographa californica nucleopolyhedrovirus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"CRK4 PK, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
CaM PK II,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Calcium-Calmodulin-Dependent PK Type II,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"ARABIDOPSIS THALIANA REPLICATION PROTEIN A 1A protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Autonomous Replication,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Chromosome Replication Order, Temporal",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Chromosome Replication Pattern, Temporal",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Chromosome Replication Timing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Picornaviruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(((12aR)-12-((11S)-7,8-difluoro-6,11-dihydrodibenzo(b,E)thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12ahexahydro-1H-(1,4)oxazino(3,4-C)pyrido(2,1-F)(1,2,4)triazin-7-yl)oxy)methyl methyl carbonate",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((11)C)(R)-1-(4-(2-(4-methoxyphenyl)phenyl)piperazin-1-yl)-3-(2-pyrazinyloxy)-2-propanol,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((11)C)1-(7-methoxy- quinolin-4-yl)-3-(6-(trifluoromethyl)pyridin-2-yl)urea,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((11)C)2-(2',6'-dimethoxy-(1,1'-biphenyl)-3-yl)-N,N-dimethylethanamine",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((11)C)3'-Me-BTA-1,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Animal Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Civil Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Collective Human Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Equal Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Health Rights,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"COL1 protein, Ophiostoma novo-ulmi",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"CYP108D1, Novosphingobium aromaticivorans",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Ildamen-Novodigal,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Insulin Novo Monotard,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Mycobacterium novocastrense,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Corticobulbar Tracts,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Corticospinal Tracts,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Extrapyramidal Tracts,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Pyramidal Tracts,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Spinocerebellar Tracts,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Copyright,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"1D protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3ABC protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3C protease, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3D protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Abnormalities, Mouth",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Equipment Reuse,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"8-Quinolinol, 5-chloro-7-iodo-, mixt. with calamine (pharmaceutical preparation) and zinc oxide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AMT preparation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Analytic Sample Preparation Methods,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
BDP preparation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
BTK 8L preparation,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Achaete-Scute Complex Genome Region,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterial Genome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bacterial Genomes,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Chloroplast Genome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Chloroplast Genome-Encoded Proteins,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amino Acid Sequencing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Assay for Transposase-Accessible Chromatin Using Sequencing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ChIP Sequencing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Chromatin Immuno-precipitation Sequencing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Chromatin Immunoprecipitation Sequencing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
PKS beta-ketoacyl synthase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
PKS ketoreductase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Antitumor Assays, Xenograft Model",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Antitumor Drug Screening Assays,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Assays, Biological",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Biologic Assays,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Bioluminescent Assays,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"BARS protein, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"BARS50 protein, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
De Barsy Moens Diercks syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
De Barsy syndrome,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Progeroid syndrome of De Barsy,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((3alpha,3'alpha,4beta,4'beta)-3,3')-dimethoxy-cis-(4,4'-bis(3,4,5,10-tetrahydro-1H-naphtho(2,3-)pyran))-5,5',10,10'-tetraone",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((cis-Pt(NH(3))(2))(2)(mu-OH)(mu-pyrazolate))(2+),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((cis-Pt(NH3)2Cl)2 4,4'-dipyridyl sulfide(NO3)2)",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((cis-Pt(NH3)2Cl)2 bpsu(NO3)2),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
((cis-RuCl2(Me2SO)3)H2N(CH2)4NH2(cis-PtCl2(NH3))),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"11kDa protein synthesis inhibitor, Vaccinia virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"12-kDa protein, potato virus M",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"126-kDa protein, Tobacco mosaic virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"12K late protein, Vaccinia virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"130k protein, Tobacco mosaic virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Human Figure,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Rey-Osterrieth Complex Figure,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Preprint,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Preprints,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Preprints as Topic,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"A-T tract-binding protein, Arabidopsis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Atrio-Hisian Bypass Tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Atriohisian Tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Biliary Tract,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Biliary Tract Cancer,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(4-methoxy-C11)DNR,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(4-methoxy-C11)daunorubicin,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(C11)-GB67,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(C11)GB 67,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"8-chloro-7-hydroxy-5-(2,3-dihydrobenzofuran-7-yl)-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, (S)-isomer, C11-labeled",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"14K protein, Borna disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"18K glycoprotein, Borna disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"1D protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
2019 novel coronavirus disease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
2019 novel coronavirus disease testing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
SEM-76,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"SeM protein, Streptococcus equi",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Sem D,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Sem-2 protein, C elegans",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Sem-5 protein, C elegans",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
C0-05 ADP-ribosyltransferase,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
pneumocandin C0,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ATPase associated with diverse cellular activities,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ATPases Associated with Diverse Cellular Activities,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Activities of Daily Living,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Activities, Daily Living",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Activities, Educational",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Animal Population Groups,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Biologic Variability, Population",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Biological Variation, Population",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Continental Population Groups,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
General Social Development and Population,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
(COMPADRI)-III protocol,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
06-Paris-LA-66 protocol,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
1-UFT protocol,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3M protocol,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
5-FU-CDDP protocol,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2C protein, viral",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Antibodies, Viral",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Antigens, Neoplasm, Viral",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Antigens, Viral",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Antigens, Viral, Tumor",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Om45-GFP protein, S cerevisiae",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
cyclo(GP-p(CH2S)-GFP),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
cyclo(GP-psi(CH2SO)-GFP),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"scFV-GFP protein, recombinant",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Accessory Atrioventricular Pathways,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Accessory Conducting Pathways,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adverse Outcome Pathways,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Afferent Pathways,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Auditory Pathways,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(((1,2-dihydro-2-oxo-4-quinolinyl)methyl)thio)-N-(((4-(1-piperidinylmethyl)-2-pyridinyl)oxy)-2-butenyl)acetamide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(((2-(2-(2,4-dichlorophenyl)-4-(2-methyl-3-chlorophenyl)-1-ylmethyl)carbamoyl)methyl)-5-oxopyrrole-1-yl)-N-(3-piperidinylpropyl)acetamide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(((4-(4-amidino-N-methylbenzamido)acetyl)-1,2-phenylene)dioxy)diacetic acid",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(((5-(6-(oxolan-3-yl)amino)purin-9-yl)-3,4-dihydroxyoxolan-2-yl)methoxy)-N-methylcarboxamide",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((+)-4-((alphaR)-alpha-((2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl)-(3-phenyl)methyl)-N,N-diethylbenzamide)",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial precursor, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2S albumin precursor protein, Ricinus communis",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"2S albumin precursor, Bertholletia excelsa",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"78 kDa glucose-regulated protein precursor protein, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
ACTH-Endorphin Precursor,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
APC Viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adeno-Associated Viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
African Swine Fever-Like Viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Algal Viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Animal Viruses,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"(((12aR)-12-((11S)-7,8-difluoro-6,11-dihydrodibenzo(b,E)thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12ahexahydro-1H-(1,4)oxazino(3,4-C)pyrido(2,1-F)(1,2,4)triazin-7-yl)oxy)methyl methyl carbonate",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((+)-(5S,6R,7R)-2-isopropylamino-7-(4-methoxy-2-(2R))-3-methoxy-2-methylpropyl)-5-(3,4-methylenedioxyphenyl)cyclopenteno(1,2-b)pyridine-6-carboxylic acid",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)(hydroxy)methylidene)azanium chloride",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((1R,2R,3AS,9AS)-2-hydroxy-1-((3S)-3-hydroxyoctyl)-2,3,3A,4,9,9A-hexahydro-1H-cylopent(b)naphthalen-5-yl)oxy)acetate",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"((3 alpha-tropanyl)oxy)-5H-benzo(4,5)cyclohepta(1,2-b)pyridine",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"1,17-DATAH",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amino Acid Sequence Databases,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Automatic Data Processing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Big Data,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Clinical Trials Data Monitoring Committees,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Homolog ALignment in meiosis abnormal 3 protein, C elegans",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Radiotherapy Target Organ Alignment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Sequence Alignment,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Target Organ Alignment, Radiotherapy",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"centrosome alignment defect 1 protein, Drosophila",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"AM-protein, Physarum polycephalum",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
APL PolyCat57,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Actinomadura polychroma,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adult Polycystic Kidney Disease,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adult Polycystic Kidney Disease Type 1,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Administration, Library",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Associations, Library",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Catalogs, Library",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA Library,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Dental Library,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Depth Intoxication,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Depth Perception,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
AFLP Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Activation Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Activation Analysis, Neutron",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Actuarial Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Amino Acid Sequence Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Economy, Token",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Token Economy,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Analysis, DNA Mutational",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
DNA Mutational Analysis,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Mutational Analysis, DNA",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"25-kDa subunit, Im cleavage factor, human",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"25-kDa subunit, Im cleavage factor, rat",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3-keto-5-aminohexanoate cleavage enzyme,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3-keto-6-acetamidohexanoate cleavage enzyme,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"77-kDa subunit, cleavage stimulation factor, mouse",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
OriC replicon,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Replicon,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
bhk (kinase),0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"p23 protein, BHK, mammalian",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"1D protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3ABC protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3C protease, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3D protein, Foot-and-mouth disease virus",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Anus, Imperforate, with Hand, Foot, and Ear Anomalies",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Conferences, Consensus Development as Topic",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Consensus,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Consensus Development,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Consensus Development Conference,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Consensus Development Conference, NIH",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Adenine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Cytosine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Deoxyadenine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Deoxycytosine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Deoxyguanine Nucleotides,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
293T Cells,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3T3 Cells,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3T3 Cells, BALB",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"3T3 Cells, NIH",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
3T3-L1 Cells,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Illumina Sequencing,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Illuminating Gas Poisoning,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Illumination,0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
"Poisoning, Illuminating Gas",0015023cc06b5362d332b3baf348d11567ca2fbb,has_body
Communicable Disease Contact Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_title
Contact Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_title
Fluorescent Protein Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_title
Infectious Disease Contact Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_title
Neuroanatomical Tract-Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_title
21-formyl sarsasapogenin,00340eea543336d54adda18236424de6a5e91c9d,has_title
"3C-like protease, SARS coronavirus",00340eea543336d54adda18236424de6a5e91c9d,has_title
"3CL(pro) protein, SARS-CoV",00340eea543336d54adda18236424de6a5e91c9d,has_title
"3a protein, SARS-CoV",00340eea543336d54adda18236424de6a5e91c9d,has_title
"7a protein, SARS virus",00340eea543336d54adda18236424de6a5e91c9d,has_title
International Perspectives,00340eea543336d54adda18236424de6a5e91c9d,has_title
Multinational Perspectives,00340eea543336d54adda18236424de6a5e91c9d,has_title
MNA SARS-CoV-2 S1 subunit vaccines,00340eea543336d54adda18236424de6a5e91c9d,has_title
SARS-CoV-2,00340eea543336d54adda18236424de6a5e91c9d,has_title
SARS-CoV-2 S protein,00340eea543336d54adda18236424de6a5e91c9d,has_title
SARS-CoV-2 convalescent plasma treatment,00340eea543336d54adda18236424de6a5e91c9d,has_title
SARS-CoV-2 convalescent sera treatment,00340eea543336d54adda18236424de6a5e91c9d,has_title
"Health Insurance for Aged and Disabled, Title 18",00340eea543336d54adda18236424de6a5e91c9d,has_title
"Health Insurance for Aged, Disabled, Title 18",00340eea543336d54adda18236424de6a5e91c9d,has_title
"Health Insurance for Aged, Title 18",00340eea543336d54adda18236424de6a5e91c9d,has_title
"Medical Assistance, Title 19",00340eea543336d54adda18236424de6a5e91c9d,has_title
AFLP Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_title
Activation Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_title
"Activation Analysis, Neutron",00340eea543336d54adda18236424de6a5e91c9d,has_title
Actuarial Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_title
Amino Acid Sequence Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_title
"Grants, Peer Review",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Organizations, Peer Review",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Peer Group,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Peer Influence,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Peer Pressure,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Genetic Heterogeneity,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Heterogeneity, Genetic",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Population Heterogeneity,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
AFLP Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Activation Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Activation Analysis, Neutron",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Actuarial Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Amino Acid Sequence Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Agency for International Development,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Educational Exchange, International",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Exchange, International Educational",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
International Agencies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
International Aspects,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Communicable Disease Contact Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Contact Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Fluorescent Protein Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Infectious Disease Contact Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Neuroanatomical Tract-Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Alu Repetitive Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Amino Acid Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
CRISPR Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
CRISPR Spacer Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
DNA Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Developed Countries,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Developing Countries,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Industrialized Countries,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Least Developed Countries,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Less-Developed Countries,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
21-formyl sarsasapogenin,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"3C-like protease, SARS coronavirus",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"3CL(pro) protein, SARS-CoV",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"3a protein, SARS-CoV",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"7a protein, SARS virus",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Preprint,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Preprints,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Preprints as Topic,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Information Dissemination,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
(68Ga)Glu-urea-Lys(Ahx)-HBED-CC,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
2-CC-F-EP cpd,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
4-(2-CC)-2-TFBN cpd,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
5-CC-M-P-O cpd,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"ALP CC chemokine protein, mouse",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Agency for Healthcare Research and Quality (U.S.),00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Air Quality,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Air Quality, Indoor",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Continuous Quality Management,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Data Quality,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Easterlin Hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Hygiene Hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Lyon Hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
MNA SARS-CoV-2 S1 subunit vaccines,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
SARS-CoV-2,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
SARS-CoV-2 S protein,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
SARS-CoV-2 convalescent plasma treatment,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
SARS-CoV-2 convalescent sera treatment,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Copyright,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
ATP-Sensitive Potassium Channels,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Acid Sensing Ion Channels,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Acid-Sensing Ion Channels,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
BK Channels,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Big K Channels,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Arthrogryposis multiplex congenita, pulmonary hypoplasia, cryptorchidism, and unusual ophthalmological findings",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Host-Finding Behavior,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Incidental Findings,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Morphological and Microscopic Findings,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Neurologic Findings,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Amino Acid Sequence Analyses,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Analyses, Demographic",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Analyses, Dental Stress",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Analyses, Multiregional",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Biological Oxygen Demand Analyses,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"1,17-DATAH",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Amino Acid Sequence Databases,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Automatic Data Processing,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Big Data,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Clinical Trials Data Monitoring Committees,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
2019 novel coronavirus,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
2019 novel coronavirus disease,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
2019 novel coronavirus disease testing,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
2019 novel coronavirus infection,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
2019 novel coronavirus testing,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Encephalitis, Epidemic",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Epidemic Acute Poliomyelitis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Epidemic Encephalitis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Epidemic Hemorrhagic Fever Virus,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Epidemic Neurolabyrinthitis,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Access to Information,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Ambulatory Care Information Systems,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Ambulatory Information Systems,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Ancillary Information Systems,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Bio-Physical Information Therapy,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Stigmatization,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Phylogenetic Biogeography,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Phylogenetic DNA Barcode,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Phylogenetic DNA Barcoding,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"(Arg(14),Lys(15))NC",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
(DAniF)3Mo2(((m-CF3)C6H5)NC(O)C6H4(O)CN((m-CF3)C6H5))Mo2(DAniF)3,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
(DAniF)3Mo2((C6H5)NC(O)C6H4(O)CN(C6H5))Mo2(DAniF)3,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
(NC)2Cu(I),00340eea543336d54adda18236424de6a5e91c9d,has_abstract
(NC)2Cu(II),00340eea543336d54adda18236424de6a5e91c9d,has_abstract
CBA Studies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Candidate Gene Association Studies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Case Control Studies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Case Studies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Case Studies, Organizational",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"PLETHORA 5 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"PLETHORA 7 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"PLETHORA1 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"PLETHORA2 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"PLETHORA3 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Acute Respiratory Distress Syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Adult Respiratory Distress Syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
"Choreoathetosis, Hypothyroidism, And Neonatal Respiratory Distress",00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Emotional Distress,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Fetal Distress,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Sickness Presence,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Licensed Practical Nurses,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Licensed Vocational Nurses,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Licenses,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Dental Societies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Greek Letter Societies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Greek-Letter Societies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Hospital Societies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
International Federation of Red Cross and Red Crescent Societies,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Achaete-Scute Complex Genome Region,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Bacterial Genome,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Bacterial Genomes,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Chloroplast Genome,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Chloroplast Genome-Encoded Proteins,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
Journals as Topic,00340eea543336d54adda18236424de6a5e91c9d,has_abstract
((Cu(II)(MePY2)Me2N)2(S2)),00340eea543336d54adda18236424de6a5e91c9d,has_body
(ACADGI)S2,00340eea543336d54adda18236424de6a5e91c9d,has_body
"4-thioanisyl-2-biphenylyl-3-hydroxypropionic acid, (1:S2:R*,R*)-isomer",00340eea543336d54adda18236424de6a5e91c9d,has_body
"4-thioanisyl-2-biphenylyl-3-hydroxypropionic acid, (1:S2:R*,S*)-isomer",00340eea543336d54adda18236424de6a5e91c9d,has_body
"4-trifluoromethylphenyl-2-biphenylyl-3-hydroxypropionic acid, (1:S2:R*,R*)-isomer",00340eea543336d54adda18236424de6a5e91c9d,has_body
Date Fruit,00340eea543336d54adda18236424de6a5e91c9d,has_body
Date Palm Fruit,00340eea543336d54adda18236424de6a5e91c9d,has_body
Date Palm Trees,00340eea543336d54adda18236424de6a5e91c9d,has_body
Date Palms,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dates,00340eea543336d54adda18236424de6a5e91c9d,has_body
Absence Seizure Disorder,00340eea543336d54adda18236424de6a5e91c9d,has_body
Absence Seizures,00340eea543336d54adda18236424de6a5e91c9d,has_body
Absence Status,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Absence defect of limbs, scalp, and skull",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Absence of Brain, Congenital",00340eea543336d54adda18236424de6a5e91c9d,has_body
1-M-D-BIC-CDAA,00340eea543336d54adda18236424de6a5e91c9d,has_body
BIC,00340eea543336d54adda18236424de6a5e91c9d,has_body
BIC mustard,00340eea543336d54adda18236424de6a5e91c9d,has_body
BIC protocol,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Bic-C gprotein, Drosophila",00340eea543336d54adda18236424de6a5e91c9d,has_body
Actinopolymorpha singaporensis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Burkholderia singaporensis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Desulforhopalus singaporensis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Desulfovibrio singaporenus,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hb G-Singapore,00340eea543336d54adda18236424de6a5e91c9d,has_body
Action Research,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Administration Research, Nursing",00340eea543336d54adda18236424de6a5e91c9d,has_body
Administrative Nursing Research,00340eea543336d54adda18236424de6a5e91c9d,has_body
Adult Stem Cell Research,00340eea543336d54adda18236424de6a5e91c9d,has_body
Agency for Health Care Policy and Research,00340eea543336d54adda18236424de6a5e91c9d,has_body
3D Molecular Structure,00340eea543336d54adda18236424de6a5e91c9d,has_body
5' mRNA Cap Structure,00340eea543336d54adda18236424de6a5e91c9d,has_body
Animal Structures,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bacterial Structures,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cell Membrane Structures,00340eea543336d54adda18236424de6a5e91c9d,has_body
Legal Cases,00340eea543336d54adda18236424de6a5e91c9d,has_body
Review of Reported Cases,00340eea543336d54adda18236424de6a5e91c9d,has_body
AIDS-Related Opportunistic Infections,00340eea543336d54adda18236424de6a5e91c9d,has_body
Acinetobacter Infections,00340eea543336d54adda18236424de6a5e91c9d,has_body
Actinobacillus Infections,00340eea543336d54adda18236424de6a5e91c9d,has_body
Actinomyces Infections,00340eea543336d54adda18236424de6a5e91c9d,has_body
Actinomycetales Infections,00340eea543336d54adda18236424de6a5e91c9d,has_body
Four Corners Virus,00340eea543336d54adda18236424de6a5e91c9d,has_body
"(6Fe-6S) prismane-cluster-containing protein, Desulfovibrio vulgaris",00340eea543336d54adda18236424de6a5e91c9d,has_body
Atypical Cluster Headache,00340eea543336d54adda18236424de6a5e91c9d,has_body
Breakpoint Cluster Region Protein,00340eea543336d54adda18236424de6a5e91c9d,has_body
"CD24 antigen (small cell lung carcinoma cluster 4 antigen), human",00340eea543336d54adda18236424de6a5e91c9d,has_body
CRISPR Clusters,00340eea543336d54adda18236424de6a5e91c9d,has_body
2-(2''-DCAB)-3-(IQ),00340eea543336d54adda18236424de6a5e91c9d,has_body
2-(2-BE)NB-IQ cpd,00340eea543336d54adda18236424de6a5e91c9d,has_body
2-A-3M-IQ,00340eea543336d54adda18236424de6a5e91c9d,has_body
2-C-HP-IQ,00340eea543336d54adda18236424de6a5e91c9d,has_body
2-IQ-glucuronide,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dynamic Light Scattering,00340eea543336d54adda18236424de6a5e91c9d,has_body
Low Angle Scattering,00340eea543336d54adda18236424de6a5e91c9d,has_body
Quasi-Elastic Light Scattering (QELS),00340eea543336d54adda18236424de6a5e91c9d,has_body
Radiation Scattering,00340eea543336d54adda18236424de6a5e91c9d,has_body
Raman Scattering,00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Simulation,00340eea543336d54adda18236424de6a5e91c9d,has_body
High Fidelity Simulation Training,00340eea543336d54adda18236424de6a5e91c9d,has_body
Microgravity Simulation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Molecular Docking Simulation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Molecular Docking Simulations,00340eea543336d54adda18236424de6a5e91c9d,has_body
Conflict Resolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Moderate Resolution Imaging Spectroradiometer,00340eea543336d54adda18236424de6a5e91c9d,has_body
4-(4-(Dimethylamino)-N-methyl-L-phenylalanine)virginiamycin S1,00340eea543336d54adda18236424de6a5e91c9d,has_body
"ATPase, Actin-S1",00340eea543336d54adda18236424de6a5e91c9d,has_body
Actin S1 ATPase,00340eea543336d54adda18236424de6a5e91c9d,has_body
Aspergillus Nuclease S1,00340eea543336d54adda18236424de6a5e91c9d,has_body
CD4 S1 peptide,00340eea543336d54adda18236424de6a5e91c9d,has_body
Agent-Based Modeling,00340eea543336d54adda18236424de6a5e91c9d,has_body
Anatomic Models,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Antitumor Assays, Xenograft Model",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Autoimmune Disease Models, Nervous System",00340eea543336d54adda18236424de6a5e91c9d,has_body
Biobehavioral Model,00340eea543336d54adda18236424de6a5e91c9d,has_body
Abortion Rate,00340eea543336d54adda18236424de6a5e91c9d,has_body
Age Specific Death Rate,00340eea543336d54adda18236424de6a5e91c9d,has_body
Age-Specific Birth Rate,00340eea543336d54adda18236424de6a5e91c9d,has_body
Age-Specific Death Rate,00340eea543336d54adda18236424de6a5e91c9d,has_body
Age-Specific Fertility Rate,00340eea543336d54adda18236424de6a5e91c9d,has_body
criterion 424 catalyst,00340eea543336d54adda18236424de6a5e91c9d,has_body
Space Exploration,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Administration Routes, Drug",00340eea543336d54adda18236424de6a5e91c9d,has_body
Drug Administration Routes,00340eea543336d54adda18236424de6a5e91c9d,has_body
Transmucosal Administration Routes,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Center, University Medical",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Centers, University Medical",00340eea543336d54adda18236424de6a5e91c9d,has_body
"DNA segment, Chr 17, Wayne State University 104, expressed protein, mouse",00340eea543336d54adda18236424de6a5e91c9d,has_body
Edinburgh University solution of lime,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Health Services, University",00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus disease,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus disease testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus infection,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Agency for Health Care Policy and Research,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Analysis, Policy",00340eea543336d54adda18236424de6a5e91c9d,has_body
Antinatalist Policy,00340eea543336d54adda18236424de6a5e91c9d,has_body
Economic Policy,00340eea543336d54adda18236424de6a5e91c9d,has_body
Environmental Policy,00340eea543336d54adda18236424de6a5e91c9d,has_body
Easterlin Hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hygiene Hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Lyon Hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Agency for Healthcare Research and Quality (U.S.),00340eea543336d54adda18236424de6a5e91c9d,has_body
Air Quality,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Air Quality, Indoor",00340eea543336d54adda18236424de6a5e91c9d,has_body
Continuous Quality Management,00340eea543336d54adda18236424de6a5e91c9d,has_body
Data Quality,00340eea543336d54adda18236424de6a5e91c9d,has_body
"6,6,16-trifluorohexadecanoic acid, 18F-labeled in position 16",00340eea543336d54adda18236424de6a5e91c9d,has_body
"7,7,16-trifluorohexadecanoic acid, 18F-labeled in position 16",00340eea543336d54adda18236424de6a5e91c9d,has_body
Benign Paroxysmal Positional Vertigo,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chromosomal Position Effect,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chromosomal Position Effects,00340eea543336d54adda18236424de6a5e91c9d,has_body
Achaete-Scute Complex Genome Region,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bacterial Genome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bacterial Genomes,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chloroplast Genome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chloroplast Genome-Encoded Proteins,00340eea543336d54adda18236424de6a5e91c9d,has_body
Datasets as Topic,00340eea543336d54adda18236424de6a5e91c9d,has_body
Assessment of Health Care Needs,00340eea543336d54adda18236424de6a5e91c9d,has_body
Assessment of Healthcare Needs,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Assessment, Biomedical Technology",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Assessment, Educational",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Assessment, Geriatric",00340eea543336d54adda18236424de6a5e91c9d,has_body
Hb D Portugal,00340eea543336d54adda18236424de6a5e91c9d,has_body
Portugal,00340eea543336d54adda18236424de6a5e91c9d,has_body
hemoglobin D Portugal,00340eea543336d54adda18236424de6a5e91c9d,has_body
Caribbean Netherlands,00340eea543336d54adda18236424de6a5e91c9d,has_body
Kingdom of the Netherlands,00340eea543336d54adda18236424de6a5e91c9d,has_body
Netherlands,00340eea543336d54adda18236424de6a5e91c9d,has_body
Netherlands Antilles,00340eea543336d54adda18236424de6a5e91c9d,has_body
Netherlands East Indies,00340eea543336d54adda18236424de6a5e91c9d,has_body
Developed Countries,00340eea543336d54adda18236424de6a5e91c9d,has_body
Developing Countries,00340eea543336d54adda18236424de6a5e91c9d,has_body
Industrialized Countries,00340eea543336d54adda18236424de6a5e91c9d,has_body
Least Developed Countries,00340eea543336d54adda18236424de6a5e91c9d,has_body
Less-Developed Countries,00340eea543336d54adda18236424de6a5e91c9d,has_body
Copyright,00340eea543336d54adda18236424de6a5e91c9d,has_body
Phylogeny,00340eea543336d54adda18236424de6a5e91c9d,has_body
Wuhan coronavirus,00340eea543336d54adda18236424de6a5e91c9d,has_body
Wuhan coronavirus vaccine,00340eea543336d54adda18236424de6a5e91c9d,has_body
Wuhan seafood market pneumonia virus,00340eea543336d54adda18236424de6a5e91c9d,has_body
Age Distribution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Animal Distribution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bernoulli Distribution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Binomial Distribution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Body Fat Distribution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Alu Repetitive Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
Amino Acid Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
CRISPR Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
CRISPR Spacer Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
DNA Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
SNOMED Clinical Terms,00340eea543336d54adda18236424de6a5e91c9d,has_body
"1,17-DATAH",00340eea543336d54adda18236424de6a5e91c9d,has_body
Amino Acid Sequence Databases,00340eea543336d54adda18236424de6a5e91c9d,has_body
Automatic Data Processing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Big Data,00340eea543336d54adda18236424de6a5e91c9d,has_body
Clinical Trials Data Monitoring Committees,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Aborigines, Australian",00340eea543336d54adda18236424de6a5e91c9d,has_body
Anti-Australia Antigens,00340eea543336d54adda18236424de6a5e91c9d,has_body
Australia,00340eea543336d54adda18236424de6a5e91c9d,has_body
Australia Antigen,00340eea543336d54adda18236424de6a5e91c9d,has_body
Australian Capital Territory,00340eea543336d54adda18236424de6a5e91c9d,has_body
Human Figure,00340eea543336d54adda18236424de6a5e91c9d,has_body
Rey-Osterrieth Complex Figure,00340eea543336d54adda18236424de6a5e91c9d,has_body
Acinetobacter johnsonii,00340eea543336d54adda18236424de6a5e91c9d,has_body
Actinomyces johnsonii,00340eea543336d54adda18236424de6a5e91c9d,has_body
Borrelia johnsonii,00340eea543336d54adda18236424de6a5e91c9d,has_body
"CbsT2 protein, Lactobacillus johnsonii",00340eea543336d54adda18236424de6a5e91c9d,has_body
Cytophaga johnsonae,00340eea543336d54adda18236424de6a5e91c9d,has_body
Direction compound,00340eea543336d54adda18236424de6a5e91c9d,has_body
Directional Coronary Atherectomy,00340eea543336d54adda18236424de6a5e91c9d,has_body
"11kDa protein synthesis inhibitor, Vaccinia virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"12-kDa protein, potato virus M",00340eea543336d54adda18236424de6a5e91c9d,has_body
"126-kDa protein, Tobacco mosaic virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"12K late protein, Vaccinia virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"130k protein, Tobacco mosaic virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
Gulf of Mexico,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hb J Mexico,00340eea543336d54adda18236424de6a5e91c9d,has_body
"LPMV P protein, La Piedad Michoacan Mexico virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
Mexico,00340eea543336d54adda18236424de6a5e91c9d,has_body
Mexicor,00340eea543336d54adda18236424de6a5e91c9d,has_body
Aeromonas finlandiensis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Borrelia finlandensis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Borreliella finlandensis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Finland,00340eea543336d54adda18236424de6a5e91c9d,has_body
hemoglobin Finlandia,00340eea543336d54adda18236424de6a5e91c9d,has_body
"B-cell lineage specific activator protein, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
"BREAKING OF ASYMMETRY IN THE STOMATAL LINEAGE protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_body
"CONSERVED ONLY IN THE GREEN LINEAGE160 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_body
Casitas B-Lineage Lymphoma Protein,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Casitas B-lineage lymphoma b protein, rat",00340eea543336d54adda18236424de6a5e91c9d,has_body
Guidor USA,00340eea543336d54adda18236424de6a5e91c9d,has_body
"PRSV-P (USA) protein, Papaya ringspot virus P",00340eea543336d54adda18236424de6a5e91c9d,has_body
"PRSV-W (USA) protein, Papaya ringspot virus W",00340eea543336d54adda18236424de6a5e91c9d,has_body
(1-2)-linked N-3-hydroxypropionyl-alpha-D-perosamine,00340eea543336d54adda18236424de6a5e91c9d,has_body
"1,2-propanediol dehydrogenase (NAD-linked)",00340eea543336d54adda18236424de6a5e91c9d,has_body
"2',5'-linked triadenylic acid",00340eea543336d54adda18236424de6a5e91c9d,has_body
2'-ethylcarbonate-linked paclitaxel,00340eea543336d54adda18236424de6a5e91c9d,has_body
"2,2'-bis(2-oxazoline) linked poly(lactic acid)",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Homolog ALignment in meiosis abnormal 3 protein, C elegans",00340eea543336d54adda18236424de6a5e91c9d,has_body
Radiotherapy Target Organ Alignment,00340eea543336d54adda18236424de6a5e91c9d,has_body
Sequence Alignment,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Target Organ Alignment, Radiotherapy",00340eea543336d54adda18236424de6a5e91c9d,has_body
"centrosome alignment defect 1 protein, Drosophila",00340eea543336d54adda18236424de6a5e91c9d,has_body
Risk Evaluation and Mitigation,00340eea543336d54adda18236424de6a5e91c9d,has_body
"ABERRANT LATERAL ROOT FORMATION 5 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_body
"ALTERED ROOT ARCHITECTURE protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_body
Astragalus membranaceus root,00340eea543336d54adda18236424de6a5e91c9d,has_body
Astragalus membranaceus root extract,00340eea543336d54adda18236424de6a5e91c9d,has_body
Astragalus membranaceus root powder,00340eea543336d54adda18236424de6a5e91c9d,has_body
CA(Oxford) Antigen,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hb J-Oxford,00340eea543336d54adda18236424de6a5e91c9d,has_body
hemoglobin J Oxford,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Confounding Factors, Epidemiology",00340eea543336d54adda18236424de6a5e91c9d,has_body
Epidemiology,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Epidemiology, Molecular",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Epidemiology, Pharmaceutical",00340eea543336d54adda18236424de6a5e91c9d,has_body
Genetic Epidemiology,00340eea543336d54adda18236424de6a5e91c9d,has_body
Democratic Republic of Germany,00340eea543336d54adda18236424de6a5e91c9d,has_body
Federal Republic of Germany,00340eea543336d54adda18236424de6a5e91c9d,has_body
Germany,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Germany, Democratic Republic of",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Germany, East",00340eea543336d54adda18236424de6a5e91c9d,has_body
Age Groups,00340eea543336d54adda18236424de6a5e91c9d,has_body
Animal Population Groups,00340eea543336d54adda18236424de6a5e91c9d,has_body
Anti-Abortion Groups,00340eea543336d54adda18236424de6a5e91c9d,has_body
Anti-Vaccination Groups,00340eea543336d54adda18236424de6a5e91c9d,has_body
Anti-Vaccine Groups,00340eea543336d54adda18236424de6a5e91c9d,has_body
Ageratum yellow vein China virus,00340eea543336d54adda18236424de6a5e91c9d,has_body
China,00340eea543336d54adda18236424de6a5e91c9d,has_body
China-Sumac,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chinaberry Tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
Linmingia china,00340eea543336d54adda18236424de6a5e91c9d,has_body
"RELL1 protein, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
"RELL2 protein, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
rellidep,00340eea543336d54adda18236424de6a5e91c9d,has_body
Correlation Studies,00340eea543336d54adda18236424de6a5e91c9d,has_body
Correlation Study,00340eea543336d54adda18236424de6a5e91c9d,has_body
Correlation of Data,00340eea543336d54adda18236424de6a5e91c9d,has_body
Genotype-Phenotype Correlation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Genotype-Phenotype Correlations,00340eea543336d54adda18236424de6a5e91c9d,has_body
Guanine-Quartets,00340eea543336d54adda18236424de6a5e91c9d,has_body
Editorial,00340eea543336d54adda18236424de6a5e91c9d,has_body
Editorial Comment,00340eea543336d54adda18236424de6a5e91c9d,has_body
Editorial Policies,00340eea543336d54adda18236424de6a5e91c9d,has_body
18F-ML-10 compound,00340eea543336d54adda18236424de6a5e91c9d,has_body
18F-ML-8 compound,00340eea543336d54adda18236424de6a5e91c9d,has_body
"3-hydroxy-3,5-dihydro ML-236C",00340eea543336d54adda18236424de6a5e91c9d,has_body
3-hydroxy-ML-236B,00340eea543336d54adda18236424de6a5e91c9d,has_body
"3alpha-hydroxy-3,5-dihydro-ML-236C sodium salt",00340eea543336d54adda18236424de6a5e91c9d,has_body
3' Polyadenylation Signal,00340eea543336d54adda18236424de6a5e91c9d,has_body
"60 kDa nuclear localization signal binding protein, rat",00340eea543336d54adda18236424de6a5e91c9d,has_body
"7S RNA, signal recogniton particle",00340eea543336d54adda18236424de6a5e91c9d,has_body
"AGS1 - activator of G-protein signalind protein, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
"APC regulator of WNT signaling pathway protein, zebrafish",00340eea543336d54adda18236424de6a5e91c9d,has_body
"CG5445-RD protein, Drosophila",00340eea543336d54adda18236424de6a5e91c9d,has_body
Gelum oral-rd,00340eea543336d54adda18236424de6a5e91c9d,has_body
IgG4-RD,00340eea543336d54adda18236424de6a5e91c9d,has_body
RD 4-2025,00340eea543336d54adda18236424de6a5e91c9d,has_body
RD 4-2217,00340eea543336d54adda18236424de6a5e91c9d,has_body
Acute Respiratory Distress Syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Adult Respiratory Distress Syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Choreoathetosis, Hypothyroidism, And Neonatal Respiratory Distress",00340eea543336d54adda18236424de6a5e91c9d,has_body
Emotional Distress,00340eea543336d54adda18236424de6a5e91c9d,has_body
Fetal Distress,00340eea543336d54adda18236424de6a5e91c9d,has_body
Access to Information,00340eea543336d54adda18236424de6a5e91c9d,has_body
Ambulatory Care Information Systems,00340eea543336d54adda18236424de6a5e91c9d,has_body
Ambulatory Information Systems,00340eea543336d54adda18236424de6a5e91c9d,has_body
Ancillary Information Systems,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bio-Physical Information Therapy,00340eea543336d54adda18236424de6a5e91c9d,has_body
Age Discrimination,00340eea543336d54adda18236424de6a5e91c9d,has_body
Discrimination Learning,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Discrimination, Psychological",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Discrimination, Psychology",00340eea543336d54adda18236424de6a5e91c9d,has_body
Pitch Discrimination,00340eea543336d54adda18236424de6a5e91c9d,has_body
Behavior Observation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Behavior Observation Techniques,00340eea543336d54adda18236424de6a5e91c9d,has_body
Behavioral Observation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Behavioral Observation Techniques,00340eea543336d54adda18236424de6a5e91c9d,has_body
Clinical Observation Units,00340eea543336d54adda18236424de6a5e91c9d,has_body
Acupuncture Points,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cell Cycle Transition Points,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cell Cycle-Transition Points,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hazard Analysis Critical Control Points,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hazard Analysis and Critical Control Points,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus disease testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019-nCoV disease testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019-nCoV infection testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019-nCoV testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Body Measures,00340eea543336d54adda18236424de6a5e91c9d,has_body
Body Weights and Measures,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chemical Safety Measures,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cost Measures,00340eea543336d54adda18236424de6a5e91c9d,has_body
Measures,00340eea543336d54adda18236424de6a5e91c9d,has_body
(68Ga)Glu-urea-Lys(Ahx)-HBED-CC,00340eea543336d54adda18236424de6a5e91c9d,has_body
2-CC-F-EP cpd,00340eea543336d54adda18236424de6a5e91c9d,has_body
4-(2-CC)-2-TFBN cpd,00340eea543336d54adda18236424de6a5e91c9d,has_body
5-CC-M-P-O cpd,00340eea543336d54adda18236424de6a5e91c9d,has_body
"ALP CC chemokine protein, mouse",00340eea543336d54adda18236424de6a5e91c9d,has_body
Amino Acid Substitution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Drug Substitution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Freeze Substitution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Generic Substitution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hydroxyethyl Starch (130 KD-0.4 Substitution),00340eea543336d54adda18236424de6a5e91c9d,has_body
Anatomic Models,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Autoimmune Disease Models, Nervous System",00340eea543336d54adda18236424de6a5e91c9d,has_body
Biological Models,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chemical Models,00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Models,00340eea543336d54adda18236424de6a5e91c9d,has_body
Adolescent Nutrition Sciences,00340eea543336d54adda18236424de6a5e91c9d,has_body
Adolescent Nutritional Sciences,00340eea543336d54adda18236424de6a5e91c9d,has_body
Animal Nutrition Sciences,00340eea543336d54adda18236424de6a5e91c9d,has_body
Animal Nutritional Sciences,00340eea543336d54adda18236424de6a5e91c9d,has_body
Behavioral Sciences,00340eea543336d54adda18236424de6a5e91c9d,has_body
Forested Areas,00340eea543336d54adda18236424de6a5e91c9d,has_body
Laminar Air-Flow Areas,00340eea543336d54adda18236424de6a5e91c9d,has_body
Poverty Areas,00340eea543336d54adda18236424de6a5e91c9d,has_body
Primary Somatosensory Areas,00340eea543336d54adda18236424de6a5e91c9d,has_body
Secondary Motor Areas,00340eea543336d54adda18236424de6a5e91c9d,has_body
Family Relationships,00340eea543336d54adda18236424de6a5e91c9d,has_body
Husband-Wife Comparisons,00340eea543336d54adda18236424de6a5e91c9d,has_body
Paired Comparisons,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Cardiomyoplasty, Dynamic",00340eea543336d54adda18236424de6a5e91c9d,has_body
Dynamic Cardiomyoplasty,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dynamic Electrocardiography,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dynamic Light Scattering,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dynamic Orthoses,00340eea543336d54adda18236424de6a5e91c9d,has_body
(227)Th-DOTA-rituximab,00340eea543336d54adda18236424de6a5e91c9d,has_body
(227)Th-p-isothiocyanato-benzyl-DOTA-trastuzumab,00340eea543336d54adda18236424de6a5e91c9d,has_body
"1,3,5,6-TH-MB-X",00340eea543336d54adda18236424de6a5e91c9d,has_body
"1,3,7-TH-HMB-X",00340eea543336d54adda18236424de6a5e91c9d,has_body
"1-(2,4-D-H-L)-TH",00340eea543336d54adda18236424de6a5e91c9d,has_body
Hb Hopkins-I,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hopkinsiaxanthin,00340eea543336d54adda18236424de6a5e91c9d,has_body
Pitt Hopkins syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Pitt-Hopkins syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Pitt-Hopkins-Like Syndrome 1,00340eea543336d54adda18236424de6a5e91c9d,has_body
Sickness Presence,00340eea543336d54adda18236424de6a5e91c9d,has_body
Switzerland,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cl-diF(arrows)dAdo,00340eea543336d54adda18236424de6a5e91c9d,has_body
Anterior Cruciate Ligament Reconstruction,00340eea543336d54adda18236424de6a5e91c9d,has_body
Breast Reconstruction,00340eea543336d54adda18236424de6a5e91c9d,has_body
Image Reconstruction,00340eea543336d54adda18236424de6a5e91c9d,has_body
Mandibular Reconstruction,00340eea543336d54adda18236424de6a5e91c9d,has_body
Maxillo-Mandibular Reconstruction,00340eea543336d54adda18236424de6a5e91c9d,has_body
Reliability (Epidemiology),00340eea543336d54adda18236424de6a5e91c9d,has_body
Reliability and Validity,00340eea543336d54adda18236424de6a5e91c9d,has_body
Reliability of Results,00340eea543336d54adda18236424de6a5e91c9d,has_body
Test-Retest Reliability,00340eea543336d54adda18236424de6a5e91c9d,has_body
Action Potential Optical Mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
Anatomic Electrical Activity Optical Mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
Body Surface Mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
Body Surface Potential Mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
Brain Electrical Activity Mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
"ETS-domain lacking protein, Drosophila",00340eea543336d54adda18236424de6a5e91c9d,has_body
"LACK antigen, Leishmania",00340eea543336d54adda18236424de6a5e91c9d,has_body
Lack of Coordination,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Megalencephaly, Mega Corpus Callosum, And Complete Lack Of Motor Development",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Slp homolog lacking C2 domains b protein, humam",00340eea543336d54adda18236424de6a5e91c9d,has_body
Quantum Dots,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Reduction in Cnn dots 5 protein, Drosophila",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Xolka dots protein, Xenopus",00340eea543336d54adda18236424de6a5e91c9d,has_body
Biological Co-Evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Biological Evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chemical Evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Clonal Evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cultural Evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Licensed Practical Nurses,00340eea543336d54adda18236424de6a5e91c9d,has_body
Licensed Vocational Nurses,00340eea543336d54adda18236424de6a5e91c9d,has_body
Licenses,00340eea543336d54adda18236424de6a5e91c9d,has_body
Past Trends,00340eea543336d54adda18236424de6a5e91c9d,has_body
Trend HP,00340eea543336d54adda18236424de6a5e91c9d,has_body
Trendelenburg Position,00340eea543336d54adda18236424de6a5e91c9d,has_body
Trendinol,00340eea543336d54adda18236424de6a5e91c9d,has_body
trendione,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bacterial Genomes,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Genomes, Bacterial",00340eea543336d54adda18236424de6a5e91c9d,has_body
Plastid Genomes,00340eea543336d54adda18236424de6a5e91c9d,has_body
Antibody Diversity,00340eea543336d54adda18236424de6a5e91c9d,has_body
Antigenic Diversity,00340eea543336d54adda18236424de6a5e91c9d,has_body
Biological Diversity,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cultural Diversity,00340eea543336d54adda18236424de6a5e91c9d,has_body
Diversity Outbred Mice,00340eea543336d54adda18236424de6a5e91c9d,has_body
CBA Studies,00340eea543336d54adda18236424de6a5e91c9d,has_body
Candidate Gene Association Studies,00340eea543336d54adda18236424de6a5e91c9d,has_body
Case Control Studies,00340eea543336d54adda18236424de6a5e91c9d,has_body
Case Studies,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Case Studies, Organizational",00340eea543336d54adda18236424de6a5e91c9d,has_body
Guanine-Quartets,00340eea543336d54adda18236424de6a5e91c9d,has_body
"QUARTET 3 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_body
"QUARTET1 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_body
"ARC-mediator transcriptional coactivator subunit protein, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
Aeromonas media,00340eea543336d54adda18236424de6a5e91c9d,has_body
Anterior Median Oculomotor Nucleus,00340eea543336d54adda18236424de6a5e91c9d,has_body
Antigen-Mediated Clonal Selection,00340eea543336d54adda18236424de6a5e91c9d,has_body
Arterial Media,00340eea543336d54adda18236424de6a5e91c9d,has_body
Uncertainty,00340eea543336d54adda18236424de6a5e91c9d,has_body
Augmentative and Alternative Communications Systems,00340eea543336d54adda18236424de6a5e91c9d,has_body
Communications Media,00340eea543336d54adda18236424de6a5e91c9d,has_body
Communications Personnel,00340eea543336d54adda18236424de6a5e91c9d,has_body
Median-Ulnar Nerve Communications,00340eea543336d54adda18236424de6a5e91c9d,has_body
Satellite Communications,00340eea543336d54adda18236424de6a5e91c9d,has_body
New South Wales,00340eea543336d54adda18236424de6a5e91c9d,has_body
Wales,00340eea543336d54adda18236424de6a5e91c9d,has_body
Congenital Fibrosis Syndrome with Synergistic Divergence,00340eea543336d54adda18236424de6a5e91c9d,has_body
External Ophthalmoplegia with Synergistic Divergence,00340eea543336d54adda18236424de6a5e91c9d,has_body
"External Ophthalmoplegia, Synergistic Divergence, Jaw Winking, and Oculocutaneous Hypopigmentation",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Fibrosis of Extraocular Muscles, Congenital, with Synergistic Divergence",00340eea543336d54adda18236424de6a5e91c9d,has_body
Family Dynamics,00340eea543336d54adda18236424de6a5e91c9d,has_body
Fluid Dynamics,00340eea543336d54adda18236424de6a5e91c9d,has_body
Mitochondrial Dynamics,00340eea543336d54adda18236424de6a5e91c9d,has_body
Molecular Dynamics,00340eea543336d54adda18236424de6a5e91c9d,has_body
Molecular Dynamics Simulation,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Analysis, Regression",00340eea543336d54adda18236424de6a5e91c9d,has_body
Corpus Luteum Regression,00340eea543336d54adda18236424de6a5e91c9d,has_body
Geographically Weighted Regression,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hearing loss ankle anomalies and neurological regression-dementia,00340eea543336d54adda18236424de6a5e91c9d,has_body
Linear Regression,00340eea543336d54adda18236424de6a5e91c9d,has_body
"(Arg(14),Lys(15))NC",00340eea543336d54adda18236424de6a5e91c9d,has_body
(DAniF)3Mo2(((m-CF3)C6H5)NC(O)C6H4(O)CN((m-CF3)C6H5))Mo2(DAniF)3,00340eea543336d54adda18236424de6a5e91c9d,has_body
(DAniF)3Mo2((C6H5)NC(O)C6H4(O)CN(C6H5))Mo2(DAniF)3,00340eea543336d54adda18236424de6a5e91c9d,has_body
(NC)2Cu(I),00340eea543336d54adda18236424de6a5e91c9d,has_body
(NC)2Cu(II),00340eea543336d54adda18236424de6a5e91c9d,has_body
Resuscitation Decisions,00340eea543336d54adda18236424de6a5e91c9d,has_body
Supreme Court Decisions,00340eea543336d54adda18236424de6a5e91c9d,has_body
United States Supreme Court Decisions,00340eea543336d54adda18236424de6a5e91c9d,has_body
court decisions,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Amino Acid Metabolism, Inborn Errors",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Carbohydrate Metabolism, Inborn Errors",00340eea543336d54adda18236424de6a5e91c9d,has_body
Congenital Errors of Steroid Metabolism,00340eea543336d54adda18236424de6a5e91c9d,has_body
Diagnostic Errors,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Errors, Diagnostic",00340eea543336d54adda18236424de6a5e91c9d,has_body
Bilateral Synchronous Inferior Petrosal Sinus Sampling,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chorionic Villi Sampling,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chorionic Villus Sampling,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cord Blood Sampling,00340eea543336d54adda18236424de6a5e91c9d,has_body
Experience Sampling,00340eea543336d54adda18236424de6a5e91c9d,has_body
C10-UK-2A antibiotic,00340eea543336d54adda18236424de6a5e91c9d,has_body
C9-UK-2A antibiotic,00340eea543336d54adda18236424de6a5e91c9d,has_body
PHC-UK,00340eea543336d54adda18236424de6a5e91c9d,has_body
STX-uk,00340eea543336d54adda18236424de6a5e91c9d,has_body
UK 1,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Dentistry, Evidence-Based",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Emergency Medicine, Evidence-Based",00340eea543336d54adda18236424de6a5e91c9d,has_body
Evidence Based Health Care Management,00340eea543336d54adda18236424de6a5e91c9d,has_body
Evidence Based Healthcare Management,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Evidence Based Management, Health Care",00340eea543336d54adda18236424de6a5e91c9d,has_body
Congenital shortness of the costocoracoid ligament,00340eea543336d54adda18236424de6a5e91c9d,has_body
Congenital shortness with mild spondylorhizomelic dwarfism,00340eea543336d54adda18236424de6a5e91c9d,has_body
Glaucoma-Lens Ectopia-Microspherophakia-Stiffness-Shortness Syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Hyperostosis frontalis interna, obesity, shortness and cognitive impairment",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Mental retardation with pterygia, shortness and distinct facial appearance",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Arrow protein, Drosophila",00340eea543336d54adda18236424de6a5e91c9d,has_body
Arrowhead,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Arrowhead protein, Drosophila",00340eea543336d54adda18236424de6a5e91c9d,has_body
Arrowroot,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Arrowroot, Brazilian",00340eea543336d54adda18236424de6a5e91c9d,has_body
MNA SARS-CoV-2 S1 subunit vaccines,00340eea543336d54adda18236424de6a5e91c9d,has_body
SARS-CoV-2,00340eea543336d54adda18236424de6a5e91c9d,has_body
SARS-CoV-2 S protein,00340eea543336d54adda18236424de6a5e91c9d,has_body
SARS-CoV-2 convalescent plasma treatment,00340eea543336d54adda18236424de6a5e91c9d,has_body
SARS-CoV-2 convalescent sera treatment,00340eea543336d54adda18236424de6a5e91c9d,has_body
Effort Syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Effort-Induced Upper Extremity Deep Vein Thrombosis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Effort-Related Upper Extremity Deep Vein Thrombosis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Effortil,00340eea543336d54adda18236424de6a5e91c9d,has_body
Physical Effort,00340eea543336d54adda18236424de6a5e91c9d,has_body
Availability Equivalency,00340eea543336d54adda18236424de6a5e91c9d,has_body
Availability of Health Services,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Availability, Biologic",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Availability, Biological",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Availability, Biological Nutritional",00340eea543336d54adda18236424de6a5e91c9d,has_body
Electronic Supplementary Material,00340eea543336d54adda18236424de6a5e91c9d,has_body
Electronic Supplementary Materials,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Epilepsy, Supplementary Motor",00340eea543336d54adda18236424de6a5e91c9d,has_body
Medicare Supplementary Medical Insurance Program,00340eea543336d54adda18236424de6a5e91c9d,has_body
Supplementary Eye Field,00340eea543336d54adda18236424de6a5e91c9d,has_body
Assertive Community Treatment,00340eea543336d54adda18236424de6a5e91c9d,has_body
Biological Community,00340eea543336d54adda18236424de6a5e91c9d,has_body
Biotic Community,00340eea543336d54adda18236424de6a5e91c9d,has_body
Community,00340eea543336d54adda18236424de6a5e91c9d,has_body
Community Action,00340eea543336d54adda18236424de6a5e91c9d,has_body
4-DOI,00340eea543336d54adda18236424de6a5e91c9d,has_body
DOI cpd,00340eea543336d54adda18236424de6a5e91c9d,has_body
DOI-P,00340eea543336d54adda18236424de6a5e91c9d,has_body
DOI-aminopropane,00340eea543336d54adda18236424de6a5e91c9d,has_body
L-glutamine DOI aminotransferase,00340eea543336d54adda18236424de6a5e91c9d,has_body
Phylogenetic Biogeography,00340eea543336d54adda18236424de6a5e91c9d,has_body
Phylogenetic DNA Barcode,00340eea543336d54adda18236424de6a5e91c9d,has_body
Phylogenetic DNA Barcoding,00340eea543336d54adda18236424de6a5e91c9d,has_body
AT III Glasgow,00340eea543336d54adda18236424de6a5e91c9d,has_body
Glasgow Coma Scale,00340eea543336d54adda18236424de6a5e91c9d,has_body
Glasgow Outcome Scale,00340eea543336d54adda18236424de6a5e91c9d,has_body
Glasgow antithrombin III,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Neonatally lethal short-limb skeletal dysplasia, glasgow type",00340eea543336d54adda18236424de6a5e91c9d,has_body
111In-nuclear translocation sequence-7G3,00340eea543336d54adda18236424de6a5e91c9d,has_body
3' Flanking Sequence,00340eea543336d54adda18236424de6a5e91c9d,has_body
5' Flanking Sequence,00340eea543336d54adda18236424de6a5e91c9d,has_body
5' TOP Sequence,00340eea543336d54adda18236424de6a5e91c9d,has_body
AAUAAA RNA Sequence,00340eea543336d54adda18236424de6a5e91c9d,has_body
Autochthonous Transmission,00340eea543336d54adda18236424de6a5e91c9d,has_body
"CTF8, chromosome transmission fidelity factor 8 homolog protein, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
Communicable Disease Transmission,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dentist-Patient Transmission,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Disease Transmission, Infectious",00340eea543336d54adda18236424de6a5e91c9d,has_body
Clinical Practice Patterns,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dental Practice Patterns,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dentist's Practice Patterns,00340eea543336d54adda18236424de6a5e91c9d,has_body
Feeding Patterns,00340eea543336d54adda18236424de6a5e91c9d,has_body
Inheritance Patterns,00340eea543336d54adda18236424de6a5e91c9d,has_body
"EXCESSIVE BRANCHES1 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_body
"MORE AXILLARY BRANCHES 2 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_body
(((4-(bis(2-iodoethyl)amino)phenyl)oxy)carbonyl)glutamic acid,00340eea543336d54adda18236424de6a5e91c9d,has_body
(((amino-2-ethyl)-2-aminomethyl)-2-pyridine-6-carboxylhistidyl-gamma-(2-amino-2-deoxyglucosyl)glutamylglycylamino)-4-phenyl-1-aminoacridine,00340eea543336d54adda18236424de6a5e91c9d,has_body
"((7-methoxycoumarin-4-yl)acetyl)arginyl-prolyl-lysyl-prolyl-valyl-glutamyl-norvalyl-tryptophyl-arginyl-(2,4-dinitrophenyl)lysinamide",00340eea543336d54adda18236424de6a5e91c9d,has_body
"((S)-2-(5-(1,2-dihydro-3-methyl-1-oxobenzo(f)-quinazoline-9-yl)methyl)amino-1-oxo-2-isoindolynyl)-glutaric acid",00340eea543336d54adda18236424de6a5e91c9d,has_body
"(1'-deoxy-D-mannitol-1'-yl)-L-glutamine,1',2'-lactone",00340eea543336d54adda18236424de6a5e91c9d,has_body
Edinburgh Malformation Syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Edinburgh Postnatal Depression Scale,00340eea543336d54adda18236424de6a5e91c9d,has_body
Edinburgh University solution of lime,00340eea543336d54adda18236424de6a5e91c9d,has_body
Agency for International Development,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Educational Exchange, International",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Exchange, International Educational",00340eea543336d54adda18236424de6a5e91c9d,has_body
International Agencies,00340eea543336d54adda18236424de6a5e91c9d,has_body
International Aspects,00340eea543336d54adda18236424de6a5e91c9d,has_body
Gas-Liquid-Solid Phase Transitions,00340eea543336d54adda18236424de6a5e91c9d,has_body
Beclazone Easy Breathe,00340eea543336d54adda18236424de6a5e91c9d,has_body
Breath Holding,00340eea543336d54adda18236424de6a5e91c9d,has_body
Breath Tests,00340eea543336d54adda18236424de6a5e91c9d,has_body
Breathalyzer Tests,00340eea543336d54adda18236424de6a5e91c9d,has_body
Breathing,00340eea543336d54adda18236424de6a5e91c9d,has_body
AFLP Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Activation Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Activation Analysis, Neutron",00340eea543336d54adda18236424de6a5e91c9d,has_body
Actuarial Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Amino Acid Sequence Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Acute Physiology and Chronic Health Evaluation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Systems Evaluation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Diagnostic Self Evaluation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Disability Evaluation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Drug Evaluation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Disease Outbreaks,00340eea543336d54adda18236424de6a5e91c9d,has_body
Infectious Disease Outbreaks,00340eea543336d54adda18236424de6a5e91c9d,has_body
Outbreaks,00340eea543336d54adda18236424de6a5e91c9d,has_body
outbreaks,00340eea543336d54adda18236424de6a5e91c9d,has_body
Almond Tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
Apple Tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
Apricot Tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
Arjun Tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
Arjuna Tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
Beginning of Human Life,00340eea543336d54adda18236424de6a5e91c9d,has_body
Beginning of Life,00340eea543336d54adda18236424de6a5e91c9d,has_body
(64)Cu-bis-DOTA-hypericin,00340eea543336d54adda18236424de6a5e91c9d,has_body
"35-kDa hypertonic stress protein, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
3beta-Hsd Deficiency Congenital Adrenal Hyperplasia,00340eea543336d54adda18236424de6a5e91c9d,has_body
"5-Prime-Deiodinase Deficiency, Generalized, Causing Euthyroid Hyperthyroxinemia",00340eea543336d54adda18236424de6a5e91c9d,has_body
64Cu-bis-DOTA-hypericin,00340eea543336d54adda18236424de6a5e91c9d,has_body
All-Terrain Vehicles,00340eea543336d54adda18236424de6a5e91c9d,has_body
Armored Vehicles,00340eea543336d54adda18236424de6a5e91c9d,has_body
Halobacterium gas vehicle proteins,00340eea543336d54adda18236424de6a5e91c9d,has_body
Launch Vehicle,00340eea543336d54adda18236424de6a5e91c9d,has_body
Motor Vehicles,00340eea543336d54adda18236424de6a5e91c9d,has_body
"5-HL protein, African swine fever virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"5EL protein, African swine fever virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"9-RL protein, African swine fever virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"9GL protein, African swine fever virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"A224L protein, African swine fever virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
1-TIP-4-FEP,00340eea543336d54adda18236424de6a5e91c9d,has_body
"2,4,6-TIP",00340eea543336d54adda18236424de6a5e91c9d,has_body
"3,4-DP-TIP",00340eea543336d54adda18236424de6a5e91c9d,has_body
4-DMS-TIP cpd,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hairy nose tip,00340eea543336d54adda18236424de6a5e91c9d,has_body
Preprint,00340eea543336d54adda18236424de6a5e91c9d,has_body
Preprints,00340eea543336d54adda18236424de6a5e91c9d,has_body
Preprints as Topic,00340eea543336d54adda18236424de6a5e91c9d,has_body
Benign Cough Headache,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cough,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cough Headache,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cough Suppressants,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Neuropathy, Hereditary Sensory And Autonomic, Type I, With Cough And Gastroesophageal Reflux",00340eea543336d54adda18236424de6a5e91c9d,has_body
Distance Counseling,00340eea543336d54adda18236424de6a5e91c9d,has_body
Distance Education,00340eea543336d54adda18236424de6a5e91c9d,has_body
Distance Learning,00340eea543336d54adda18236424de6a5e91c9d,has_body
Distance Perception,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Education, Distance",00340eea543336d54adda18236424de6a5e91c9d,has_body
Knowledge of Results (Psychology),00340eea543336d54adda18236424de6a5e91c9d,has_body
"Knowledge of Results, Psychological",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Knowledge of Results, Psychology",00340eea543336d54adda18236424de6a5e91c9d,has_body
Negative Results,00340eea543336d54adda18236424de6a5e91c9d,has_body
Null Results,00340eea543336d54adda18236424de6a5e91c9d,has_body
"2S albumin, brazil nut",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Acheiropody, Brazilian type",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Achondrogenesis, Brazilian",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Arrowroot, Brazilian",00340eea543336d54adda18236424de6a5e91c9d,has_body
"BbTX-II, Bothrops brazili",00340eea543336d54adda18236424de6a5e91c9d,has_body
Amino Acid Sequence Analyses,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Analyses, Demographic",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Analyses, Dental Stress",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Analyses, Multiregional",00340eea543336d54adda18236424de6a5e91c9d,has_body
Biological Oxygen Demand Analyses,00340eea543336d54adda18236424de6a5e91c9d,has_body
News,00340eea543336d54adda18236424de6a5e91c9d,has_body
Newsletters,00340eea543336d54adda18236424de6a5e91c9d,has_body
Newspaper Article,00340eea543336d54adda18236424de6a5e91c9d,has_body
Newspapers,00340eea543336d54adda18236424de6a5e91c9d,has_body
Newspapers as Topic,00340eea543336d54adda18236424de6a5e91c9d,has_body
Africa South of the Sahara,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Africa, Southern",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Amerinds, South American",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Asia, Southeastern",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Blastomycosis, South American",00340eea543336d54adda18236424de6a5e91c9d,has_body
21-formyl sarsasapogenin,00340eea543336d54adda18236424de6a5e91c9d,has_body
"3C-like protease, SARS coronavirus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"3CL(pro) protein, SARS-CoV",00340eea543336d54adda18236424de6a5e91c9d,has_body
"3a protein, SARS-CoV",00340eea543336d54adda18236424de6a5e91c9d,has_body
"7a protein, SARS virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"14K protein, Borna disease virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"18K glycoprotein, Borna disease virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"1D protein, Foot-and-mouth disease virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus disease,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus disease testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
"differentially expressed in hematopoietic lineages protein, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
(iodoacetamido)proxyl,00340eea543336d54adda18236424de6a5e91c9d,has_body
1-palmitoyl-2-(14-proxylstearoyl)glycero-3-phospho-N-(4-azido-3-nitrophenyl)ethanolamine,00340eea543336d54adda18236424de6a5e91c9d,has_body
"1-palmitoyl-2-(14-proxylstearoyl)glycero-3-phospho-N-(4-azido-3-nitrophenyl)ethanolamine, (3)H-labeled",00340eea543336d54adda18236424de6a5e91c9d,has_body
3-(2-iodoacetamido)proxyl,00340eea543336d54adda18236424de6a5e91c9d,has_body
3-aminomethyl-proxyl,00340eea543336d54adda18236424de6a5e91c9d,has_body
Democratic People's Republic of Korea,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Hemorrhagic Fever Virus, Korean",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Hemorrhagic Fever, Korean",00340eea543336d54adda18236424de6a5e91c9d,has_body
Korea,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Korea, Democratic People's Republic of",00340eea543336d54adda18236424de6a5e91c9d,has_body
Audience Research,00340eea543336d54adda18236424de6a5e91c9d,has_body
Affective Symptoms,00340eea543336d54adda18236424de6a5e91c9d,has_body
Behavioral Symptoms,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cognitive Symptoms,00340eea543336d54adda18236424de6a5e91c9d,has_body
Depressive Symptoms,00340eea543336d54adda18236424de6a5e91c9d,has_body
Drug Reaction with Eosinophilia and Systemic Symptoms,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Administrative Claims, Healthcare",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Analysis, Claims",00340eea543336d54adda18236424de6a5e91c9d,has_body
Claims Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Claims Review,00340eea543336d54adda18236424de6a5e91c9d,has_body
Insurance Claims Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Policy Makers,00340eea543336d54adda18236424de6a5e91c9d,has_body
suchengbeisine,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hb Southern Italy,00340eea543336d54adda18236424de6a5e91c9d,has_body
Italy,00340eea543336d54adda18236424de6a5e91c9d,has_body
hemoglobin Southern Italy,00340eea543336d54adda18236424de6a5e91c9d,has_body
Calothrix marchica,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cylindrospermum marchicum,00340eea543336d54adda18236424de6a5e91c9d,has_body
"E3 ubiquitin-protein ligase MARCH11, mouse",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Fractures, March",00340eea543336d54adda18236424de6a5e91c9d,has_body
"MARCH I protein, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
COP9 Signalsome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Constitutive Photomorphogenesis 9 Signalsome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Nuclear Export Signals,00340eea543336d54adda18236424de6a5e91c9d,has_body
Nuclear Localization Signals,00340eea543336d54adda18236424de6a5e91c9d,has_body
Peroxisomal Targeting Signals,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Drug Evaluations, Preclinical",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Evaluations, Preclinical Drug",00340eea543336d54adda18236424de6a5e91c9d,has_body
Preclinical Drug Evaluations,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dataset,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dataset as Topic,00340eea543336d54adda18236424de6a5e91c9d,has_body
Datasets as Topic,00340eea543336d54adda18236424de6a5e91c9d,has_body
1-D-IE-P,00340eea543336d54adda18236424de6a5e91c9d,has_body
15-prop-PGF2alpha-IE,00340eea543336d54adda18236424de6a5e91c9d,has_body
17-IE-ADOO,00340eea543336d54adda18236424de6a5e91c9d,has_body
2-(MNPSM)IE,00340eea543336d54adda18236424de6a5e91c9d,has_body
"5,6-epoxymogroside IE",00340eea543336d54adda18236424de6a5e91c9d,has_body
Clustering,00340eea543336d54adda18236424de6a5e91c9d,has_body
Disease Clustering,00340eea543336d54adda18236424de6a5e91c9d,has_body
Space-Time Clustering,00340eea543336d54adda18236424de6a5e91c9d,has_body
Adenine Nucleotides,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cytosine Nucleotides,00340eea543336d54adda18236424de6a5e91c9d,has_body
Deoxyadenine Nucleotides,00340eea543336d54adda18236424de6a5e91c9d,has_body
Deoxycytosine Nucleotides,00340eea543336d54adda18236424de6a5e91c9d,has_body
Deoxyguanine Nucleotides,00340eea543336d54adda18236424de6a5e91c9d,has_body
Stigmatization,00340eea543336d54adda18236424de6a5e91c9d,has_body
"sidestep protein, Drosophila",00340eea543336d54adda18236424de6a5e91c9d,has_body
"12F polysaccharide, Streptococcus pneumoniae",00340eea543336d54adda18236424de6a5e91c9d,has_body
"2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase, Klebsiella pneumoniae",00340eea543336d54adda18236424de6a5e91c9d,has_body
"ATP-dependent Clp protease proteolytic subunit, Streptococcus pneumoniae",00340eea543336d54adda18236424de6a5e91c9d,has_body
"AcoK protein, Klebsiella pneumoniae",00340eea543336d54adda18236424de6a5e91c9d,has_body
"AcrR protein, Klebsiella pneumoniae",00340eea543336d54adda18236424de6a5e91c9d,has_body
Phylogeography,00340eea543336d54adda18236424de6a5e91c9d,has_body
Analytic Sample Preparation Methods,00340eea543336d54adda18236424de6a5e91c9d,has_body
Analytical Chemistry Methods,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Barrier Methods, Contraceptive",00340eea543336d54adda18236424de6a5e91c9d,has_body
Census Methods,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Communication Methods, Total",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Analysis, Bayesian",00340eea543336d54adda18236424de6a5e91c9d,has_body
Bayesian Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bayesian Approach,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bayesian Forecast,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bayesian Method,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Emphysema, Congenital, With Deafness, Penoscrotal Web, And Mental Retardation",00340eea543336d54adda18236424de6a5e91c9d,has_body
Food Web,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Glottic Web, Congenital Anterior",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Laryngeal Web, Familial",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Laryngeal web, congenital heart disease and low stature",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Economic Values, Life",00340eea543336d54adda18236424de6a5e91c9d,has_body
Laboratory Alert Values,00340eea543336d54adda18236424de6a5e91c9d,has_body
Laboratory Critical Values,00340eea543336d54adda18236424de6a5e91c9d,has_body
Life Economic Values,00340eea543336d54adda18236424de6a5e91c9d,has_body
Normal Values,00340eea543336d54adda18236424de6a5e91c9d,has_body
Practice Gaps,00340eea543336d54adda18236424de6a5e91c9d,has_body
Professional Practice Gaps,00340eea543336d54adda18236424de6a5e91c9d,has_body
"gapstatin protein, Actinobacillus",00340eea543336d54adda18236424de6a5e91c9d,has_body
ras-GAPs,00340eea543336d54adda18236424de6a5e91c9d,has_body
Caribbean Netherlands,00340eea543336d54adda18236424de6a5e91c9d,has_body
Kingdom of the Netherlands,00340eea543336d54adda18236424de6a5e91c9d,has_body
Netherlands,00340eea543336d54adda18236424de6a5e91c9d,has_body
Netherlands Antilles,00340eea543336d54adda18236424de6a5e91c9d,has_body
Netherlands East Indies,00340eea543336d54adda18236424de6a5e91c9d,has_body
"00261 long non coding RNA, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
10Sa RNA,00340eea543336d54adda18236424de6a5e91c9d,has_body
15S RNA,00340eea543336d54adda18236424de6a5e91c9d,has_body
"16S RNA pseudouridine 516 synthase, E coli",00340eea543336d54adda18236424de6a5e91c9d,has_body
16S Ribosomal RNA,00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Applications Software,00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Software,00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Software Applications,00340eea543336d54adda18236424de6a5e91c9d,has_body
Portable Software Applications,00340eea543336d54adda18236424de6a5e91c9d,has_body
Portable Software Apps,00340eea543336d54adda18236424de6a5e91c9d,has_body
(2-HB)(2-MP)A,00340eea543336d54adda18236424de6a5e91c9d,has_body
"1,3,6,-HB-MDP",00340eea543336d54adda18236424de6a5e91c9d,has_body
"1,5-HB-PMA-P",00340eea543336d54adda18236424de6a5e91c9d,has_body
1-(4-HB)-DDP,00340eea543336d54adda18236424de6a5e91c9d,has_body
1-O-(HP)-(HB)-G,00340eea543336d54adda18236424de6a5e91c9d,has_body
Plotosus,00340eea543336d54adda18236424de6a5e91c9d,has_body
Plott syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Allosteric Sites,00340eea543336d54adda18236424de6a5e91c9d,has_body
Alternative Splice Sites,00340eea543336d54adda18236424de6a5e91c9d,has_body
Antibody Binding Sites,00340eea543336d54adda18236424de6a5e91c9d,has_body
Att Attachment Sites,00340eea543336d54adda18236424de6a5e91c9d,has_body
AttB Attachment Sites,00340eea543336d54adda18236424de6a5e91c9d,has_body
Household Articles,00340eea543336d54adda18236424de6a5e91c9d,has_body
Speech disturbance - use of faulty phrasing and unrelated words,00340eea543336d54adda18236424de6a5e91c9d,has_body
Animal Population Groups,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Biologic Variability, Population",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Biological Variation, Population",00340eea543336d54adda18236424de6a5e91c9d,has_body
Continental Population Groups,00340eea543336d54adda18236424de6a5e91c9d,has_body
General Social Development and Population,00340eea543336d54adda18236424de6a5e91c9d,has_body
Amino Acid Sequencing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Assay for Transposase-Accessible Chromatin Using Sequencing,00340eea543336d54adda18236424de6a5e91c9d,has_body
ChIP Sequencing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chromatin Immuno-precipitation Sequencing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chromatin Immunoprecipitation Sequencing,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Encephalitis, Epidemic",00340eea543336d54adda18236424de6a5e91c9d,has_body
Epidemic Acute Poliomyelitis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Epidemic Encephalitis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Epidemic Hemorrhagic Fever Virus,00340eea543336d54adda18236424de6a5e91c9d,has_body
Epidemic Neurolabyrinthitis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Assisted Radiographic Image Interpretation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer-Assisted Radiographic Image Interpretation,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Data Interpretation, Statistical",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Data Interpretations, Statistical",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Image Interpretation, Computer Assisted",00340eea543336d54adda18236424de6a5e91c9d,has_body
Communicable Disease Contact Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Contact Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Fluorescent Protein Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Infectious Disease Contact Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Neuroanatomical Tract-Tracing,00340eea543336d54adda18236424de6a5e91c9d,has_body
COVID-19 pandemic,00340eea543336d54adda18236424de6a5e91c9d,has_body
"H1N1 Influenza Pandemic, 1918-1919",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Influenza Pandemic, 1918-1919",00340eea543336d54adda18236424de6a5e91c9d,has_body
Pandemics,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Spanish Flu Pandemic, 1918-1919",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Grants, Peer Review",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Organizations, Peer Review",00340eea543336d54adda18236424de6a5e91c9d,has_body
Peer Group,00340eea543336d54adda18236424de6a5e91c9d,has_body
Peer Influence,00340eea543336d54adda18236424de6a5e91c9d,has_body
Peer Pressure,00340eea543336d54adda18236424de6a5e91c9d,has_body
Likelihood Functions,00340eea543336d54adda18236424de6a5e91c9d,has_body
Maximum Likelihood Estimates,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Diversification, Hospital",00340eea543336d54adda18236424de6a5e91c9d,has_body
Hospital Diversification,00340eea543336d54adda18236424de6a5e91c9d,has_body
300IR 5-grass pollen sublingual tablet,00340eea543336d54adda18236424de6a5e91c9d,has_body
Anginol-tablets,00340eea543336d54adda18236424de6a5e91c9d,has_body
Examination Tables,00340eea543336d54adda18236424de6a5e91c9d,has_body
Kohle-Tabletten Boxo-Pharm,00340eea543336d54adda18236424de6a5e91c9d,has_body
Life Table Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
1-Isochromen-1-ones,00340eea543336d54adda18236424de6a5e91c9d,has_body
1H-2-Benzopyran-1-ones,00340eea543336d54adda18236424de6a5e91c9d,has_body
"2,3-dihydro-7H-thiazolo(3,2,a)pyrimidin-7-ones",00340eea543336d54adda18236424de6a5e91c9d,has_body
2-Phenyl-3-Hydroxy-Benzopyran-4-Ones,00340eea543336d54adda18236424de6a5e91c9d,has_body
2-Phenyl-Benzopyran-4-Ones,00340eea543336d54adda18236424de6a5e91c9d,has_body
Spearman Rank Correlation Coefficient,00340eea543336d54adda18236424de6a5e91c9d,has_body
Information Dissemination,00340eea543336d54adda18236424de6a5e91c9d,has_body
3' Untranslated Regions,00340eea543336d54adda18236424de6a5e91c9d,has_body
5' Untranslated Regions,00340eea543336d54adda18236424de6a5e91c9d,has_body
Antarctic Regions,00340eea543336d54adda18236424de6a5e91c9d,has_body
Arctic Regions,00340eea543336d54adda18236424de6a5e91c9d,has_body
Body Regions,00340eea543336d54adda18236424de6a5e91c9d,has_body
Date Palm Trees,00340eea543336d54adda18236424de6a5e91c9d,has_body
Decision Trees,00340eea543336d54adda18236424de6a5e91c9d,has_body
Sweet Gum Trees,00340eea543336d54adda18236424de6a5e91c9d,has_body
Trees,00340eea543336d54adda18236424de6a5e91c9d,has_body
Treeshrews,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus infection,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019-nCoV infection,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019-nCoV infection testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
AIDS-Related Opportunistic Infections,00340eea543336d54adda18236424de6a5e91c9d,has_body
Absidia corymbifera Infection,00340eea543336d54adda18236424de6a5e91c9d,has_body
A1120 agent,00340eea543336d54adda18236424de6a5e91c9d,has_body
A15 imaging agent,00340eea543336d54adda18236424de6a5e91c9d,has_body
AF 2 (cross-linking agent),00340eea543336d54adda18236424de6a5e91c9d,has_body
AR-1 (antiarrhythmia agent),00340eea543336d54adda18236424de6a5e91c9d,has_body
Abortifacient Agents,00340eea543336d54adda18236424de6a5e91c9d,has_body
Almond Tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
Apple Tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
Apricot Tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
Arjun Tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
Arjuna Tree,00340eea543336d54adda18236424de6a5e91c9d,has_body
Algorithms,00340eea543336d54adda18236424de6a5e91c9d,has_body
Augmented Reality,00340eea543336d54adda18236424de6a5e91c9d,has_body
Mixed Reality,00340eea543336d54adda18236424de6a5e91c9d,has_body
Reality Testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Reality Therapy,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Therapy, Reality",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Amyotrophy, Thenar, Of Carpal Origin",00340eea543336d54adda18236424de6a5e91c9d,has_body
CNS Origin Vertigo,00340eea543336d54adda18236424de6a5e91c9d,has_body
Central Nervous System Origin Vertigo,00340eea543336d54adda18236424de6a5e91c9d,has_body
Congenital Amaurosis of Retinal Origin,00340eea543336d54adda18236424de6a5e91c9d,has_body
Delirium of Mixed Origin,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Hospitals, Packaged",00340eea543336d54adda18236424de6a5e91c9d,has_body
Package Inserts,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Package Inserts, Drug",00340eea543336d54adda18236424de6a5e91c9d,has_body
Packaged Hospitals,00340eea543336d54adda18236424de6a5e91c9d,has_body
Ad5-nCoV COVID-19 vaccine,00340eea543336d54adda18236424de6a5e91c9d,has_body
COVID-19,00340eea543336d54adda18236424de6a5e91c9d,has_body
COVID-19 artificial antigen presenting cells vaccine,00340eea543336d54adda18236424de6a5e91c9d,has_body
COVID-19 convalescent plasma treatment,00340eea543336d54adda18236424de6a5e91c9d,has_body
COVID-19 convalescent serum treatment,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Analysis, Bayesian",00340eea543336d54adda18236424de6a5e91c9d,has_body
Bayesian Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bayesian Approach,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bayesian Forecast,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bayesian Method,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Emphysema, Congenital, With Deafness, Penoscrotal Web, And Mental Retardation",00340eea543336d54adda18236424de6a5e91c9d,has_body
Food Web,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Glottic Web, Congenital Anterior",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Laryngeal Web, Familial",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Laryngeal web, congenital heart disease and low stature",00340eea543336d54adda18236424de6a5e91c9d,has_body
MNA SARS-CoV-2 S1 subunit vaccines,00340eea543336d54adda18236424de6a5e91c9d,has_body
SARS-CoV-2,00340eea543336d54adda18236424de6a5e91c9d,has_body
SARS-CoV-2 S protein,00340eea543336d54adda18236424de6a5e91c9d,has_body
SARS-CoV-2 convalescent plasma treatment,00340eea543336d54adda18236424de6a5e91c9d,has_body
SARS-CoV-2 convalescent sera treatment,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus disease,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus disease testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus infection,00340eea543336d54adda18236424de6a5e91c9d,has_body
2019 novel coronavirus testing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Blood Alcohol Content,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bone Mineral Content,00340eea543336d54adda18236424de6a5e91c9d,has_body
Digestive Tract Contents,00340eea543336d54adda18236424de6a5e91c9d,has_body
G+C Content,00340eea543336d54adda18236424de6a5e91c9d,has_body
GC Content,00340eea543336d54adda18236424de6a5e91c9d,has_body
((OC-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV)),00340eea543336d54adda18236424de6a5e91c9d,has_body
"(2S,3R,6R,7R)-7- (4-hydroxy-3-methoxyphenyl)-2,6-bis(hydroxymethyl)-15,43-dimethoxy-5,8-dioxa-1(1,3),4(1,4)-dibenzenacycloundecaphane-16,3-diol",00340eea543336d54adda18236424de6a5e91c9d,has_body
"42,43,44,45,46,47,55-heptanor-41-oxohomoyessotoxin",00340eea543336d54adda18236424de6a5e91c9d,has_body
"42,43,44,45,46,47,55-heptanor-41-oxoyessotoxin",00340eea543336d54adda18236424de6a5e91c9d,has_body
43 kDA-heparin binding protein (brain),00340eea543336d54adda18236424de6a5e91c9d,has_body
Phylogeny,00340eea543336d54adda18236424de6a5e91c9d,has_body
Guanine-Quartets,00340eea543336d54adda18236424de6a5e91c9d,has_body
3D Molecular Structure,00340eea543336d54adda18236424de6a5e91c9d,has_body
5' mRNA Cap Structure,00340eea543336d54adda18236424de6a5e91c9d,has_body
Animal Structures,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bacterial Structures,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cell Membrane Structures,00340eea543336d54adda18236424de6a5e91c9d,has_body
21-formyl sarsasapogenin,00340eea543336d54adda18236424de6a5e91c9d,has_body
"3C-like protease, SARS coronavirus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"3CL(pro) protein, SARS-CoV",00340eea543336d54adda18236424de6a5e91c9d,has_body
"3a protein, SARS-CoV",00340eea543336d54adda18236424de6a5e91c9d,has_body
"7a protein, SARS virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
Handbook,00340eea543336d54adda18236424de6a5e91c9d,has_body
Handbooks,00340eea543336d54adda18236424de6a5e91c9d,has_body
Likelihood Functions,00340eea543336d54adda18236424de6a5e91c9d,has_body
Maximum Likelihood Estimates,00340eea543336d54adda18236424de6a5e91c9d,has_body
Ahumada-Del Castillo syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Argonz-Ahumada-Del Castillo syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Argonz-Del Castillo Syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chitayat Moore Del Bigio syndrome,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Chromosome 7, terminal 7p deletion (del 7p21-p22)",00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Applications Software,00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Software,00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Software Applications,00340eea543336d54adda18236424de6a5e91c9d,has_body
Portable Software Applications,00340eea543336d54adda18236424de6a5e91c9d,has_body
Portable Software Apps,00340eea543336d54adda18236424de6a5e91c9d,has_body
Action Potential Optical Mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
Anatomic Electrical Activity Optical Mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
Body Surface Mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
Body Surface Potential Mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
Brain Electrical Activity Mapping,00340eea543336d54adda18236424de6a5e91c9d,has_body
Situation Awareness,00340eea543336d54adda18236424de6a5e91c9d,has_body
Situational Awareness,00340eea543336d54adda18236424de6a5e91c9d,has_body
Situational Ethics,00340eea543336d54adda18236424de6a5e91c9d,has_body
Situational Therapy,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Syncope, Situational",00340eea543336d54adda18236424de6a5e91c9d,has_body
3-(2''-O-palmitoyl-myo-inosityl-(1''-6')-glucopyranoside)sitosterol,00340eea543336d54adda18236424de6a5e91c9d,has_body
3-O-(4'-hydroxybenzyl)-beta-sitosterol,00340eea543336d54adda18236424de6a5e91c9d,has_body
3-O-(4-feruloyl)sitostanol,00340eea543336d54adda18236424de6a5e91c9d,has_body
3-O-HOBz-sitosterol,00340eea543336d54adda18236424de6a5e91c9d,has_body
3beta-sitosterol,00340eea543336d54adda18236424de6a5e91c9d,has_body
Easterlin Hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Hygiene Hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Lyon Hypothesis,00340eea543336d54adda18236424de6a5e91c9d,has_body
(C(2)H(10)N(2))(5)(NH(4))(4)H(2)(Se(2)W(10)V(8)O(62)).9H(2)O,00340eea543336d54adda18236424de6a5e91c9d,has_body
1400 W,00340eea543336d54adda18236424de6a5e91c9d,has_body
2N(w)OHC2-Arg,00340eea543336d54adda18236424de6a5e91c9d,has_body
31-homorifamycin W,00340eea543336d54adda18236424de6a5e91c9d,has_body
3744 W,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Homolog ALignment in meiosis abnormal 3 protein, C elegans",00340eea543336d54adda18236424de6a5e91c9d,has_body
Radiotherapy Target Organ Alignment,00340eea543336d54adda18236424de6a5e91c9d,has_body
Sequence Alignment,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Target Organ Alignment, Radiotherapy",00340eea543336d54adda18236424de6a5e91c9d,has_body
"centrosome alignment defect 1 protein, Drosophila",00340eea543336d54adda18236424de6a5e91c9d,has_body
Biological Co-Evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Biological Evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chemical Evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Clonal Evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
Cultural Evolution,00340eea543336d54adda18236424de6a5e91c9d,has_body
(1-6)-beta-D-glucan-protein complex,00340eea543336d54adda18236424de6a5e91c9d,has_body
(125I)IPOS protein,00340eea543336d54adda18236424de6a5e91c9d,has_body
(2Fe-2S) protein I,00340eea543336d54adda18236424de6a5e91c9d,has_body
"(3H-MeSO2)2TCB-binding protein, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
"(6-4) photolyase protein, Xenopus",00340eea543336d54adda18236424de6a5e91c9d,has_body
Alu Repetitive Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
Amino Acid Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
CRISPR Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
CRISPR Spacer Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
DNA Sequences,00340eea543336d54adda18236424de6a5e91c9d,has_body
Husband-Wife Comparisons,00340eea543336d54adda18236424de6a5e91c9d,has_body
Paired Comparisons,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Della protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_body
Agitated Emergence,00340eea543336d54adda18236424de6a5e91c9d,has_body
Anesthesia Emergence Delirium,00340eea543336d54adda18236424de6a5e91c9d,has_body
Delayed Emergence from Anesthesia,00340eea543336d54adda18236424de6a5e91c9d,has_body
Emergence Agitation,00340eea543336d54adda18236424de6a5e91c9d,has_body
Emergence Delirium,00340eea543336d54adda18236424de6a5e91c9d,has_body
Chloroplasts,00340eea543336d54adda18236424de6a5e91c9d,has_body
2-(2''-DCAB)-3-(IQ),00340eea543336d54adda18236424de6a5e91c9d,has_body
2-(2-BE)NB-IQ cpd,00340eea543336d54adda18236424de6a5e91c9d,has_body
2-A-3M-IQ,00340eea543336d54adda18236424de6a5e91c9d,has_body
2-C-HP-IQ,00340eea543336d54adda18236424de6a5e91c9d,has_body
2-IQ-glucuronide,00340eea543336d54adda18236424de6a5e91c9d,has_body
Abuse of Health Services,00340eea543336d54adda18236424de6a5e91c9d,has_body
Acceptability of Health Care,00340eea543336d54adda18236424de6a5e91c9d,has_body
Acceptability of Healthcare,00340eea543336d54adda18236424de6a5e91c9d,has_body
Acceptors of Health Care,00340eea543336d54adda18236424de6a5e91c9d,has_body
Access to Health Care,00340eea543336d54adda18236424de6a5e91c9d,has_body
AFLP Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Activation Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Activation Analysis, Neutron",00340eea543336d54adda18236424de6a5e91c9d,has_body
Actuarial Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Amino Acid Sequence Analysis,00340eea543336d54adda18236424de6a5e91c9d,has_body
Aquatic Biology,00340eea543336d54adda18236424de6a5e91c9d,has_body
Biology,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Biology, Computational",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Biology, Developmental",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Biology, Marine",00340eea543336d54adda18236424de6a5e91c9d,has_body
Cell Tracking,00340eea543336d54adda18236424de6a5e91c9d,has_body
"GPT (growing plus-end tracking) 1 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_body
"GPT (growing plus-end tracking) 2 protein, Arabidopsis",00340eea543336d54adda18236424de6a5e91c9d,has_body
Patient Tracking,00340eea543336d54adda18236424de6a5e91c9d,has_body
Single Molecule Tracking,00340eea543336d54adda18236424de6a5e91c9d,has_body
"1,17-DATAH",00340eea543336d54adda18236424de6a5e91c9d,has_body
Amino Acid Sequence Databases,00340eea543336d54adda18236424de6a5e91c9d,has_body
Automatic Data Processing,00340eea543336d54adda18236424de6a5e91c9d,has_body
Big Data,00340eea543336d54adda18236424de6a5e91c9d,has_body
Clinical Trials Data Monitoring Committees,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Applications, Medical Informatics",00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Applications Software,00340eea543336d54adda18236424de6a5e91c9d,has_body
Computer Software Applications,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Informatics Applications, Medical",00340eea543336d54adda18236424de6a5e91c9d,has_body
Investigational New Drug Applications,00340eea543336d54adda18236424de6a5e91c9d,has_body
(PATH)ZnOH,00340eea543336d54adda18236424de6a5e91c9d,has_body
1-epi-pathylactone A,00340eea543336d54adda18236424de6a5e91c9d,has_body
"APC regulator of WNT signaling pathway protein, zebrafish",00340eea543336d54adda18236424de6a5e91c9d,has_body
Accessory Atrioventricular Pathway,00340eea543336d54adda18236424de6a5e91c9d,has_body
Accessory Atrioventricular Pathways,00340eea543336d54adda18236424de6a5e91c9d,has_body
Abuse Reporting,00340eea543336d54adda18236424de6a5e91c9d,has_body
Adverse Drug Reaction Reporting Systems,00340eea543336d54adda18236424de6a5e91c9d,has_body
Age Reporting,00340eea543336d54adda18236424de6a5e91c9d,has_body
Annual Report,00340eea543336d54adda18236424de6a5e91c9d,has_body
Annual Reports as Topic,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Ataxia, Fatal X-Linked, with Deafness and Loss of Vision",00340eea543336d54adda18236424de6a5e91c9d,has_body
Binocular Vision,00340eea543336d54adda18236424de6a5e91c9d,has_body
"CUG-binding protein and embryonic lethal abnormal vision-type RNA-binding protein 3-like factor 6, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
Color Vision,00340eea543336d54adda18236424de6a5e91c9d,has_body
Color Vision Defects,00340eea543336d54adda18236424de6a5e91c9d,has_body
Phylogenetic Biogeography,00340eea543336d54adda18236424de6a5e91c9d,has_body
Phylogenetic DNA Barcode,00340eea543336d54adda18236424de6a5e91c9d,has_body
Phylogenetic DNA Barcoding,00340eea543336d54adda18236424de6a5e91c9d,has_body
Autoimmune Lymphoproliferative Disease without Fas Mutations,00340eea543336d54adda18236424de6a5e91c9d,has_body
Autoimmune lymphoproliferative syndrome without FAS mutations,00340eea543336d54adda18236424de6a5e91c9d,has_body
"Encephalopathy, Neonatal Severe, Due To Mecp2 Mutations",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Lipodystrophy, Familial Partial, Associated With PPARg Mutations",00340eea543336d54adda18236424de6a5e91c9d,has_body
"Mutations, Silent",00340eea543336d54adda18236424de6a5e91c9d,has_body
"(((1,2-5,6-di-O,O-isopropylideneglucofuranos-3-yl)oxocarbonyl)methyl)cobalt tricarbonyl triphenylphosphine",00340eea543336d54adda18236424de6a5e91c9d,has_body
"((2RS)-2-(4-(4-chlorophenoxy)-alpha,alpha,alpha-trifluoro-o-tolyl)-1-(1H-1,2,4-triazol-1-yl)propan-2-ol",00340eea543336d54adda18236424de6a5e91c9d,has_body
"((2S)-3-cyclohexyl-2-O-1-O-((1R,2R)2-O-(alpha-fucopyranosyl)cyclohexyl)-beta-galactopyrano-3-yl-2-methyl)propanoate",00340eea543336d54adda18236424de6a5e91c9d,has_body
"((3)H)-1-((S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl)-4-(o-tolyl)-piperazine",00340eea543336d54adda18236424de6a5e91c9d,has_body
((9S)-drummondol-9-O-beta-D-glucopyranoside),00340eea543336d54adda18236424de6a5e91c9d,has_body
Clostridium maximum,00340eea543336d54adda18236424de6a5e91c9d,has_body
Maximum Allowable Concentration,00340eea543336d54adda18236424de6a5e91c9d,has_body
Maximum Expiratory Pressure,00340eea543336d54adda18236424de6a5e91c9d,has_body
Maximum Inspiratory Pressure,00340eea543336d54adda18236424de6a5e91c9d,has_body
Maximum Likelihood Estimates,00340eea543336d54adda18236424de6a5e91c9d,has_body
Approach Behavior,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bayesian Approach,00340eea543336d54adda18236424de6a5e91c9d,has_body
Biobehavioral Approach,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dietary Approaches To Stop Hypertension,00340eea543336d54adda18236424de6a5e91c9d,has_body
Dietary Approaches To Stop Hypertension Diet,00340eea543336d54adda18236424de6a5e91c9d,has_body
111In-nuclear translocation sequence-7G3,00340eea543336d54adda18236424de6a5e91c9d,has_body
3' Flanking Sequence,00340eea543336d54adda18236424de6a5e91c9d,has_body
5' Flanking Sequence,00340eea543336d54adda18236424de6a5e91c9d,has_body
5' TOP Sequence,00340eea543336d54adda18236424de6a5e91c9d,has_body
AAUAAA RNA Sequence,00340eea543336d54adda18236424de6a5e91c9d,has_body
"ACS1 protein, Haemophilus influenzae",00340eea543336d54adda18236424de6a5e91c9d,has_body
Avian Influenza,00340eea543336d54adda18236424de6a5e91c9d,has_body
"BM2 polypeptide, influenza B virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"BNP protein, influenza B virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
"CM2 protein, Influenza C virus",00340eea543336d54adda18236424de6a5e91c9d,has_body
Blood-Borne Pathogens,00340eea543336d54adda18236424de6a5e91c9d,has_body
Bloodborne Pathogens,00340eea543336d54adda18236424de6a5e91c9d,has_body
Extraintestinal Pathogenic E. coli,00340eea543336d54adda18236424de6a5e91c9d,has_body
Extraintestinal Pathogenic Escherichia coli,00340eea543336d54adda18236424de6a5e91c9d,has_body
"GLI pathogenesis-related 1 (glioma) protein, human",00340eea543336d54adda18236424de6a5e91c9d,has_body
Date Palm Trees,00340eea543336d54adda18236424de6a5e91c9d,has_body
Decision Trees,00340eea543336d54adda18236424de6a5e91c9d,has_body
Sweet Gum Trees,00340eea543336d54adda18236424de6a5e91c9d,has_body
Trees,00340eea543336d54adda18236424de6a5e91c9d,has_body
Treeshrews,00340eea543336d54adda18236424de6a5e91c9d,has_body
One Health Initiative,00340eea543336d54adda18236424de6a5e91c9d,has_body
One Medicine Initiative,00340eea543336d54adda18236424de6a5e91c9d,has_body
